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“Theory is when we know all there is to know about something but 
nothing works. Practice is when everything works, but nobody can tell 
why and how. But, here, today, we combine theory and practice: 
nothing works and nobody can tell why.”
Albert Einstein
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CHAPTER 1
INTRODUCTION
1.1 BIOMATERIALS
The field of biomaterials encompass distinct disciplines including life sciences, medicine, materials 
science and engineering. This dates from egyptian history, where gold-filled teeth and glass eyes 
were commonly used. Although the necessity  of replacing tissue and organs is quite old and known, 
new development of well-defined and effective biomaterials is needed to ensure that the appropriate 
parameters are being addressed. The most popular definition of biomaterial, proposed in 1983 
during the Consensus Development Conference on Clinical Application of Biomaterial, describes 
these as “any material (other than a drug) or combination of material, synthetic or natural in origin, 
which can be used for any period of time, as a whole or as a part of a system which treats, 
augments, or replaces any tissue, organ, or function of the body”.1 Although this definition paved 
the way for the development of many interesting biomaterials, making quite clear the concept of 
biocompatibility, it  did not include any reference about the interactions between biomaterial and 
living organism. Indeed, researchers in the field of biomaterials are aware of the potential benefits 
that can be obtained by fully  understanding all events that occur at the biological environment/
material interface (Figure 1.1 A). 
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Figure 1.1 A Illustration of interactions at interface between biological environment and a 
biomaterial: adsorbed proteins can undergo conformational changes that lead to loss of 
biological functions and consequently inflammation.
Hence the definition of biomaterial was extended during the Consensus Conference on Biomaterials 
in 1991, in which they was defined as “ materials designed to interface with biological system to 
evaluate, support or replace any tissue, organ or body function”.2 This definition fits very well with 
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1 Galletti, P., M.; Beretos, J., W., J. Biomed. Mater. Res., 1983, 17, 539-555.
2 2nd Consensus Conference on Biomaterials, J. Mater. Sci., 1991, 2 (1), 62.
the modern research because provide a basic principle to synthesize new and better biomaterials, 
able to favorably  interact with cells and a whole tissue. This is mostly  due to the necessity of 
producing materials able to evoke either minimal host response, according to the most  common 
definition of biocompatibility,3 or specific biological response of tissues, depending on the purpose. 
For instance, all devices for blood preservation, e.g. filters, pocket and tubes for emodialysis, 
should be designed to minimize the coagulation; whereas, bone implants should be projected to 
appropriately interact with the surrounding tissue to allow and help  tissue regeneration and 
eventually the integration of the biomaterial. Overall, in order to successfully produce biomaterials, 
they  should perform several expectations: biocompatibility, proper physical characteristics (in terms 
of hydrophobicity, hydrophilicity, mechanical properties, stability, biodegradability, etc) and 
appropriate biological activity (tailored interactions at biological environment/material interface).4
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Figure 1.1 C. Illustration of the factors that must be integrated to achieve successful biomaterials for tissue regeneration.
(Image from reference 5).
Figure 1.1 C depicts all these factors in the case of tissue engineering, even if it can be almost 
considered for all biomedical applications, suggesting that biological and medical criteria should 
fully meet physico-chemical properties of the material. 
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terials, Elsevier Sci., Amsterdam, 1988.
4 Lloyd, A., W., Med. Device Technol., 2002, 13, 18-22.
5 Seal, B., L.; Otero, T., C.; Panitch, A.,Materials Sci. Eng. Rev., 2001, 34, 147-230.
Today a large number of biomaterials have been introduced in medical practice, such as bone inset, 
ligaments grafts, vascular grafts, heart  valves, intraocular lenses, dental implants, pacemakers, 
biosensors, plates implant, joint replacement, drug and gene delivery systems, etc (Figure 1.1 B).  
Ligament
Artificial heart
Coronary stent
Heart valves
Intraocular lense
Bone implantSkin
Breast implant
Dental implant
Drug delivery system
Figure 1.1 B. Some example of biomedical applications of biomaterials in human body.
Biomaterials can be classified on the basis of their medical applications, biological interactions with 
living organism or physico-chemical properties.6 7 According with their chemical nature, they can 
be classified in: ceramics, metals, polymers and composites.8 For now ceramic biomaterials consist 
of alumina, zirconia, bioglass, carbon and hydroxyapatite, which are useful for producing 
orthopedic and dental implants. 
They  are highly  bioinert  materials and are endowed with good mechanical properties that make 
them suitable for hard tissue substitution. 
Metals biomaterials are usually  made of iron (Fe), chromium (Cr), cobalt (Co), nickel (Ni), titanium 
(Ti), tantalum (Ta), niobium (Nb), molybdenum (Mo), gold (Au), tungsten (W) and their alloys. 
Having outstanding mechanical, electrical and thermal properties, metals have been extensively 
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7 Ratner, B., D.; Hoffman, A., S.; Choen, F., J.; Lemon, J., E., Biomaterials Sci., 2nd ed.: An introduction to materials in medicine, Elsevier Acade-
mic Press, New York, 2004.
8 Black, J.; Hasting, G., W., Handbook of Biomaterials Properties, Chapman and Hall, London, UK, 1998.
used as biomaterials for cardiovascular, dental and orthopedic applications; especially as 
pacemakers, coronary  stent, heart valves and dental prosthesis. In spite of this they do not  fulfill 
biocompatibility requirements due to corrosion and ions release phenomena.9
Polymeric biomaterials are the most  versatile class of material and show very heterogeneous 
properties in function of the polymeric architecture employed, thus they have been used in a wide 
range of biomedical applications. They are largely  biocompatible if compared with metals and can 
be designed in order to degrade after the therapeutic effect is accomplished.  Along the latter line 
biodegradable polymeric material can be used as temporary prostheses, three-dimensional porous 
scaffolds for tissue engineering applications and as drug/gene and protein delivery systems 
(DDS).10 Polymeric biomaterials have several important uses in addition to tissue reconstruction 
and DDS. Examples include poly(methyl methacrylate) bone cement, poly(glycolic acid) 
degradable sutures, poly(glycolic-co-lactic acid) bone screws and poly(vinyl siloxaene) dental 
impression materials.11  Polymers such as poly(ethylene glycol), are currently used to extend the 
bioavailability of some drugs and proteins. Poly(hydroxyethyl methacrylate) is used to produce soft 
contact lenses and silicon rubber is basically the main material to make implantable drug delivery 
devices. Poly(urethane), poly(tetrafluoroethylene), poly(methylmetacrylate), poly
(ethyleneterephtalate), poly(lactic acid) and poly(glycolic-co-lactic acid) are other examples of 
polymeric material usefull as implants or scaffolds for tissue regeneration. Finally, dextran and poly
(hydroxyethylaspartamide) are few examples of plasma expander.12 13  Generally, polymers can be 
easly  designed and prepared in order to specifically tune their chemical, physical and biological 
properties, leading us to foresee their behavior in the biological environment, and then to fit the 
requests for specific applications.
Composite biomaterials are combinations of two or more materials (e.g., polymers-ceramics, 
metals-ceramics, or other combinations of materials), that if properly  designed may show peculiar 
chemical and physical properties which cannot be achieved by using a single material. For instance, 
more stable and hard materials can be made by combining nano/micro-fibers with polymeric 
matrices.
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Small, 2009, 5 (9), 996-1006.
10 Mallapragda, K.; Narasimha, B.; Handbook of Biodegradable Polymeric Materials, American Scientific Publishers, Stevenson Ranch, Califor-
nia, 2006.
11 Seal, B., L.; Otero, T., C.; Panitch, A.,Materials Sci. Eng. Rev., 2001, 34, 147-230.
12 Jorgensen, P., S.; Rasmussen, S., W.; Rornoim, C., Clin. Appl. Thromb. Hemost., 1997, 3, 267-269.
13 Neri, P.; Antoni, G.; Benvenuti, F.; Cocola, F.; Gazzei, G., J. Medicinal Chem., 1973, 16, 893-897.
1.1.1 DRUG DELIVERY SYSTEMS
Today, pharmacotherapy is mostly based upon the administration of very  known low-molecular-
weight drugs, which therapeutic effect arises from their quasi-specific binding with receptors. Very 
few pharmaceuticals exhibit unique specificity  for their pharmacological target, and the 
pharmacokinetic-pharmacodynamic profile is often suboptimal. For instance, although β2-agonists 
prevailingly interact  with β2 receptors they can bind the others β-adrenergic receptors affording 
undesired side effects. In addition it can be unaware of others synergic interactions, that cause 
iatrogenic effects. So, improving the therapeutic index of drugs is a main goal in many therapeutic 
areas, in which iatrogenic and side effects are very considerable, such as cancer, inflammatory, 
infective and heart diseases. Two distinct approaches can be taken in the quest for improvement 
(Figure 1.1.1 A). 
i.New and more specific drug design.
ii.Research of new and more specific targets
Improving of pharmacokinetic-pharmacodynamic 
profile of known drugs by designing DDS
Improvement of therapeutic index
Figure 1.1.1 A. Schematic representation of new pharmacological approaches.
First the search for unique pharmacological cell targets and new drug design.14 Along this line, in 
the face of the progresses obtained though genomics,   target-oriented drugs and target-oriented 
macromolecular therapeutics have been developed, including antibody,15  proteins, peptides and 
oligonucleotides16 (siRNA). Unfortunately, results have shown that, overall, the clinical benefit has 
been much more modest than was predicted by theory.17  The alternative to new drug design is the 
development of a drug delivery system (DDS) able to address a known drug to its site of action 
(targeting) and/or to control the release to ensure that an optimal concentration of drug is 
maintained at the therapeutic target over a desired time frame. Among these requests, the control of 
the drug release and consequently  their bioavailability is achievable and represents already reality 
today. Sustained, prolonged, protracted, extended and retarded release can be indeed obtained by 
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15 Nelson, A., L.; Dhimolea, E.; Reichert, J., M., Nat. Rev. Drug Discovery, 2010, 9, 767-774.
16 Tiemann, K.; Rossi, J., J., EMBO Mol. Med., 2009, 1 (3), 142-151.
17 Jarvis, L., M.; Chem. Eng. News, 2010, 88 (28) p28.
using different technologies, which differ from the conventional one in a fundamental aspect 
(Figure 1.1.1 B). For the conventional systems, namely compresses, solutions, capsules, etc., drug is 
rapidly released once the site of absorption is reached and, after absorption, it can go to the site of 
action to get eliminated. Since in this systems the velocity of release is greater than the velocity of 
absorption (Kr >>> Ka) the process is limited by the letter parameter and strongly  depends on the 
way of administration. Generally drugs diffuse rapidly  into healthy tissue and are distributed evenly 
within the body, reaching small amount of the drug at  the site of action for few time. In contrast, 
prolonged release systems show the inverse behavior (Kr <<<Ka) and hence the amount of drug in 
blood can essentially be modulated by controlling the value of the Kr. 
Figure 1.1.1 B. Illustration of biopharmaceutics mechanisms and pharmacokinetics after 
administration of a delivery system: the drug is released, absorbed across biological membranes, 
and eliminated following complexes equilibria.
In order to maintain a sufficient and constant plasmatic concentration of drug, the velocity of 
release should fulfill some necessities, i.e (i) to equal the velocity of bioelimination of drug and (ii) 
to be constant (kinetic of zero order). Different early micro- and macro-technologies make full use 
of this strategy to guarantee a better performance of several drugs, including silicon-based 
implantable device , osmotically controlled oral drug delivery technology (OROS), biodegradable 
polymeric implants and microparticles.18 19  They were useful for sustaining the release of orally 
administered low-molecular-weight drugs and to improve the bioavailability of drugs/peptides 
administered by the nasal, transdermal and pulmonary routes.20 
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20 Duncan, R.; Gaspar, R., Mol. Pharmaceutics, 2011, 8, 2101-2141.
On the other hand, although drug targeting was object of several studies, except for rare cases, it has 
not been yet achieved.20 A number of nano-sized delivery systems are under investigation to 
circumvent this issue, whose drug is physically or chemically bound into the polymeric system, 
encompassing liposomes, nanocapsules, nanoparticles, DNA-drug complexes, non-covalent 
polymeric nanocarriers and macromolecular pro-drugs (i.e., polymer-drug conjugates and protein-
drug conjugates).21 22 23 2425 The concept of targeting, that points out the cell-specific drug release, 
was kicked off by Ringsdorf.26 In Ringsdorf’s model (Figure 1.1.1 C) the drug is bound to a 
macromolecule by means of a spacer molecule, which should bear specific cleavage point to 
provide release of the drug at the site of action by appropriate stimuli (changing of pH, specific 
enzymatic reaction, etc.). 
Figure 1.1.1 C. Schematic representation of Ringsdorf’s model.
The drug-polymer conjugate must also contain targeting molecules, e.g. sugar or antibody moieties, 
which guarantee the cell-specific delivery  of the drug by interacting with their antigen or receptor. 
Finally, in the case of poorly soluble polymers, a solubilizing moiety can be conjugate to the 
polymer backbone to taylor the bioavailability of the drug-polymer conjugate. The design of 
effective macromolecular pro-drugs should fulfill many  requests. Obviously, the chosen 
macromolecule should ideally  be water soluble, nontoxic, and non immunogenic, as well as 
degraded and/or eliminated from the organism.27 28  From the polymer chemistry standpoint, the 
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21  Haag, R.; Kratz, F., Angew. Chem. Int. Ed., 2006, 45, 1198-1215.
22 Cornu, G.; Michaux, J., L.; Sokal, G.; Trouet, A., Eur. J. Cancer, 1974, 10, 695-700.
23 Speiser, P., P.; Front. Biol., 1979, 48, 653-668.
24 Couvreur, P.; Tulkens, P.; Roland, M.; Trouet, A.; Speiser, P., FEBS, Lett., 1977, 84 (2), 323-326.
25 Moreno-Aspitia, A.; Perez, E., A., Fut. Oncol., 2005, 1 (6), 755-762.
26 Ringsdorf, H., J. Polym. Sci. Polym. Symp., 1975, 51, 135-153.
27 Haag, R.; Kratz, F., Angew. Chem. Int. Ed., 2006, 45, 1198-1215. 
28 Godwin, A.; Bolina, K.; Clochard, M.; Dinand, E.; Rankin, S.; Simic, S.; Brocchim, S., 2001, 53, 1175-1184.
macromolecule should carry functional groups that are liable to react with the respective moieties. 
N-(2-hydroxypropyl)methacrylamides (HPMA)s copolymers were intensively  studied according 
with this model, and some of these were transferred into clinical trials for cancer therapy. 29  30 31 
Unfortunately most of these have shown not enough efficacy and unclear results. However HPMAs 
copolymers provided the thrust for the synthesis of other promising polyvalent ad well-defined 
polymers with both structural and architectural variations, such as monofunctional linear, 
polyfunctional linear and dendritic polymers, that have paved the way  for designing tailor-made 
supramolecolar complexes which are able to vehicle many  drug and/or bioactive macromolecules. 
These include (i) nanoparticles, nanocapsules and interpolyelectrolytic complexes (IPEC) (ii) 
nanogels (iii) drug-loaded polymeric micelles with core-shell architectures and (iv) polymer as drug 
(e.g, PAMAM) (Figure 1.1.1 D).32 33 34 35 
Figure 1.1.1 D. Main classes of nano-sized DDS for cell-specific drug release. The inset gives an idea of the type of 
system that ca be used to vehicle a drug in a specific body district (targeting).
These DDS apart from some structural variation fit the requirements of Ringsdorf’s model above 
listed, since they are endowed with targeting moiety (EPR effect36 due to the nano-sized dimension 
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Fraier, D.; Frigerio, E.; Cassidy, J., Clin. Cancer, Res., 1999, 5, 83-94. 
30 Nowotnik, D., P.; Cvitkovic, Adv. Drug Deliv. Rev., 2009, 61 (13), 1214-1219.
31 National Characterisation Laboratory. 2005, http://ncl.cancer.gov/ncl_business_plan.pdf
32 Couvreur, P.; Tulkens, P.; Roland, M.; Trouet, A.; Speiser, P., FEBS, Lett., 1977, 84 (2), 323-326. 
33 Ringsdorf, H., J. Polym. Sci. Polym. Symp., 1975, 51, 135-153. 
34 Hurwitz, E.; Levy, R.; Maron, R.; Wilchek, M.; Arnon, R.; Sela, M., Cancer Res., 1975, 35, 1175-1181.
35 Slepnev, V., I.; Kuzneskova, L., E.; Gubin, A., N.; Batrakova, E., V.; Alakhov, V.; Kabanov, A., V.; Biochem. Int., 1992, 26, 587-595.
36 Matsumura, Y.; Maeda, H., Cancer Res., 1986, 6, 6387-6392.
or receptor-mediated targeting37 ) and stimulus-triggered drug release ability. The most interesting 
systems should combine both enhanced site specificity towards diseased organ, cell, intracellular 
compartment (e.g., nucleus) and local controlled release of the drug. To date this is the main goal of 
“nanomedicinists”. 
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1.1.2 HETERO-DIFUNCTIONAL POLYMERS AND THEIR APPLICATIONS
Hetero-difunctional polymers (HDPs) are a class of polymers bearing two different functional 
groups at theirs chain ends  and, if properly synthesized, are able to selectively  react with capping 
agents which provide specific biological properties (Figure 1.1.2 A). Because their chemical 
versatility, the design of degradable and bioactive HDPs has been received increasing attention for 
the synthesis of high-performance biomaterials for biotechlogical applications, such as for instance 
drug conjugates, liposomes,  surface modification and protein modification (Figure 1.1.2 A). 
Protein modification
Copolymerization
Surface modification
= targeting agent
Macromolecular pro-drug 
Conjugation
Amphiphiles Liposome
= drug
= protein
= surface
= Lipophilic polymer
= Functions available for
further reactions
in
tar eti g agent
s
lipop lymer
functi  availa le
for furth r reactions
Figure 1.1.2 A. Representation of how HDPs can be used for obtaining protein-conjugate, block-copolymers, surface-
modified device, and hetero-diterminated poymers.
For example, hetero-difunctional PEGs have been successful as spacers between two distinct 
chemical entities and as surface and protein modification agents in drug delivery  systems.38 39 40 41 
In such systems the chains of linear PEG are highly flexible and their hydrophilicity improves the 
solubility of compounds upon conjugation and so ensure good solubility under physiological 
conditions. In order to manufacture PEG-modified surfaces and proteins, several types of hetero-
difunctional PEG are used. Indeed, because PEG chains possessing a functional group at only one 
end are not suitable for subsequent derivatization/modification, which is frequently crucial for the 
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design of biomaterials or for biomedical applications, and homo-difunctional PEGs can lead to 
undesired cross-linking molecules, hetero-difunctional PEG is required. Although there are several 
commercially available hetero-difunctional PEG derivatives, they have a relatively high costs. 
Moreover, the synthetic pathway used for their synthesis can be considered hazardous, due to the 
high toxicity and  explosiveness of the reagents.42 43 In the light of this, PEGylation is so far to be 
eligible for the synthesis of new generation of biomaterials that should be made considering several 
aspects: biodegradability, ecocompatibility of reagents, safety of the industrial processes, etc. 
Mostly, the synthesis of other biodegradable HDPs might be interesting. 
Synthetic approaches
In principle, the basic methodology for the synthesis of HDPs obtained by step-polymerization is 
based upon the condensation or addition reaction of A-A and B-B monomer systems, involving the 
reaction between the A and B functions until the maximum conversion (Scheme 1.1.2 B). 
Scheme 1.1.2 B. Products of polycondensation or polyaddition of A-A/B-B systems in stoichiometric and 
nonstoichiometric conditions.
Unfortunately, this system has serious limitations.44 The firs drawback, in order of importance, to 
use the A-A/B-B system is  the stringent requirement of exact precision of measurement to ensure 
equimolar amounts of each monomers. Indeed, high molecular weight  polymers can be prepared 
only if this important aspect is taken in consideration, because the excess of either A-A or B-B 
monomer leads to the formation of low molecular weight and homo-telechelic macromolecules, due 
to the termination of growing chains by the excess of functionality. In other words, the 
polymerization proceeds until one reactant is completely used up  and all the chain ends posses the 
same functional group (the one in excess) (Figure 1.1.2 B).  In the face of this marked 
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shortcomings, others ways have been developed to produce HDPs. In particular, two strategies exist 
for unequivocally preparing hetero-diterminated polymers, either the ring-opening polymerization 
of cyclic precursors or the polymerization of hetero-difunctional A-B monomers. 
The ring-opening polymerization (ROP) is of commercial interest in a number of systems and is 
based upon the polymerization of cyclic monomers in the presence of ionic initiators. From the 
chemical viewpoint ROP is a chain polymerization, consisting of a sequence of initiation, 
propagation and termination reactions. Indeed, the typical ROP involves the formation and 
propagation of  ionic centers and the molecular weight depends on the conversion degree and the 
monomer/initiator ratio.45 One of the potentiality of this approach is that it can be performed living 
ROPs for the synthesis of block-copolymers and HDPs (Figure 1.1.3 C). 
Figure 1.1.3 C. Mechanism of propagation of a living ring opening polymerization.
Many HDPs have been successfully  synthesized using this approach, as for instance PEGs, ε-
caprolactam and poly(silyl ester)s. 46 47 48 49 50 However, cyclic monomers required for this type of 
polymerization are not so easy to do, most this are toxic and, the last  but not the least, they  are not 
available for all polymer types. 
As the use of an hetero-difunctional A-B monomer (HDM) let us overcome these problems, since a 
broad amount of A-B monomers are available for step-polymerization or, alternatively, can be easily 
synthesized.51  52  The self-polymerization of hetero-difunctional A-B monomers avoids the 
difficulties of controlling the stoichiometric balance of the reacting functions, since they are present 
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within the same molecule. Thus, they can be polymerized to high molecular weight polymers with 
controlled structures by simply  choosing the chain end. HDPs, mono-functional polymers, dendritic 
polymers and block-copolymers may be synthesized by self-polymerization of the plane HDM, 
polymerization of the HDM  with a monofunctional monomer, polymerization of the HDM in the 
presence of a multifunctional monomer (number of functions > 3) or step-by-step  polymerization of 
different types of HDMs, respectively (Figure 1.1.2 D). 
Figure 1.1.2 D. Potentials of HDMs to lead to polymers with outstanding biotechnological applications.
As can be seen in Figure 1.1.2 D, further functionalization of those polymers can be obtained by 
using the B groups available as chain ends, thus permitting the synthesis of purpose-tailoring 
biomaterials. Another important aspect, related to the use of HDMs, regards the control of the 
molecular weight. In the synthesis of polymers one is usually  interested in obtaining a product of 
very specific molecular weight, since the biological and physico-chemical properties of polymers 
can be highly dependent on molecular weight.53  54  55  Since the degree of polymerization is a 
function of  reaction time, the desired molecular weight can be obtained by quenching the reaction 
at the appropriate time. Unfortunately, in this manner will be obtained products, which can be liable 
to subsequent reactions due to the presence of chain ends that can react further with each other. The 
adding of a chain end monomer, as in the case previously described, avoids this issue because the 
molecular weight of the product is strictly dependent on the HDM/chain end ratio. The molecular 
weight distribution in this type of polymerization have been derived statistically for different type 
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of monomer systems.56 57 Thus, the appropriate use of the HDM/chain end monomer ratio allows to 
prepare polymers with established molecular weight. Comparison of A-B and A-A/B-B systems 
have been widely reported for many polymers, including poly(imide)s58, poly(amide)s59, poly(silyl 
esters)s60, poly(ester)s61, poly(carbonate)s62  and poly(quinoline)s.63  Overall it was found that 
polymerization via HDMs (A-B) entailed reduced difficulties in reaching the designed polymer 
architecture, relatively faster propagation rates and higher degree of polymerization. 
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1.1.3 DENDRITIC POLYMERS
Dendritic polymers are a class of polymers consisting of high number of treelike branching with 
well-defined structure, which depends on the functional groups of monomers adopted. 64  65  66  67 
This types of polymers have features that differ from the linear one and for this reason growing 
interest is quite noticeable for research directed towards macromolecules with highly branched 
structures. The most  important difference is that whereas linear polymers have random coil 
structures and  are spatially  anisotropic, dendritic polymers have globular shapes with the 
dimension of the macromolecules about the same in all directions (spatially isotropic). Thereby, the 
attractive secondary force between the molecules in the linear and dendritic polymers are different. 
In particular, the attractive secondary forces are greater for linear polymers because the molecules 
may pack together and attract each other minimizing the free energy of the system (Figure 1.1.3 A). 
Figure 1.1.3 A. Entanglement of linear polymer chains by comparison with dendritic polymers.
Furthermore, dendritic polymers, having globular shape and limited mobility  of their chains, may 
not undergo chain entanglements as do linear polymers.68  Thus, unlike the linear polymers, 
dendritic polymers seldom have sufficient intermolecular interaction to be useful for the preparation 
of fibers, rubbers and plastics. However, because their low secondary  interactions and globular 
shape, dendritic polymers show higher solubility, lower viscosity and lower hydrodynamic volume 
if compared with linear polymers, conferring them different biological, physical and chemical 
properties. In particular, the lower hydrodynamic volume leads the macromolecules to be easily 
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internalized by the cells 69  70  and the lower viscosity  may facilitate coating, extrusion or other 
manufacturing processes.71 Nevertheless, the increasing interest for dendritic polymers is above all 
related to the presence of a much larger number of chain ends with potential reactive groups, which 
can be used for further derivatizations of the polymers, such as with targeting agents, monoclonal 
antibody, drugs and other polymers (Figure 1.1.3 B). 
Figure 1.1.3 B. Potential applications of functional dendritic polymers.
Such polymers can be exploited for the development of macromolecular carrier for drug delivery, 
gene therapy, catalysis and sensors. 72  Two types of dendritic polymers have been developed: 
hyperbranched polymers and dendrimers (Figure 1.1.3 C). Each of these polymers shows 
advantages and drawbacks which relate to macromolecular structure and the production economy. 
Dendrimers offer the potential for producing polymers whose molecular size and structure are more 
regular and less polydisperse than hyperbranched polymers, whereas the latter are easier and 
cheaper to synthesize. Many exciting results related to chemical architecture, synthetic procedure, 
encapsulating properties, aggregation behavior, self-assembly in solution and surface conjugation 
with prospective applications in drug delivery, nanocomposite materials have been reported. 73 74 75 
However, several factors limit the prospective use of conventional dendrimers for large scale 
applications, such as: the enormous cost in synthesis and purification steps, due to the exponential 
reaction time and decreasing yield for each generation of branching, and the steric crowding that 
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lead to structural defects by  distorting the shape of dendrimers. For the purpose of this thesis we 
will deal with only the hyperbranched polymers, staying away from dendrimers. 
Figure 1.1.3 C Schematic representation of synthetic approaches for dendrimers (up) and hyperbranched 
(bottom) polymers
Hyperbranched polymers, also known as random hyperbranched polymers, has branches that occur 
in a random way  and they are usually  characterized by the degree of  branching (DB), that for high 
molecular weight polymers is about  0.5 . They compositionally are not so far from conventional 
dendrimers, but show a lower degree of branching and a less regular architecture (Figure 1.1.3 C). 
These molecules have attracted the most attention in biomedical field in recent years especially 
when prospective applications were considered.76 77 78These polymers are synthesized in one-pot 
way without lengthy stages of step-wise reaction and purification necessary with traditional 
dendrimers. Hyperbranched polymers, from the polydisperty  point of view, are similar to linear 
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polymers, first of all because they show costitutional isomerism, resulting from the different 
placement of monomer units. For example, for the polymer derived from an AB2 multifunctional 
monomer (Figure 1.1.3 D) it can be noticed many  isomers, such as those arising from placement of 
the lower leftmost AB2 unit at any the other positions around the perimeter of the molecule.79 
Dendritic unit Chain end unit
Linear unit
Example of 
costitutional isomers
Figure 1.1.3 D. Costitutional isomerism for an AB2-derived dendritic polymer.
In addition, there are three different types of repeat units: dendritic, linear and terminal units 
defined as units having two, one and no B groups reacted, respectively. Because this functional 
heterogeneity, the synthesis of hyperbranched polymers entails inherent and troublesome issues 
which limit the control of molecular weight and shape.79 One is the occurrence of intramolecular 
cyclization, which decreases the functional groups available for polymerization. Another difficulty 
is the steric crowding, that occurs at the periphery of hyperbranched macromolecules with 
increasing molecular size, where some reactive functions become inaccessible for the reaction and 
the reaction take place only along accessible directions.80 Thus, the steric crowding may  not limit 
the polymer molecular weight, but affects the molecular shape due to the increased linear unit on 
the macromolecule surface. 
Considering these issues related to these two classes of polymers, hyperbranched polymers will 
probably  be used in large-scale applications, where lower cost is a necessity, and dendrimers in 
particular applications, where higher cost is justified. In spite of that, not too many ABf monomer 
are available for the synthesis of new and original hyperbranched polymers, especially in the case 
of biodegradable and biocompatible polymers such as poly(amidoamine)s, and so further efforts are 
necessary to afford new synthetic approaches.
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Theoretical considerations
Since the lack of Bf monomers, other synthetic pathway for the synthesis of hyperbranched 
architectures have been developed. When one or more monomers with more than two functional 
groups are present in the reacting mixture the resulting polymer will be branched instead of linear 
and with certain monomers crosslinking can also take place. For example, crosslinking of a A-A 
system will  occur when the multifunctional monomer (Bf ) carry  at least 3 functional groups in the 
presence of B-B monomer. (Figure 1.1.3 E). Thus, branches of two parallel chains can react 
together leading to a crosslinked macromolecule because of the presence of the reactive -B-B and -
B-A chain ends. When crosslinking statistically  prevails the branching reaction, the gel point can be 
reached and it will be observed the loss of fluidity of the reacting mixture. So, the gelation differs to 
the crosslinking because it corresponds to the formation of an infinite network whose polymer 
molecules have been crosslinked to each other.81 In order to control the crosslinking reaction so that 
it can be obtained hyperbranched polymers, several theories are available.82 83 The Flory84 85  and 
Stockmayer86  87  88  one is statistically derived and represents the best approach to obtain well-
defined hyperbranched polymers. Indeed, using this approach, hyperbranched polymers can 
potentially be synthesized by  the A2 + B2 + Bf systems, or analogous combinations of monomers, 
usually  used to produce cross-linked polymers (Figure 1.1.3 E). It is possible to synthesize 
hyperbranched polymers only if cross-linking is minimized  by controlling the stoichiometric 
conditions of the starting mixture (See “Results and Discussion” session).
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Crosslinking
Crosslink moiety
Linear moiety
Figure 1.1.3 E. Structure of a cross-linked macromolecules.
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1.1.4 POLYMERIC NANOPARTICLES AND THEIR ROLE IN NANOMEDICINE
Recent years have witnessed unprecedented increasing of investigations in the field of 
nanomedicine and nanotechnology, since nanoparticles brings significant advantages in the 
diagnosis and treatment of several diseases.89 Although nanoparticles (NPs) vary in size  from 10 to 
1000 nm, it  is accepted the definition in which NPs are designed as particles with size < 100 nm, 
because it is recognized that NPs with higher hydrodynamic diameter generally do not show 
marked improvement of their original physico-chemical properties.89, 90  In particular, it  is known 
that nanoparticles with the size in the range of 200 nm can accumulate at the solid tumor site by  the 
so called enhanced permeation and retention (EPR) effect, resulting in effective drug targeting 
(Figure 1.1.4 A). 91 
blood vessel
normal endothelial cells
endothelial cells near a tumor  
tumor
Figure 1.1.4 A.  Enhanced permeation and retention  effect (EPR) for polymeric nanoparticles: endothelial cells that are 
close to the tumor are more permeable and the NPs can diffuse across blood vessel towards tumorous cells.
NPs are usually classified on the basis of the materials used for preparing them. Among these, 
polymeric and inorganic NPs can be distinguished. Those obtained from polymeric material are of 
great importance because of their chemical and technological versatility. Indeed, biocompatible, 
biodegradable and functionalized NPs with different phisico-chemical properties may successfully 
be prepared by using the available polymer architectures. NPs are important tools to accomplish a 
huge number of medical applications, including drug delivery, gene delivery  and diagnosis because 
of their unique and attractive features, such as: high surface area/mass ratio and their quantum 
properties. 
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New surface
accessible to molecules
Initial surface
Cutting sections
Figure 1.1.4 B. Representation of the process of increasing in accessible surface by consecutive cutting: after each 
cutting the accessible surface become exponentially greater than the initial surface.
Figure 1.1.4 B shows how the overall surface of a cube can exponentially increases after breaking 
into small pieces. Increasing surface area, the percentage of molecules on the surface increase, 
leading to particles of the same material but with different behavior. More precisely, NPs are 
endowed with peculiar properties, arising from their nanometric size, that make they able to 
efficiently adsorb and bind bioactive compounds, to diffuse rapidly through the submucosal layer of 
the gastrointestinal tract and across the endothelial cells into blood vessels, to hardly physically 
interact with other molecules and cellular membrane.92 Such particles may efficiently carry drugs, 
genetic material and proteins in a specific body district and consequently  either release their loaded 
compounds or tagging a specific tissue, organ or tumor. In addition, there are many technological 
advantages to use NPs. One is that  they can be easily  formulated as stable liquid by suspending 
them into an aqueous solution. Indeed, according to the Sokes-Einstain’s law, due to their small 
size, nanoparticles are less prone to gravitationally settling. As particle size decreases to the 
nanoscale, their settling velocity  become less than their Brownian motion, avoiding the 
gravitational settling. Thus, using NPs homogeneous suspensions with longer shelf life can be 
obtained. Furthermore, according to Noyes-Whitney equation, the dissolution of poorly water-
soluble drugs can be enhanced (until 40%) by  preparing nano-sized drugs.93 NPs can also offer 
unique magnetic and optical properties with relevance in targeted treatment and diagnostic. For 
example, ferromagnetic materials lose their magnetization at particle size less than 20 nm, but still 
respond to a magnetic stimulus. Such particles can be directed to tumors for locally releasing of 
antitumoral drugs by heating them through pulsed electromagnetic radiation.94 
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Although the use of nanomedicine allows to improve the therapeutic index of many  drugs, being the 
letter the margin between the dose needed for therapeutic effect and the dose inducing adverse 
effects, the toxicological and environmental evaluation of these systems must be carefully 
performed. Since the surface of NPs is the crucial determinant of particle response and the unique 
difference in comparison to bulk material, this should be fully  investigated from the toxicological 
standpoint.95 96 97 Particular emphasis should be dedicated to non degradable or slowly degradable 
NPs, that, due to the accumulation and and persistence in the site of delivery, might cause  chronic 
inflammatory reaction.98  However, it cannot be assumed that current assays and analytical 
procedures are appropriate to detect all potential risks associates with the use of NPs. So additional 
development of these research field may be needed. Others important aspects that should be better 
studied are the biopharmaceutics and the pharmacokinetics parameters of NPs after administration, 
since their body distribution may significantly change in contrast to micro-sized particles.
Polymeric NPs as drug delivery systems
Polymeric nanoparticles are being used as vehicles for drug, gene and protein delivery. The 
structure, function and biomedical application of these materials have already reviewed.99  100  101 
Herein it will report a summary of these example and considerations. Various polymers have been 
used in drug delivery as they can effectively  deliver the drug to a target site and thus increase the 
therapeutic benefit, while minimizing side effects. PEGylated proteins, antibodies and most recently 
aptamers have been particularly successful, and the letter are undergoing clinical screening as 
treatment for cancer, diabetic nephropathy  and coronary disease.102  Among the polymers with 
potential as drug delivery system, biodegradable polymers allow utilization of higher molecular 
weight platforms, like NPs, to optimize pharmacokinetics, and they  are essential for treatment that 
require chronic administration of drugs. Overall, drug-loaded polymeric NPs can be obtained by 
means of two different methods: (i) dispersion of the preformed polymer with drugs and (ii) 
polymerization of monomers in presence of drugs. 
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Different types of NPs can be obtained depending on the method adopted. The drug can be 
dissolved, entrapped or encapsulated into a NP, leading to nanoparticles, nanospheres or 
nanocapsules respectively (Figure 1.1.4 C). 
nanocapsules
core of drug
cluster of drug
nanosphere
nanoparticles
Dispersion of preformed
polymers into a drug solution
Polymerization of a solution of 
monomer in the presence of a drug
Evaporation of solvent
or precipitation
Evaporation of solvent
or coprecipitation
Figure 1.1.4 C. Methods for preparing nano-sized particles: nanocapsules, nanospheres, and nanoparticles.
These usually show various drug release profiles, which can be exploited to make “tailor-made” 
nanoparticles. Because plasma protein adsorption and phagocytosis of NPs can occur when they are 
administrated intravenously in vivo, thus affording to bioelimination of drugs, the surface of NPs 
should be carefully studied. Apart from their size, the amount of adsorbed blood circulating proteins 
(opsonins) are under the influence of surface hydrophobicity, determining the in vivo fate of NPs . 
Indeed, it was observed that PLA NPs, when incubated in human plasma and serum, adsorb high 
amount of IgG, apolipoprotein-E and C3 protein (a protein used for recognition of foreign surface) 
(Figure 1.1.4 D1).103  104  Hence, it is necessary  to modify  NPs surface for designing effective and 
long circulating NPs.  
Several methods of surface modification was developed in order to avoid these issues. In Figure 
1.1.4 D are shown some approaches. One is surface coating by adsorbing hydrophilic polymers or 
surfactants after NPs formation. Although poloxamer105, poloxamine106, polysorbate (tween 80)107 
and lauryl ethers (Brij-35) have been widely used for these purpose, PEG-coated NPs have mostly 
received the attention of researchers because of their well-known toxicity profile.108 Another road to 
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lead to this outcome is to prepare NPs by self-assembling of amphiphilic di-block-copolymers in 
aqueous solution, in which the lipophilic moiety will form the core and the hydrophilic moieties the 
shell of the NP. Using this technique long circulating poly(lactide-co-glycolide)-PEG (PLGA-PEG) 
and poly(lactide)-PEG (PLA-PEG) NPs were easily obtained and being particularly popular due to 
their good biological properties.109 110 In particular their half-life was improved by a factor within 
180.111 The protective effect of PEG was explained considering that the presence of hydrophilic and 
flexible chains onto the NP surface entails a steric effect which prevent NPs from interacting with 
other macromolecules (e.g. proteins) (Figure 1.1.4 D3).112  In recent years this technique have 
provided the forward thrust for developing many long circulating NPs. However, PEGylation is too 
far to be considered as a versatile strategy  and so further studies have to be done for elaborating 
new and more effective approaches. 
A particular type of NPs are interpolyelectolytic complexes (IPEC), obtaining by self-assembling 
opposite charged polyelectolytes, that are polymers carrying ionizable groups in their polymeric 
backbone. These NPs have been widely studied for protein and gene delivery as protein-polymer 
and DNA/siRNA-polymer complexes can be produced by simply mixing the two macromolecules 
at appropriate ratios, affording to anionic or cationic NPs of nanometric dimensions (<100 nm) and 
surprisingly homogenous (Figure 1.1.4 E).113 Usually  stable NPs can be obtained since their Z-
potential may be modulated by adjusting the starting charge ratio. Several cationic polymers have 
been evaluated for their ability to get IPEC with DNA, the most significant being poly-L-lysine 
(pLL) and polyethyleneimine (pEI).114 115 However these polymers were quite toxic and cannot be 
used for clinical applications, thus others efficient polymers have successfully been developed.116
Polyampholytes are a class of polymers bearing basic and acidic groups in their polymer chain and 
have the unique property of changing their overall charge in function of the pH, displaying a self-
buffering ability. 
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Figure 1.1.4 D Opsonization process of hydrophobic NPs by C3 protein and their elimination through macrophages 
(Panel 1); methods to obtain surface modified NPs (Panel 2) and the effect of hydrophilic polymer density on the 
opsonization process. 
Figure 1.1.4 E This figure represents the formation of IPECs by mixing solutions of genetic material or negative 
charged protein and polycations  (Panel 1); and the formation of PEG/lipid-coating IPEC (Panel 2 and 3 respectively).
For this reason they usually show a minimal toxicity and good transfection efficiency comparing to 
the purely cationic one.117 118 However, IPEC, after intravenous administration, may interact with 
opposite charged proteins and erythrocytes, causing erythrolysis. PEG-coating IPEC were prepared 
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to get round this problem (Figure 1.1.4 E2).119  PEGylation of IPEC also avoids the inherent 
inclination of these systems to accumulate into lungs, liver and kidneys, thus being liable to 
clearance. Despite this, PEGylation reduces the expression efficiency of IPEC by interfering with 
intracellular trafficking mechanisms, such as for instance the endosomal escaping. Another 
technique used to avoid the erythrolysis and bioaccumulation is based upon the formation of 
lipopolyplexes, in which the IPEC has a lipidic and neutral shell obtaining by adding ionic lipids 
into the IPEC mixture (See Figure 1.1.4 E3). Unfortunately, like liposomes, lipopoliplexes trig 
opsonization in vivo and nedeed further surface modifications. Although a vast number of natural 
and synthetic polymer-based nanoparticles, IPEC and nanocapsules have been explored, few have 
progressed into clinical trial. Self-assembling cyclodextrin-polymer conjugate-based nanoparticles 
pioneered by Davis and colleagues have made this transition as a transferrin targeted siRNA.120
NPs as diagnostic devices.
NPs are being actively  developed for tumor imaging in vivo and biomolecular profiling of cancer 
biomarkers, because of their superficial characteristics and the EPR effect above mentioned.121 
Many tumor cells express protein biomarkers, namely  particular proteins that are overexpressed in 
status of allostasis (eg, estrogen receptor, progesterone receptor for breast cancers), on which 
therapeutic regimen is changed. So simultaneous detection and quantification of several proteins on 
small tumor samples is nedeed in order to monitoring the evolution of specific tumors. Dendrimers, 
carbon naotubes, niosomes, quantum dots, 
gold-conteining NPs, silver-conteining and other polymers are a large and well-established group of 
organic and inorganic particles that are being used as contrast agent or other diagnostic 
applications.122 123 124 For example, semiconductor fluorescent nanocrystals, such as quantum dots 
containing a cadmium selenide core and a zinc sulphide shell surrounded by a coating of 
amphiphilic polymeric ligands, have been conjugated to antibodies, allowing detection and 
quantification of these target biomarkers in a tumor section (Figure 1.1.4 F).125 
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Emerging use of nanoparticles in diagnosis and treatment 
of breast cancer
Maksym V Yezhelyev, Xiaohu Gao, Yun Xing, Ahmad Al-Hajj, Shuming Nie, Ruth M O’Regan
The biological application of nanoparticles is a rapidly developing area of nanotechnology that raises new 
possibilities in the diagnosis and treatment of human cancers. In cancer diagnostics, fl uorescent nanoparticles 
can be used for multiplex simultaneous profi ling of tumour biomarkers and for detection of multiple genes and 
matrix RNA with fl uorescent in-situ hybridisation. In breast cancer, three crucial biomarkers can be detected and 
accurately quantifi ed in single tumour sections by use of nanoparticles conjugated to antibodies. In the near 
future, the use of conjugated nanoparticles will allow at least ten cancer-related proteins to be detected on tiny 
tumour sections, providing a new method of analysing the proteome of an individual tumour. Supermagnetic 
nanoparticles have exciting possibilities as contrast agents for cancer detection in vivo, and for monitoring the 
response to treatment. Several chemotherapy agents are available as nanoparticle formulations, and have at least 
equivalent eﬃ  cacy and fewer toxic eﬀ ects compared with conventional formulations. Ultimately, the use of 
nanoparticles will allow simultaneous tumour targeting and drug delivery in a unique manner. In this review, we 
give an overview of the use of clinically applicable nanoparticles in oncology, with particular focus on the diagnosis 
and treatment of breast cancer. 
Introduction
Nanobiotechnology, defi ned as biomedical applications 
of nano-sized systems, is a rapidly developing area 
within nanotechnology. Nanomaterials, which measure 
1–1000 nm, allow unique interaction with biological 
systems at the molecular level. They can also facilitate 
important advances in detection, diagnosis, and 
treatment of human cancers and have led to a new 
discipline of nano-oncology.1,2 Nanoparticles are being 
actively developed for tumour imaging in vivo, bio-
molecular profi ling of cancer biomarkers, and targeted 
drug delivery. These nanotechnology-based techniques 
can be applied widely in the management of diﬀ erent 
malignant diseases.
Some breast cancers express protein biomarkers (eg, 
oestrogen receptor, progesterone receptor, and ERBB2) 
on which therapeutic decisions are made. Semiconductor 
fl uorescent nanocrystals, such as quantum dots, have 
been conjugated to antibodies, allowing for simultaneous 
labelling and accurate quantifi cation of these target 
proteins in one breast tumour section (fi gure 1).3 The 
use of nanoparticles—not only quantum dots of diﬀ erent 
sizes and emission spectra, but also gold-containing 
nanoparticles (ie, Raman probes)—will allow the 
simultaneous detection and quantifi cation of several 
proteins on small tumour samples, which will ultimately 
allow the tailoring of specifi c anticancer treatment to an 
individual patient’s specifi c tumour protein profi le.4 The 
ability to detect molecular targets simultaneously on 
individual tumour samples could allow correlation 
between gene products and proteins in real time.5 In 
addition, the eﬀ ects of an individual treatment on 
expression of the target protein can be monitored before 
and after treatment, and provide a rapid method to 
measure the eﬃ  cacy of a targeted therapy. 
Nanotechnological approaches (eg, nanocantilevers 
and nanoprobes) are being actively investigated in 
cancer imaging.6 Nanoparticles coupled with cancer-
specifi c targeting ligands can be used to image tumours 
and detect peripheral metastases.7 Supermagnetic 
nanoparticles that have a metal core and are 
bioconjugated with antibodies against ERBB2 have 
shown promising results for simultaneous imaging 
and targeting of breast cancers therapeutically in vivo.8 
Moreover, nanoparticles conju gated to cancer-specifi c 
ligands could be used in early identifi cation of tumours, 
allowing early intervention with a chemopreventive 
agent.
Several nanotechnological approaches have been used 
to improve delivery of chemotherapeutic agents to 
cancer cells with the goal of minimising toxic eﬀ ects on 
healthy tissues while maintaining antitumour eﬃ  cacy. 
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Figure 1: Basic structure of inorganic nanoparticles  Yezhelyev,M., et al., Lancet Oncology, 2006, 7, 657-667
Figure 1.1.4 F Basic structure of diagnostic NPs (image from reference 126).
This structure enables quantum dots to emit narrow and symmetrical electromagnetic signals within 
450 and 850 nm by changing the size or chemical composition of the nanoparticles, that may be 
exploited to make different dyed NPs visualizable all together with a light source.126 Furthermore, 
measurement of fluorescent  intensity permits to quantify  the biomarker real-time. Unfortunately, 
due to the presence of cadmium and other toxic heavy metal cores, quantum dots have limited 
applications in vivo. The use of gold/silver-containing nanoparticles, which are able to generate 
Raman signals, is another way to obtain reporter NPs for spectroscopic labeling (Figure 1.1.4 F). 
Typically a silica shell with the report molecule is present in these systems to allow protein 
conjugation and Raman scattering. When illuminated with a laser beam, these NPs emit a shifted 
electromagnetic spectrum, like a fingerprint, which can be used to trace a map of the biomarkers 
and their amount.127 Finally, supermagnetic NPs containing a metal core, such as iron, nickel or 
cobalt, and a polymeric shell, which enable them to be conjugated with proteins, are widely used as 
contrast enhancement agents to improve the sensitivity of MRI (Figure 1.1.4 F). 
Polymer-based NPs as theranostic systems
Theranostic NPs are recent systems developed to carry out a double function, both therapeutical and 
diagnostical. They  show great promise in the emerging field of personalized medicine, because they 
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permit detection as well as monitoring of an individual patient’s cancer at an early  stage, and 
delivering anticancer drugs over an extended period for enhanced therapeutic efficacy  (Figure 1.1.4 
G).128 129 
blood vessel
Drug release
tumor
Imput
Output (image)
Figure 1.1.4 G. Mechanism of action of a theranostic device.
Furthermore, real-time and non invasive monitoring of the theranostic NPs enables clinicians to 
rapidly decide whether the regimen is effective in an individual patient or not.130  Successful 
application of cancer theranosis require discovery of highly  efficient tumor-homing nanoparticles 
which can diagnose and deliver targeted therapy. Cancer researcher have been investigating various 
nanoparticles for this purpose, made of lipidic micelles, inorganic particles and polymeric 
particles.131 132  For instance Kim’s group have developed very stable chitosan-based NPs that 
simultaneously  execute cancer diagnosis and therapy thanks to their near-infrared fluorescent label 
and by releasing paclitaxel into tumor site.133 Fong-Yu Cheng et al. have successfully  synthesized 
quantum dots-loaded FITC-labeled PLGA NPs with different size, demonstrating their potential use 
for molecular imaging and drug delivery.134 However, notwithstanding the EPR effect, results have 
shown a non exhaustive effect.135 
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These bad results might be explained in view of the quickly elimination underwent by NPs after 
administrating into the circulating blood by means of immune system.136 137
It may  be concluded that the use of biodegradable polymers for preparing NPs with therapeutic, 
diagnostic and theranostic purposes is well established, yet currently  there is not an high number of 
commercial available products that utilize this technology. Polymeric nanoparticles have great 
utility  to improve the bioavailability and to vehicle several bioactive agents, like vaccines, anti-
tumorals, DNA and siRNA. Many polymeric NPs have been developed to guarantee long 
circulation of these therapeutic agents, but further approaches should be investigated to better tailor 
the particles’ surface, thus reaching these goals. From the polymer chemistry viewpoint, this can be 
made by synthesizing new polymers to match the hydrophilic/lipophilic properties of NPs surface 
towards a specific type of tissue, cell or molecule. Furthermore, it might be expected that friendly 
processes will be developed.
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1.1.5 POLYMER-PRETEIN CONJUGATES
Peptides/protein-synthetic polymer conjugates are hybrid materials, which covalently combine one 
or more copies of a peptide sequence or protein with one or more synthetic polymer chain (Figure 
1.1.5 A).138139  From an engineering standpoint, conjugates are interesting because they show 
biological and chemical features of both the biomacromolecules and the synthetic polymers, 
allowing the unique opportunity to combine the best of two “parallel worlds” and to overcome the 
shortcomings inherent to the components alone. 
Polymerization or
Coupling
Protein/Peptide Protein/Peptide-Polymer Conjugate
Functional groups
Polymer chain
Figure 1.1.5 A. Representation of a Peptide/protein-synthetic polymer conjugates.
In one hand proteins display hierarchical structure formation that provides specific recognition and 
binding domains useful for obtaining a therapeutical effect. In the other hand synthetic polymers, 
which show biocompatibility, resistance to enzymatic degradation, increased bioavailability and 
passive targeting (EPR effect), can be exploited for improving the toxicity, the lack of 
bioavailability and the immunogeneticity of proteins.140  Thereby peptides protein-polymer 
conjugates are of interest to researchers in diverse fields, such as medicine, nanotechnology, 
medical engineering, polymer chemistry and bioengineering, because combining characteristic 
properties of peptide or protein and polymers is possible to improve pharmacokinetics with 
unsubstantial effects on pharmacodynamics.141 For example covalent attachment of polymers to 
proteins is known to improve protein efficacy by increasing lifetime in vivo and decreasing 
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immunogenicity  of proteins.142 143 144 In some case, protein-polymer conjugates can exhibit higher 
biological activity, if compared to the unmodified protein, when attached to surface.145 In others 
words this can be translated to fewer doses of drug for patients to reach the same therapeutic effect 
than the wild-type one. Examples of polymer-protein/peptide conjugation have been throughout 
summarized.146 147 148 For instance, Davis et al have found that covalent conjugation of linear poly
(ethylene glycol)  chain (PEGylation) to bovine serum albumin (BSA) and bovine liver catalase was 
and effective strategy to reduce the immunogenecity  of these proteins and increase their 
bioavailability.149 150 PEGylation, to date, is established as a powerful and safe strategy to improve 
the in vivo properties of therapeutics proteins and peptides; because PEGylated biological products 
exhibit often a reduced affinity  for the target receptor that can lead to a lower clearance by  target-
mediated clearance mechanisms.151  152  Maeda et al, in the 1980, discovered that conjugates of 
neocarcinostatine (NCS) and styrene-maleic anhydride copolymers (SMACS) are able to 
accumulate in tumor tissue due to a passive targeting mechanism, which was referred to as the 
enhanced permeability  and retention (EPR) effect. 153 Actually, in spite of all these examples, only 
PEGylation holds an important role in current pharmaceutics applications. In particular, PEG-
Interferon® conjugates are good examples of drugs now used in medicine as non immunogenic and 
highly  bioavailable antiviral agents.154 Although PEGylation is extensively used and safe, there are 
some recent evidence that show as PEGylated biomolecules might display local and chronic toxicity 
in kidneys.155 
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The development of many  other improved strategies for the synthesis of new peptide/protein-
polymer conjugates is so needed. 
Synthetic approach
Preparation of peptides/protein-polymer conjugates, over the past years, paves the way for 
numerous novel applications of this class of materials. The continuos expansion of the number of 
synthetic strategy that can be used to prepare these conjugates is due to the development of 
advanced methodologies for preparing synthetic peptides, creative use of controlled polymerization 
techniques, chemoselective coupling systems and residue/site specific protein modification reaction, 
that are reported in Table 1.1.5 A. 156
Table 1.1.5 A. Main Synthetic strategies for the Preparation of Protein-Polymer Conjugates.7992 Macromolecules, Vol. 42, No. 21, 2009 Klok
Heise, Menzel, and co-workers, who have developed various
initiators that allow (controlled) NCA polymerization as well
as the controlled polymerization of vinyl monomers such as
styrene or methyl methacrylate via nitroxide-mediated po-
lymerization (NMP) or atom transfer radical polymerization
(ATRP) in one pot.33-35 In addition to divergently growing a
polypeptide block from a synthetic polymer initiator, pepti-
de-synthetic hybrid block copolymers can also be prepared
by convergent coupling of presynthesized polymer segments.
A very attractive reaction for the convergent synthesis of
peptide-synthetic hybrid block copolymers is the Huisgen
1,3-dipolar cycloaddition reaction (“click chemistry”). This
reaction not only is high yielding but also is compatible with a
broad range of functional groups,36,37 which makes it particu-
larly attractive for the synthesis of biopolymer conjugates. The
use of click chemistry for the convergent synthesis of pepti-
de-synthetic hybrid block copolymers was first described by
Taton, Lecommandoux, and co-worker, who used this strategy
to prepare poly(γ-benzyl-L-glutamate)-b-poly(2-(dimethylami-
no)ethyl methacrylate) (PBLG-b-PDMAEMA) diblock copo-
lymers38 and has been used to prepare various other hybrid
block copolymers since then.39,40
Solid Phase Peptide Synthesis. Solid phase peptide synth-
esis nowadays is a routine technique that allows access to
peptides containing up to 50 amino acid residues with perfect
control over chain length and monomer sequence.41,42 For
the convergent synthesis of peptide-synthetic polymer con-
jugates, either via selective modification of a suitable end-
reactive polymer or via functionalization of appropriate
reactive side chains, a broad range of reactions is available.
A detailed overview of these coupling conditions has been
published in a recent overview.43 Traditional peptide cou-
pling conditions are frequently used for the synthesis of
peptide-synthetic polymer conjugates. These reaction con-
ditions are attractive as they generally provide high conver-
sions and are compatible with standard solid phase peptide
synthesis protocols. N-terminal modification of solid-sup-
ported peptides with carboxylic acid-modified poly(ethy-
lene glycol) (PEG) derivatives, for example, has been widely
used to prepare a variety of peptide-synthetic polymer con-
jugates.44-47 A drawback is that these reactions are usually
not bioorthogonal and cannot be used to synthesize conju-
gates in homogeneous (aqueous) solution from unprotected
peptides. There is, however, a plethora of bioorthogonal
coupling reactions that canbe used for this purpose. Examples
include various Pd0-catalyzed coupling reactions, Staudinger
ligation, cycloaddition reactions (Diels-Alder, 1,3-dipolar
cycloaddition), reductive alkylation, oxime and hydrazone
formation, thiol addition reactions, and oxidative coupling.43
Althoughvarious of these strategies have beenused toprepare
protein-synthetic polymer conjugates (vide infra), only the
Huisgen 1,3-dipolar cycloaddition reaction has been em-
ployed in several instances for the synthesis of peptide-syn-
thetic polymer conjugates.48-51 It is obvious that the range of
other bioorthogonal coupling reactions that is available pro-
vides ample opportunities for the synthesis of novel, complex
peptide-synthetic polymer conjugates without the need for
possible complex protective group strategies.
The divergent synthesis of peptide-synthetic polymer
conjugates can be carried out on the solid phase as well as
in homogeneous solution. Divergent solid phase synthesis of
peptide-synthetic polymer conjugates is frequently carried
out using commercially available Tentagel resins in which
poly(ethylene glycol) chains are attached to the solid support
via a labile linker.45,52-54 To avoid aggregation and facilitate
the synthesis of difficult peptide sequences, so-called switch
ester segments can be introduced in the peptide backbone.
After completion of the synthesis, the peptide backbone can
be re-established via a selective O f N acyl switch.52 In
addition to the use of switch ester segments, there are various
other strategies that can be used to prepare difficult peptide
sequences, including the use of backbone amide protecting
groups55 or microwave synthesis.56 These latter two ap-
proaches, however, to the best of our knowledge have not
yet been explored for the preparation of peptide-synthetic
polymer conjugates. Instead of grafting the peptide segment
step-by-step from a soluble or insoluble synthetic polymer
support, the synthetic polymer segment can also be grown
from appropriate initiator modified resin-bound peptides
using controlled radical polymerization techniques.57-59
These polymerization techniques have also been used to
Table 3. Overview of the Main Synthetic Strategies for the Preparation of Peptide/Protein-Synthetic Polymer Conjugates
conjugate synthesis
peptide/protein synthesis convergent divergent
R-amino acid
N-carboxyanhydride (NCA)
ring-opening polymerization
• click coupling of R-alkyne/R-azido polypeptides with
alkyne/azide functionalized nonpeptidic polymers38-40
• NCA ring-opening polymerization using primary
amine,18,26,27,32 amido-amine nickelacycle,28-30
N-trimethylsilylamine,24 or primary amine hydro-
chloride22,31 macroinitiators
• one-pot synthesis using dual initiators forNCA ring-
opening polymerization and NMP/ATRP33-35
solid phase peptide
synthesis (SPPS)
• N-terminal PEGylation of solid
supported peptides44-47
• SPPS of the peptide segment on a PEG modified
solid support45,52-54
• Solution click coupling of azide/alkyne chain end/side
chain functionalized synthetic polymers with azide/
alkyne functionalized peptides48-51
• controlled radical polymerization of vinylmonomers
using peptide-based initiators or chain transfer
agents57-67
• (controlled) polymerization of peptide-functiona-
lized monomers68-74
protein biosynthesis • protein PEGylation82,84,85 •ATRP or RAFT polymerization of vinyl monomers
using protein-based macroinitiators or chain
transfer agents90-95
• bioorthogonal (Staudinger ligation,86
click chemistry,49,87 and oxidative coupling88)
conjugation of appropriate functional proteins and
synthetic polymers
Scheme 1
Table 1.1.5 A shows an overview of the main synthetic approaches that are available for the 
preparation of protein-polymer conjugates. These are lis ed accordi g to th  method used for the 
synthesis of the protein moiety as well as with careful consideration to the conjugation strategy 
used. Briefly, it can be noticed that there are three main techniques used for the synthesis of the 
protein part involving the (1) N-carboxyanhydride (NCA) ring-opening polymerization, (2) solid 
phase peptide synthesis (SPPS) and (3) protein biosynthesis. The synthesis of the conjugate can be 
performed in a convergen , diverg t or grafting t rough fashion. Figure 1.1.5 B repo ts the three 
synthetic ways using the controlled radical polymerizations techniques.157  The convergent one 
involves  h  coupling  pre-synthesiz d peptide an  polymer building blocks, the divergent 
synthesis can be carried out in two different ways: (1) by polymerization of monomers using a 
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protein as macroinitiator and (2) by synthesizing a peptide on a soluble or solid-supported polymer, 
whereas the grafting through strategy is a mix o the two approaches where all repeat units on the 
conjugate can bear a pendant peptide or protein moiety . 
Figure 1.1.5 B. Controlled radical polymerizations for obtaining protein-polymer conjugates. 
Each of these synthetic approach has peculiar advantages and drawbacks, which should be taken 
into consideration in order to obtain the pre-established goal. Nevertheless, in agreement with this 
scheme, it is rather evident that further functionalizations of the protein-polymer conjugate can not 
be easily obtained by using the conventional approach. RAFT and ATRP polymerization allow of 
preparing polymers with a broad range of functional groups that are able to orthogonally react  with 
different chemical and biological species, affording, for example, targeted protein-polymer 
conjugates. Unfortunately these polymerization ways are very  expansive and involve complex and 
hardly  scalable synthetic pathways. This shortcoming can be overcome by using other new and 
original approaches involving the in-situ polymerization of hetero-difunctional monomers in the 
presence of soluble protein (Figure 1.1.5 C). 
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In this way can be prepared functionalized protein-polymer conjugates, with low polydispersity, 
that might undergo further coupling reactions, namely  with targeting agents, or drugs.158 In the past 
Paolo Ferruti’s group has adopted a synthetic strategy to prepare functionalized BSA employing a 
large excess of telechelic oligomers carrying Michael acceptor as end-chains (doubly-vinyl 
terminated oligomers, DVTO). However, despite tedious purification procedures, covalent 
“bridged” conjugates cannot be excluded.159
Figure 1.1.5 C. Innovative method for preparing protein-polymer conjugates with targeting agents.
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1.1.6 HYDROGEL SCAFFOLDS FOR TISSUE ENGINEERING APPLICATIONS
Tissue engineering aims to stimulate or facilitate the re-growth of damaged or diseased tissue by 
employing a combination of biomaterials, cells and bioactive molecules.160 To date, thousands of 
clinical procedures are performed to replace or repair tissues in the human body that have been 
damaged by disease or trauma. The classical clinical route to replace a damaged tissue is based 
upon the donor graft tissues technique, consisting in the autografts, allografts, or xenografts of a 
healthy tissue (Figure 1.1.6 A). 
I. Conjunctival autograft II. Bone allograft
III. Tibial bone xenograft 
I.Amar Agarwal, Ocular Surgery News U.S. Edition, 2011
II.Siemionow, M., D. et al, The Lancet, 2009,  374, 203–209
III.Mônica Diuana Calasans-Maia et al, Acta ortop. bras., 2009, 17, 6 São Paulo
Figure 1.1.6 A. Schematic representation of graft techniques useful in tissue engineering. In the panel (I) 
is reported a step-by-step conjunctival autograft, consisting in harvesting conjunctival limbal from 
contralateral eye (A, B) and implanting the harvested tissue into the unhealthy eye (C,D,E,F). In the panel 
(II) can be seen a typical allograft of facial bone after injury, where bones were implanted after their 
harvesting from a crops. In the panel (III) is reported a xenograft of tibial bone in rabbit,  in which the 
tibial gap was filled with hydroxyapatite from bovine bone.
There are many problems associated with this medical practice which point out that the 
potentialities of this technique are limited, like a shortage of donors or donor sites, transmission of 
disease, rejection of grafts, donor site pain and morbidity, the volume of donor tissue that can be 
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safely  harvested, and the possibility  of harmful immune responses.161  In contrast, tissue 
engineering, or regenerative medicine, aims to regenerate the damaged tissue by providing a 
biocompatible scaffold that, stimulating the cellular re-growth and tissue in-growth, allows to 
restore and maintain tissue functions. Overall, tissue engineering technologies entail the successful 
interactions between three components: (i) the scaffold that holds the cells together to generate the 
tissue’s physical shape; (ii) the cells that arrange the new tissue; and (iii) the biological signaling 
molecules, such as growth factors, that direct the cells to express the desired tissue phenotype 
(Figure 1.1.6 B).162 163
Figure 1.1.6 B. Schematic representation of the interactions that should be take into consideration for reaching the goal 
in tissue engineering applications: the resorbable scaffold should be able to interact with steam cells present in the 
unhealthy tissue, supporting them as an extracellular matrix and mimicking physiological release of bioactive signaling 
molecules, as for instance growth factors.
A scaffold is  an artificial structure capable of supporting three-dimensional tissue formation with or 
without seeded allotropic cells.163 In particular, biodegradable polymeric scaffolds for tissue 
engineering have received much attention because they can be gradually replaced with new and 
functional tissue once it degrades. 
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Obviously, the degradation rate of  these scaffolds is very important, since it can affect the tissue 
regeneration: as a too fast degradation rate might not permit a physiologic tissue growth owing to 
lack of proper structural support, a too slow degradation rate might be a “stopper-like” function 
towards cellular re-growth. As shown in Figure 1.1.6 C, different types of polymeric scaffolds are 
available: (i) a typical 3D porous matrix, which is a highly porous and well interconnected open 
pore structure that allows high cell seeding density and tissue in-growth; (ii) a nanofibrous matrix 
that is prepared by  electrospinning or self-assembly would provide a better resemblance of the 
physiological environment164; (iii) a thermosensitive sol-gel transition hydrogel; and (iv) a porous 
microspheres. These are already widely  utilized as sustained protein-release formulations and have 
been applied in tissue engineering for the potential use as cell delivery  carriers or supportive 
matrices. Among the polymeric scaffolds, hydrogels play a crucial role, since they are highly 
biocompatible and similar to the cellular matrix. 
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INTRODUCTION: Progress in tissue engineering 
is conditioned by the creation of a suitable 
environment in which cells c n grow and organize 
themselves in a functional way. The development 
of biocompatible materials that would mimics the 
extracellular matrices hold technical and biological 
importance. We addressed the role of nano- and 
micron-sized fiber structures in muscle cell 
adhesion, growth, guidance and differentiation. 
 
METHODS: The nano- and micron-sized non-
wovens were prepared by an electrospinning 
procedure. Therefore, the biocompatible polymers 
polycaprolactone (PCL), poly(l-lactic acid) PLLA , 
polyethylene carbonate (PEC) as well as collagen 
were dissolved in appropriate solvents and spun by 
applying a high voltage on a needle tip. Partial 
parallelisation of the nanofibers was obtained by 
using electrostatic lens systems and a fast rotating 
drum. Selected fiber patches were coated with a 
nitrogen-functionalized amorphous hydrocarbon 
coating (a-C:H:N), by performing RF plasma 
deposition using a gaseous mixture of ammonia 
and ethylene. 
Myoblasts cell lines (C2C12) as well as rat skeletal 
muscles primary cell culture were seeded on the 
surface of biomaterials and cultured for up to 2 
weeks in growth and differentiation media. We 
used MTT staining to assess cell adhesion and 
viability after 2 days, Hematoxylin-Eosin staining 
and immunostaining to assess cell morphology, 
alignment and differentiation. 
 
RESULTS: The chemical and instrumental 
parameters used for the elelctrospinning procedure 
revealed a deep influence with respect to the PCL 
fiber diameters. Fibers with diameters from 100 
nm to 2500 nm could be obtained. Main 
influencing parameters were the composition of the 
solvents used and the applied voltage. 
Cell adhesion was dependant on the incubation of 
the materials with the adhesive protein, laminin, 
and was inversely proportional of the biomaterials 
wetttability (Spearman correlation coefficient r=-
0.55, ns). Guidance of the cell s eded on parallel 
nanofibers was observed at low cell density. 
Growth and differentiation of the cells was reduced 
when compared to standard cell culture in plastic
dishes. Interestingly, surface coating by plasma 
treatment of the biomaterials with the a-C:H:N 
provided an optimal cell adhesion that was 
increased by at least 20% with respect to non-
coated patches. The a-C:H:N coating on PCL 
yielded a reduction in water contact angle from 
132° to 14°.  Cell presented a specific 
differentiation response to C:H:N coating with 
elongated and parallel myotubes. 
Fig. 1. Polycaprolactone 
(PCL)  nanofibers 
produced by an 
electrospinning 
procedure (fiber 
diameter ca. 100 nm) 
Fig.2. Aligned and 
elongated myotubes 
obtained from myoblast 
primary cell culture on 
a-C:H:N coated PCL 
(desmin 
immunostaining) 
 
DISCUSSION & CONCLUSIONS: Our results 
provide evidence that optimization of bioartificial 
tissue construct using nanofibers is challenged by 
biomaterials properties such as wettability, 
alignment of the fibers and coating. In addition In 
addition parameters such as elasticity and porosity 
have to be considered for cell differentiation and 
the construction of a 3 dimensional bioartificial 
tissue. Furthermore, functional biografts would 
ideally contract under electrical stimulation and 
sustain the high mechanical stress represented by 
the permanent cardiac muscle 
contraction/relaxation cycles. Replacement of the 
cardiac native muscle requires the engineering of a 
complex muscle tissue that would largely benefit 
from the electrospin and plasma coating 
technologies. 
A B
C D
F gure 1.1.6 C Scaffolds for biomedical applications: highly porous polymer (panel A), nanofibrous matrix (B), 
chemically crosslinked hydrogel (C), porouse microspheres (panel D).
Hydrogel scaffolds
During the last few decades, hydrogels have gained increasing atten on as biomaterials for tissue
engineering, regenerative medicine and drug delivery applications, because of their water content 
and biocompatib lity.165 .166 167 168 
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In Table 1.1.6 A are reported most of the hydrogel commercialized scaffold and their major 
applications. There are manifold definitions of this material, but the most frequently referred one is 
given by Peppas, in which the hydrogel is defined as a three dimensional, water-swollen and 
crosslinked polymeric structure containing (i) covalent bonds, (ii) physical crosslinking due to chain 
entanglements, (iii) association bonds, or (iiii) crystallites as a result of strong interactions between 
two or more macromolecular chains.169  Hydrogels can be classified into different categories 
depending on various parameters including the macromolecular structure, the overall charge, the 
nature of the polymer and the mechanical and structural characteristics.
Table 1.1.6 A. Commercial available hydrogel scaffolds and their current applications.
# Commercial Name of the Scaffold Current Clinical and Research Applications
1 Apligraft Artificial skin 
2 Revitix Topical cosmetics
3 VCTO1 Bilayered bioengineered skin
4 inFUSE Osteoinductive carrier of bone morphogenic 
protein for spinal fusion
5 Collagraft Treatment of bone fractures
6 Healos Bone graft substitute in spina fusion
7 Biomend Regeneration of periodontal tissue
8 Gelfoam Hemostati device
9 Gelfilm Neuro, thoracic and ocular surgery
10 CultiSpher-G Microcarrier cell culture
11 Nu-Derm, AlgiSite, Curasorb Injury dressing 
12 Hyalgan, Hyalubrix, Artz Lubrificant or medical support in 
osteoarthritis
13 Bionect, Jossalind Surgery and injury healing
14 Orthovisc, Opegan R, Opelead, Healon Implantation of intraocular lens
15 EmbryoGlue In vitro fertilization
16 Hyaff Scaffold for different applications
17 Integra Dermal regeneration
18 Viscoat Surgical tool for cataract extraction and 
intraocular implantation
An exhaustive classification is reported in Table 1.1.6 B. On the basis of the macromolecular 
structure, homopolymer and copolymer hydrogels can be distinguished. Alternatively, hydrogels 
can be classified as cationic, anionic, amphoteric and non ionic, depending on the acid-base 
properties of the starting monomers. Furthermore, hydrogels can also be designated according to 
their physical status: amorphous, semi-crystalline, hydrogel-bonded, supramolecular, or 
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hydrocolloidal. Finally, hydrogel can be made using natural biopolymers, synthetic polymers, or a 
combination o these (semi-synthetic hydrogels). 
Table 1.1.6 B. Classification of hydrogels on the basis of different properties.
Homopolymer Copolymer Homopolymer Copolymer Copolymer
Natural Synthetic Semi-synthetic
Cationic      Amphoteric      Anionic      Non ionic
Amorphous      Semicrystalline      Hydrogel-bonded      Supramolecular      Hydrocolloids
Usually they are nanoporous materials and their highly porous structure can easily  be tuned by 
controlling the crosslinking degree of the gel matrix and the affinity  of the latter for the aqueous 
environment in which they are swollen. Their porosity also permits the diffusion of low molecular 
weight molecules through the matrix, thus ensuring that nutrients and metabolites may be replaced 
or removed in vivo and in vitro at rate dependent on the diffusion coefficient of these molecules. 
Hydrogels beyond their biocompatible, due to the presence of high water content and the physico-
chemical similarity to cellular matrix, are relatively deformable and can conform to the shape of the 
surface to which they are applied. Despite these advantages, up to now, they show several 
limitations. In particular, given that they have a very low elastic modulus, that is a measure of the 
mechanical strength, they can be exploited only for tissue engineering applications encompassing 
soft tissues, i.e. nerve, liver, spleen, blood vessel, kidney, cartilage, etc. For example, injectable poly
(N-isopropylacrylamide) physical hydrogels encapsulating cells have been prepared for cartilage 
and nerve regeneration.170 171 Pluronic/heparin composite hydrogels delivering growth factor also 
have been studied to induce angiogenesis.172 Photo crosslinked poly(ethylene glycol) (PEG)–based 
hydrogels have been utilized for delivery of chondrocytes and osteoblasts. 173 174 Bone morphogenic 
protein introduced into the hydrogel material (temperature-sensitive chitosan-polyol salt 
combination) has been effective in promoting de novo bone and cartilage formation in vivo.175 
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Poly(lactic acid–glycolic acid) (PLGA) grafted with PEG and PEG grafted with PLGA hydrogels 
capable of sustained insulin delivery and cartilage repair were synthesized.176 Pluronic copolymers 
at a higher concentration have been used to encapsulate chondrocytes and produce engineered 
cartilage.177 Amphoteric poly(amidoamine)s hydrogel, carrying RGD-like repeating unit, have been 
employed as guidance for peripheral nerve regeneration.178 Although mostly these materials have 
successfully  been used, their inadequate mechanical behavior did not permit their wide use in 
clinical practice. Looking into convenience and practicability, there are immense interests in 
developing injectable hydrogel scaffolds, because they are easy to use, versatile, and involve the use 
of safe adjuvants.179 Furthermore, new biodegradable and elastic polymers need to be developed to 
fit for all requirements for surgically implantable scaffolds.
In the light of these, hydrogel scaffolds should be endowed with the following features: 
I. Mechanical properties that are sufficient to shield cells from tensile forces without inhibiting 
biomechanical cues. 
II. Desired volume, shape, and mechanical strength. 
III. Acceptable biocompatibility.
IV. A highly porous and well-interconnected open pore structure to allow high cell seeding 
density and tissue in-growth.
V. Bioadsorption at predetermined time period.
VI. Biocompatible chemical compositions and their degradation products, causing minimal 
immune or inflammatory responses. 
VII. Physical structure to support cell adhesion and proliferation, facilitating cell–cell contact and 
cell migration.
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There is a troubled challenge in designing and manufacturing hydrogel scaffolds that posses all the 
above requirements and the abilities to control the release kinetics of bioactive factors over the 
period of tissue regeneration.180 Further efforts will definitely be focused on these aspects. 
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1.2 SCAFFOLDS FOR SCHWANN CELLS CULTURING AND PERIPHERAL NERVE 
REGENERATION
A large proportion of acquired peripheral neuropathies is due to traumatic injuries.181 Their clinical 
treatment is usually  based on microsurgery  techniques, such as end-to-end nerve repair or 
autologous nerve grafting. However, microsurgery alone seldom leads to a complete functional 
recovery.182 183 Cell-based therapy represents an alternative. To this purpose, Schwann Cells (SC) 
are the first  transplantable cell candidates.182 184  SC play an essential role in peripheral nerve 
regeneration since they are the main cells deputed to form myelin sheets and to secrete growth 
factors and adhesion molecules supporting the axon elongation and re-myelinization, by  this way 
enhancing the overall rate of functional recovery.185 186 However, the use of SC in bioengineered 
nerve grafts is biased by their poor availability  and slow in vitro growth rate.187 Their efficiency 
may be enhanced in vitro by supporting nerve regeneration with conduits made of biocompatible 
materials favoring in loco SC adhesion and proliferation. The physical guidance of axons is crucial 
for achieving a satisfactory nerve repair.188 A conduit for in vivo application should form a suitable 
environment for nerve regeneration by combining cellular stimulating factors with biodegradability. 
It should be non-toxic, easily  fabricated in the convenient size and shape and, in addition, its 
permeability, swelling and mechanical strength should be tunable, as it is known to play a relevant 
role for axon elongation in vivo. 188
Several polymeric materials, both of natural and synthetic origin, have been proposed as scaffolds 
for peripheral nerve regeneration. Among polymers of natural origin, the most promising one is 
probably  collagen, even if modified chitosan, agarose, alginate and fibronectin also received 
attention. 189  190  Collagen is the major protein component of the extracellular matrix and is 
considered by many scientists an ideal scaffold for tissue engineering. It interact favorably with SC 
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and shows good swelling and degradation. However, its acceptance as medical polymer is biased by 
the concern about the risk of contamination with prions, or of immunogenic reactions. Compared 
with polymers of natural origin, synthetic polymers are more reliable as regards reproducibility and 
lack of immunogenicity.191 192 They are not liable to import pathogenic agents and are much more 
versatile, since their molecular structure can be tailored to tune mechanical properties and 
degradation rate according to necessities. Among synthetic polymers, by far the most popular ones 
are polyesters, such as poly(D,L-lactic acid), poly(lactic-co-glycolic acid), poly(β-hydroxybutyrate) 
and poly(ε-caprolactone).193 194 195 They are easily fabricated, biocampatible and biodegradable to 
non-toxic products that, however, are strongly acidic and may cause inflammation to the implant 
surrounding tissues.196 
Hydrogels can be considered an attractive alternative to rigid hydrophobic scaffolds for the 
production of conduits for nerve regeneration, since their high water content makes them 
biomimetic.197 198 199 200 More recently amphoteric and cross-linked poly(amidoamine)s have been 
successfully  used for in vivo nerve repair.201 Tubes of this biomaterial, implanted in rats, have 
proved  to be biocompatible and capable of inducing peripheral nerve regeneration. However, as a 
rule, hydrogels need to be improved  from the standpoint of mechanical properties. 
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1.3 POLYAMIDOAMINES, A CLASS OF BIOCOMPATIBLE AND BIODEGRADABLE 
POLYMERS WITH PECULIAR BIOLOGICAL ACTIVITIES
Poly(amidoamine)s (PAAs) are synthetic, biocompatible and biodegradable polyelectrolytes202 
containing tert-amine (a) and amide (b) groups regularly arranged along their polymer backbone 
according to sequences
a-a-b    or    a-a-b-b
Linear PAAs are obtained by stepwise Michael-type polyaddition of primary or bis-secondary 
amines to bisacrylamides. The Michael-type addition reaction gives a wide range of polymers from 
diverse monomers, and corresponding polymers are prepared in environments in which other 
polymerization mechanism not operate.203 In biological applications, such as protein derivatization, 
the mild Michael addition reaction conditions are favorable since high temperatures, oxidizing 
radicals, and organic solvents are not feasible.204 It is important to note that  temperature and solvent 
affect this reaction. In particular polyaddition reaction rate is accelerated by  increasing temperature, 
but the resulting polymer have lower molecular weight. This can be explained considering that 
hydrolysis reaction rate, that competes with the polyaddition, contemporaneously undergo an 
exponential growth.205  Concerning solvent effects, more recently, a study  showed that mobile 
hydrogen play a key  role in the reaction mechanism of Michael-type addition, and hydrogen 
mobility  strongly  influences reaction kinetics.206 Overall, high molecular weight PAAs can only  be 
prepared in ethylene glycol and water. 
The general synthetic procedure for PAAs is reported in Scheme 1.3A. It is clear that  to obtain high-
molecular weight polymers the functions involved, namely  activated double bonds and amine 
hydrogens, must be stoichiometrically balanced.207  A perfectly  balanced reacting mixture will 
contain three types of macromolecules, a----a, b----b, and a----b in 1:1:2 ratio. More commonly, 
unbalanced mixtures will contain the same molecular species, albeit in different ratios, until the 
minority function is completely consumed. 
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Only at  this point, the product will be entirely constituted of molecules doubly terminated by the 
excess function. For this reason usually  PAAs have a number-average molecular weight in the range 
of 5,000 - 40,000, with polydispersity index of about 1.9, and needed to be fractionated to enable 
their use in biomedical field. 
constituted of molecules doubly terminated by the excess
function. There is no way, by the traditional method, to
straightforwardly obtain PAAs with controlled hetero-difunc-
tional chain terminals, that is, PAAs solely containing mole-
cules of ‘‘a!! """""" !! b’’ type. This precluded to PAAs the
access to the remarkable number of biotechnological applica-
tions, for instance liposome preparation, drug conjugation,
and protein modification, which have been so far nearly
uniquely mastered by hetero-difunctional PEGs that, how-
ever, are far to be endowed with the functional versatility of
PAAs. In the past, a PAA-albumin conjugate was prepared by
employing a large excess of doubly vinyl-terminated, low-
molecular weight PAA apt to react with the exposed protein
thiol and amine groups. However, despite tedious purifica-
tion procedures, the presence of ‘‘bridged’’ protein molecules
could not be excluded.13
Two strategies exist, in principle, for unequivocally preparing
hetero-diterminated PAAs, either the ring-opening polymer-
ization of cyclic precursors or the self-polyaddition of het-
ero-difunctional (‘‘a!!a!!b!!b’’ or ‘‘a!!a!!b’’) dimers
(HDDs). The first strategy was ruled out because it was
thought difficult to design a cyclic PAA precursor amenable
to thermal or catalytic ring-opening polymerization, espe-
cially in the case of purpose-tailored PAAs carrying reactive
side-substituents, as for instance carboxyl groups, liable to
interfere in these processes. Therefore, the preparation of
HDDs, in particular those of the ‘‘a!!a!!b!!b’’ type,
expected to polymerize according to Scheme 2, was pre-
ferred. We limited our investigation to ‘‘a!!a!!b!!b’’ type
HDDs because the procedure adopted in this investigation
was not easily applicable to the preparation of the
‘‘a!!a!!b’’ ones. A different approach would be actually
needed, hopefully to be reported in a future article.
The synthetic scope of HDDs is manifold. They can be poly-
merized to high-molecular weight PAAs without bothering
with stoichiometric balance. PAAs of controlled average mo-
lecular weight and mono-functionalized with an acrylamide-
or a sec-amine group at one end can be prepared by adding,
respectively, a controlled amount of mono-functional acryla-
mides or sec-amines, whereas the addition of multifunctional
acrylamides or amines will lead to star-like PAAs. Block PAA-
PAA or PAA-PEG copolymers with controlled structure will
be easily obtained. ‘‘Velvety-like’’ grafting of PAA chains to
properly functionalized surfaces can be achieved. PAA chains
of controlled average length can be grafted to proteins with
no risk of undesirable side reactions such as protein–protein
coupling or crosslinking. ‘‘Tadpole-like’’ PAA conjugates with
hydrophobic moieties forming in aqueous media liposomes
or nanoparticles can be prepared as functional drug carriers.
Based on this premise, the aim of this article is to report on
the preparation of some model HDDs corresponding to PAAs
extensively studied for biomedical applications and to pro-
vide selected factual examples of their synthetic potential.
EXPERIMENTAL
Materials
2,2-Bis(acrylamido)acetic acid (BAC) and 1,4-bis(acryloyl)pi-
perazine (BP) were synthesized as previously described,14,15
lithium hydroxide monohydrate (98%), piperazine hexahy-
drate (P) (99%), 2-(R, S)-methylpiperazine (MP) (95%),
1,4,8,11-tetrazacyclotetradecane (Cyclam) (98%), di-(tert-
butyl)dicarbonate (97%), thiocholesterol (TC), bovine serum
albumin (BSA) (96%), 4-acryloylmorpholine (97%), morpho-
line (99.5%), guanidine hydrochloride (98%), glacial acetic
acid, hydrochloric acid (37%), sodium hydroxide (98.5%),
sodium chloride (99%), dichloromethane (reagent grade),
trifluoroacetic acid, DOWEXVR MAC-3 ion exchange resin were
purchased from Sigma-Aldrich and used as received.
Methods
Nuclear Magnetic Resonance (NMR) Spectra
1H NMR, 13C NMR, distortionless enhanced by polarization
transfer (DEPT), 1H-1H correlation (COSY), heteronuclear
multiple bond correlation (HMBC), and heteronuclear corre-
lation (HETCOR) spectra were run at room temperature on a
Bru¨ker Advanced 400 spectrometer operating at 400.132
and 100.623 MHz, respectively.
Size Exclusion Chromatography
Size exclusion chromatography (SEC) traces were obtained
using a Knauer Pump 1000 equipped with a Knauer Auto-
sampler 3800, TKSgel G4000 PW, and G3000 PW TosoHaas
columns connected in series, light scattering/viscometer Vis-
cotek 270 Dual Detector and a refractive index detector
Waters model 2410. The mobile phase was a 0.1 M Tris
buffer pH 8.1 6 0.05 with 0.2 M sodium chloride. The sam-
ple concentration was 2% (w/v) and the flow rate 1 mL/
min. Triple detector SEC allowed determining, besides the
molecular weight, the long chain branching (LCB) frequency
of star-like PAAs by means of the dedicated Viskotek soft-
ware, which compared their Mark–Houwink plots with those
of samples of their linear counterparts of approximately the
same molecular weight and used common Zimm–Stockmayer
equations and methods.16
Dynamic Light Scattering
Dynamic light scattering (DLS) analysis was performed to
evaluate the hydrodynamic radius of polymeric micelles
using a Malvern NanoZS instrument (Malvern Instruments,
Worcestershire, UK) with a laser fitted at 532 nm and fixed
SCHEME 2 Self-polymerization of the ‘‘a!!a!!b!!b’’ type
HDDs.
SCHEME 1 Traditional synthesis of linear PAAs by Michael-
type polyaddition.
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Scheme 1.3 A. General synthesis of linear PAAs by Micheal-type polyaddition. 
The polymerization reaction take place in aqueous or alcoholic solutions, at room temperature and 
without added catalysts. Since under these conditions many  functional groups do not interfere in the 
Michael addition, the structure and the physico-chemical properties of PAAs, i cluding acid-base 
properties, may be tuned within plentiful limits. Indeed, additional functions may be directly 
introduced as side substituents, as long as they are not themselves liable to Michael-type reaction. 
Table 1.3 A shows the functional grou s that may  be inserted using this approach. For instance, 
amphoteric PAAs can be synthesized by bringing into starting bisacrylamide an acidic group.208 A 
typical amphoteric PAA, named ISA23, obtained by polyaddition of 2,2-bisacrylamidoacetic acid to 
2-methylpiperazine, contains as repeating unit  a strong acidic carboxyl group (pKa=2.3) an two 
weakly  basic tertiary amine groups (pka= 7.48 and 3.24 respectively). At pH 7.4 the amines are 
poorly protonated, but carboxyl group  is completely  deprotonated, and consequently, ISA23 carries 
excess negative charges. Anyway, PAA are highly functional polymers, thus further post-
polymerization functionalizations may  be performed in order to make they  suitable for specific 
biomedical applications (Table 1.3A).
Although the ionization profile of polyelectrolytes follows complex laws, acid-base properties of all 
PAAs are described by the Henderson-Hasselbach equation. In particular they do not depend on the 
degree of protonation of the whole macromolecule, thus PAAs with specific acid-base behavior may 
be easily prepared by choosing the acid-base properti s of the starting monomers.209 This means 
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that, in principle, it is possible to design a PAA able to pass from a prevailingly anionic to a 
prevailingly cationic status within narrow pH range. 
Table 1.3A. Some functional groups, and their general applications, that can be inserted in 
PAAs backbone by either pre-polymerization (first column) or post-polymerization 
reactions (second column). 
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This phenomenon can be exploited in order to developing smart bioresponsive PAAs able to 
respond to pH variations in a specific cell or organelle. For instance P. Griffiths et al. have 
demonstrated that in the case of ISA23, its endosomolytic activity is strictly correlated with its coil 
expansion on passing from a neutral pH (extracellular) to an acidic pH (endosomal and lysosomal) 
environments. 210 This conformational change also provides the possibility of designing polymer-
drug conjugates that are, following intravenous administration, relatively compacted, thus 
protecting a drug pay load in the circulation, where the pH is 7.4, but following pinocytic 
internalization into acidic intracellular compartments unfold, permitting pH-triggered intracellular 
drug delivery.
The degradability of polymers is also very important to allow a good renal clearance and so to avoid 
the bioaccumulation of the polymer, which can cause chronic toxicity. The degradation mechanism 
of several PAAs has been extensively studied in the past decade, in physiological conditions (i.e. 
37°C, phosphate buffer pH = 7.4).211  212  It can be concisely noticed that PAAs are liable to 
degradation by means of β-aminolytic and hydrolytic mechanisms. The degradation rate in aqueous 
media is strongly effected by basic pH and increasing temperature, as well as the nature of both the 
amine and amide moieties. Furthermore, degradation cannot seem to proceed through enzymatic 
and retro-Michael way.213 214
Since PAAs are endowed with properly chemical, physico-chemical and biological properties, they 
represent a class of polymers with recognized potential in nanomedicine and tissue engineering. 
PAAs, such as ISA23, ISA1 and AGMA1 (See Table 1.3B), can be regarded as potential 
transfection promoters because they are much less cytotoxic than other commonly used polycations, 
such as poly-L-lysine (PLL) and poly(ethyleneimine) (PEI).215 216  In Table 1.3B are reported the 
IC50 of polycations used at the moment as positive controls by comparison with some PAA. It can 
be noticed that PAAs are of two order of magnitude less toxic. In addition, amphoteric PAAs are 
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usually  non-cytotoxic (IC50 > 5 mg/ml) and have inherent fusogenic properties and stealth-like 
behavior conferring them good transfecting ability when used as gene delivery systems.217 
Table 1.3B. Toxicity of some commonly used polycations compared with the IC50 of three well-studied 
PAAs (ISA23, ISA1, and AGMA1).
For a synthetic system to be effective in vivo, it should not only be tolerated by the body, but also 
demonstrate suitable pharmacokinetic profile, i.e. the ability  to afford tissue targeting and to be 
enough bioavailable. PAAs, as ISA23 and ISA1, when studied in this respect exhibit longer 
circulation time if compared with the other polycations (See Table 1.3 C). 
Table 1.3 C. Biodistribution of 125I-labelled ISA23 and ISA1 after intravenous administration in rats.
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In particular ISA23 does not  seem to be accumulate in liver, lungs or kidney making it suitable for 
tissue targeting applications in vivo either by active or passive targeting (EPR effect)218  219 . To 
reinforce the latter point, biodistribution studies carried out in mice bearing subcutaneous B16F10 
melanoma showed that ISA23 and AGMA1 were still accumulating in tumor tissue within 5 hours, 
enabling their use as tumor targeting carrier in cancer therapy.220  221  Biological properties of 
different PAAs have been widely reported, and encompass the following: antiviral,222  gene 
promoter, 221 223 drug224225 and protein226 227 carrier, cell adhesion and proliferation.228 229
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1.3.1 PAAs AS EFFECTIVE NON-VIRAL GENE DELIVERY SYSTEMS
PAAs have been extensively  studied as transfection promoters, as they are able to change their 
biological behavior depending on the pH of the surrounding medium, thus providing fusogenic 
properties. 230  Fusogenic polymer are able to form interpolyelectrolytic (IPEC) complexes with 
genetic material protecting it  from the enzymatic degradation, and transfecting it  into host cells in 
order to perform a therapeutic effect. Cationic PAAs, as for instance ISA1, exhibit remarkable 
efficiency as gene delivery system, even if they are more toxic than the amphoteric one.231 In this 
respect, amphoteric PAAs, even those that at physiological pH are prevailingly  negative, form 
stable IPEC with nucleic acids. This might be justified by  the fact that cationic and anion charge are 
located in different spatial position along the polymer chain, thus complexation with other anionic 
macromolecules may take place. Indeed, an amphoteric PAA, named ISA23, which at pH 7.4 
carries excess negative charges, has proved as active as PEI and LipofectIN, and more active than 
LipofectACE, being non toxic and non-hemolytic. This can be ascribed to the fact that  ISA23 can 
be internalized into cells by pinocytosis and localizes in lysosomes, where the pH in 5.5; here it 
strongly increases its polycation character, becomes membrane active, and promotes the 
intracellular trafficking of nucleic acids.232 233  234  Amphoteric PAAs other than ISA23 have also 
been studied. Those that at pH 7.4 are prevailingly anionic were non-toxic and non-hemolytic. By 
contrast, AGMA1 apart, those that at  the same pH are prevailingly cationic, showed significant 
toxicity  and hemolytic activity.235  Whereas AGMA1, in spite of being fairly strongly cationic at 
physiological pH, was neither toxic nor hemolytic in vitro within a vast pH range (4.0 - 7.4).236 It 
circulated for a long time in the blood stream when injected in rats. AGMA1 also proved a powerful 
transfection promoter in vivo, with minimal preferential localization in the liver.237 The transfection 
ability  of this polymer in vivo (60% of GFP expressing cells) was definitely comparable to that 
other commercial available transfection agents, such as the JetPEI, which has 63% of GFP 
expressing cells.
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In conclusion amphoteric PAAs are endowed with unique combination of desirable requirements for 
a nonviral drug delivery system and warrant further development of this class of polymers as 
transfection agents in vivo. Hyperbranched amphoteric PAAs might be proposed for this research 
line, because of their complexing ability.
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1.3.2 PAA-PROTEIN CONJUGATES
The synthesis of homo-difunctional PAAs carrying acrylic or aminic end chains, liable to 
subsequent reactions of conjugation, have paved the way for developing PAA-protein conjugates. 
Using this approach such chimerical macromolecules have been prepared by employing a large 
excess of doubly  vinyl-terminated, low molecular weight PAAs suitable for reacting with the 
exposed protein functional groups (e.g., thiols, amine groups). Nevertheless, despite tedious 
purification procedures, this synthetic approach did not ensure a perfect molecular architecture 
control, i.e., the presence of bridged molecules could not be excluded. In view of this issue a new 
synthetic pathway for the synthesis of PAA conjugate should be accomplished.
PAA-protein conjugates have been widely investigated in the past for a huge set of different 
applications in the field of nanomedicine. In particular they were studied as intracellular ribosome-
inactivating toxins delivery  systems. Ricin is a highly toxic dimeric protein, consisting of an A-
chain (RTA), liable for cytotoxicity, and a B-chain (RTB), which acts to promote endocytosis of 
RTA, linked by  a disulphide bridge.238 239  Cationic membranes interacting PAAs were chosen to 
investigate their ability to accomplish intracytoplasmic delivery of RTA chain at tumor cells 
(B16F10), and proved capable of restoring sito-specific cytotoxic activity of RTA.240  Comparable 
results have found for gelonin, that is a toxin unable to diffuse across the cell membrane; hence it 
may not accomplish its cytotoxicity if not properly released into cells.240
ISA23 and ISA1-Mellitin (PAA-MLT) 241  conjugate have been also prepared in order to improve 
gelonin delivery into tumor cells. Mellitin is a cationic peptide derived from venom of Apis 
mellifera that display  several biological properties, such as anti-tumor and immunostimulating 
activities. Mellitin has been used as fusogenic agent too, owing to its cationic nature. ISA1-MLT 
conjugate was able to better delivery gelonin, but, unfortunately, it has shown pH-dependent 
hemolytic activity at  very low concentration, prohibiting its use in biomedical field. Whereas, the 
counterpart ISA23-MLT did not deliver gelonin. 
However, this conjugate was totally  non-toxic and non-hemolytic pointing out that it can be 
exploited as potential anticancer macromolecules.
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PAA-grafted bovine serum albumin (BSA) and human serum albumin (HSA) have been finally 
synthesized via Michael-type addition reaction involving the accessible amine groups (about 60) 
and the unique thiol group of the proteins.242 Two PAAs, one anionic (ISA23) and the other one 
cationic (ISA1) were chosen to verify the feasibility of the reaction. The synthetic pathway  showed 
proof of high versatility  and efficiency, yielding to highly branched proteins with potential in drug 
delivery.
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1.3.3 PAA-BASED NANOPARTICLES
One of the goal of pharmaceutic technologist  is to solubilise hydrophobic drug that show inherent 
low solubility  in aqueous media, and therefore low bioavailability when administrated in vivo. 
Nanoparticles carrying hydrophobic domains offer the opportunity to circumvent this issue by 
solubilising these drugs into their hydrophobic domains, thus affording to stable and effective nano-
dispersions. 
PAA-based nanoparticles have been successfully  prepared by using two different strategies: i) the 
self-assembling of PAA-chelesterol conjugates, and ii) the cosslinking of β-cyclodextrin (β-CD) 
with di-acrylated PAAs. In the first approach the cholesterol was randomly linked to the polymer as 
side pendant through redox-sensitive disulphide bonds.243 Once the polymer was put into aqueous 
media it self-assembled giving core-shell nanoparticles, in which the shell was characterized by a 
strong hydration due to the highly hydrophilic nature of PAAs. Such systems were able to load high 
amount of lipophilic drugs into the hydrophobic core, and yet retained the typical biological 
behavior of the parent PAA in terms of biocompatibility and biodistribution. In an alternative way 
PAA-based nanoparticles were obtained by cross-linking β-CD units with telechelic PAA oligomers 
with acrylic end chains.244 Not surprisingly, as β-CD are able to complex several hydrophobic small 
molecules, they  proved capable to solubilise paclitaxel up  to 5% of their own dry  weight, leading to 
very stable formulations with a shelf-stability of more than 3 years. Finally, biological studies, 
including in vivo hemolytic assay and in vitro MCF-7 cell viability test, have well established that it 
was biocompatible after intravenous injection. It is important to mention that soluble branched or 
hyperbranched β-CD/PAA systems did not  display comparable results, if ever their performance 
were enormously lower.
It is noteworthy  that both synthetic strategies mostly provided us with the possibility to fulfill 
effective nanoparticles able to load high amount of hydrophobic drugs. Nevertheless, these roads 
usually  proceed at random and may not permit a good control of the macromolecular architecture, 
which is a fundamental regulatory request that should carefully considered in modern polymer 
chemistry. 
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1.3.4 PAAs AS SCAFFOLDS FOR REGENERATIVE MEDICINE
PAAs hydrogel scaffolds can be easily  obtained by different manners. Anyway, all procedures are 
based on the introduction of tetrafunctional monomers into the main polymer chain, thus enabling 
crosslinking reaction between parallel polymer chains. One of the most efficient means for 
achieving this, is to polymerize a stoichiometrically  balanced mixture of both acrylic (B2) and 
amine (A2) monomers in the presence of primary diamines (A4) (Scheme 1.3.4 A).245 
Scheme 1.3.4 A. Synthesis of PAA hydrogels via A2 B2 A4 system.
According with this scheme, having four different mobile hydrogens, the primary amine performs 
the role of cross-linking agent yielding to hydrogels. Using this technique, depending on the type 
and the degree of cross-linking, hydrogels absorbing large amounts of water can be obtained 
without great effort. An alternative widespread way leading to PAAs hydrogels make up of 
multistep  reaction that involves the preparation of linear doubly vinyl-terminated, low molecular 
weight PAAs, and hence the radical cross-linking of these molecules, after appropriate purification, 
by means of either UV or radical initiators (Scheme 1.3.4 B).246 It was found a considerable 
reduction of degradability due to carbon-carbon bonds, and so the bioelimination of degradation 
products must be carefully studied before using for biomedical applications. Another possible 
synthetic method consists of producing linear PAAs carrying primary  amino groups as side 
substituents (NH2-PAAs),247  which can be used as macromolecular and multifunctional cross-
linking agents (Scheme 1.3.4 C).248 
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Owing to its preformed polymer cross-linker, it  appears to be particularly convenient for preparing 
double network hydrogels with different PAA.249 
Scheme 1.3.4 B. Synthesis of PAA hydrogels via radical post-polymerization of doubly vinily-terminated PAA.
Scheme 1.3.4 C Synthesis of double network PAA hydrogels through insertion of primary amines as pendants: two 
different PAA networks (one in green and the other in red) occur.
The way in which PAA hydrogels are made affects their physico-chemical performance, such as 
swelling, degradability, and mechanical strength.  Mostly, degradation tests mimicking 
physiological conditions have shown that PAA degrade at rate dependent on the cross-linking 
degree, and their degradation product proved completely non-toxic.250 Furthermore, PAA hydrogels 
obtained by  radical cross-linking degrade more slowly than those synthesized with the other 
methods, in view of their less amount of water content. 
The swelling behavior of PAA hydrogels has been widely described in literature, since it is a key 
parameter to foresee the biocompatibility of biomaterials.251 
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Indeed, higher swelling degree usually seems to be connected with higher biocompatibility, because 
ensure an efficient diffusion of small molecules (e.g., nutrients, metabolites, and degradation 
products) across the material. PAA hydrogels can be considered super-absorbent material, having 
the quality to absorb from 120 to 2000 percent of water (v/w). In addition, as role, their swelling 
degree increases with decreasing their cross-linking degree. Owing to their polyelectrolytic nature, 
their swelling degree can be influenced by  several factors, such as: ionic strength, pH, and specific 
interaction with biomacromolecules. In particular, the swelling degree of deprotonated or 
protonated PAA hydrogels is higher than that their acid/base conjugate. As results of their high 
water content in the swollen state they have inadequate mechanical strength, conferring them a 
fragile consistency that needed to be improved.252
Overall, PAA hydrogels arisen from biocompatible PAAs are biocompatible and were tested as 
substrate for cell culturing and regenerative medicine.253 It was found that, as a rule, amphoteric but 
prevailingly anionic PAA are scarcely  adhesive, whereas several cationic or prevailingly cationic 
PAAs are adhesive towards different cell lines.254  In particular, hydrogels deriving from an 
amphoteric but prevailingly  cationic PAA, named AGMA1, were particularly  considered in this 
respect. However, AGMA1 hydrogels were not eligible as conduits for peripheral nerve 
regeneration for the lack of mechanical strength. AGMA1 hydrogels of somewhat improved 
mechanical properties were obtained by  radical post-polymerization of vinyl-terminated AGMA1 
oligomers. Tubes of this material, implanted in mice, proved biocompatible and capable of inducing 
peripheral nerve regeneration.252
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1.4 MALARIA AND ANTIMALARIAL DRUGS
Parasistic infections are of great significance because of the increasing incidence of infections in 
recent years, especially  in the underdeveloped country. Among the parasistic infections, malaria 
represents the most prevalent and devastating human infection in the world.255 Indeed, the global 
burden of the malaria, covered by the portfolio of the World Health Organization’s Special 
Programme of Research and Training in Tropical Diseases, point out that there are 42,280 
thousands of infections per year and 1,124 thousands of deaths per year in the world.256 In 2010, 
malaria was endemic in 106 countries, 46 of which are in sub-Saharan Africa where the most  highly 
pathogenic of the four malaria parasites (P. falciparum) that infect humans and the most effective 
malaria vector (Anopheles gambiae) are widespread.257
Malaria in humans can be caused by  four species of protozoa of the genus of Plasmodium: P. 
falciparum, P. malariae, P. vivax and P. ovale.258 The infection of P. falciparum is mostly liable for 
the deaths. Although malaria may be passed though blood transfusion, the principal way to transfer 
this parasite is the bite of the infected female mosquito of the genus of Anopheles. The life cycle of 
the Plasmodium is depicted in Figure 1.4 A. 
Figure 1.4 A. Illustration of the life cycle of malaria parasite (image from the reference259).
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In this illustration can be seen that the pathogenic parasite is activated in the liver, affording to 
merozoites which start and hold the erythrocytic cycle. This enables them to provide erytrolyses and 
finally the death of the whole organism.
There are many drugs that show an antimalarial activity towards Plasmodium at different step  of its 
life-cycle. The pharmacological activity of the most  important examples is reported in Table 1.4 A, 
in which can be noticed that:
• there is not a drug able to perform antisporozoites activity, thus entailing that it may not 
prevent the infection.
• no drug shows a pharmacological activity upon all hepatic and erythrocytic forms of the 
parasite.
Table 1.4 A.  Activity of the antimalarial drugs: the molecules are classified on the basis of the type 
of parasite stage that they kill. 
Sporozoite Liver Stages Erythrocytic Stages
Class I Schizont Ipnozoite Merozoite Gametocyte
Chloroquine - -              - +              +
Mefloquine - -              -       +              -       
Quinine, Quinidine - -              - +              +
Pyrimethamine - +              - +              -
Sulphadoxine - +              - +              -
Tetracicline - -              - +              -
Class II
Atovaquone - +              - +              -
Proguanil - +              - +              -
Class III
Primaquine - +              + -              +
Homopolymer Copolymer Homopolymer Copolymer Copolymer
Natural Synthetic Semi-synthetic
Cationic      Amphoteric      Anionic      Non ionic
Amorphous      Semicrystalline      Hydrogel-bonded      Supramolecular      Hydrocolloids
Hence, a good therapy should be performed by using a combination of two or more antimalarial 
drugs in order to optimizing the therapeutic effect. Unfortunately, the burgeoning problem of 
resistance to hitherto effective antimalarial agents in the last decade has added urgency  to the 
necessity to discover new drugs and to make better use of existing ones.260 However the genome of 
Plasmodium falfiparum has recently been decoded,258 providing novel drug targets that give 
researchers new insight into the resistance mechanism of parasite. These advantages have already 
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afforded to fosfidomycin as novel antimalarial agent thai is now being developed rapidly261, with 
more progress sure to follow.262 Another possibility  is to better formulate known drugs to improve 
their therapeutic index by  applying pharmacokinetic and pharmacodynamic principles. Currently, 
the adopted treatment of malaria is based on administration of artemisinin-derivatives used alone or 
in combination with other drugs.263  264  Artemisinin is a lactone sesquiterpene extracted from 
Artemisia Annua, that is active against all species of Plasmodium at all sexual erythrocytic stages. 
Artemisinin and their derivatives do not bring cross-resistance phenomena, and in a paradox 
Plasmodium that exhibit resistance towards chloroquine can be more sensitive towards artemisinin.
263 Its derivative has a power of about 10-100 times higher than the other drugs and are active 
towards gametocytes, the sexual stages that are essential for transmission.265 In spite of its powerful 
activity, due to its low oral bioavailability, artemisinin is hitherto replaced by  its derivatives, 
including dihydroatemisinin, artesunate, artemether and arteether.263 However, because of their high 
lipophilicity, poor water solubility  and low stability in gastric medium, these drugs are available 
only as oily formulations for intramuscular injection, which need sterile dosage and qualified health 
workforce.266 As the bioavailability of hydrophobic drugs is hardly improved when incapsulated in 
a core-shell system, lipid-based and block-copolymer-based micelles have been recently  developed 
for the oral administration of poorly  water-soluble antimalarial drugs.267 268 Further investigations 
should be focused upon the targeting of these antimalarial agent into Plasmodium-containing 
erythrocytes, thus avoiding the undesired side effects.
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CHAPTER 2
AIM OF THE WORK
2.1 HETERO-DIFUNCTIONAL DIMERS AS BUILDING BLOCKS FOR THE SYNTHESIS OF 
POLYAMIDOAMINES WITH HETERO-DIFUNCTIONAL CHAIN TERMINALS
Though the traditional synthesis of PAAs paved the way for the development of PAAs with interest-
ing biological activities, it has a serious limitations. In order to obtain high-molecular weight prod-
ucts the functions involved in the reaction, that are, activated double bonds and amine hydrogens, 
must be stoichiometrically  balanced. However, reacting mixture will contain at least three kinds of 
macromolecules, a-⠤⠤-a, b-⠤⠤-b, and a-⠤⠤-b in 1:1:2 ratio.  Hence, there is no way, by  the tradi-
tional method, to straightforwardly obtain PAAs with controlled hetero-difunctional chain termi-
nals, that is, PAAs solely containing molecules of a-⠤⠤-b type. This precluded to PAAs the access 
to the remarkable number of biotechnological applications, for instance liposomes preparation, con-
trolled drug conjugation, and protein modification, which have been so far nearly uniquely mastered 
by hetero-difunctional PEGs that, however, are far to be endowed with the functional versatility of 
PAAs. Two strategies exits, in principle, for unequivocally synthesizing hetero-diterminated PAAs, 
either the ring-opening polymerization of cyclic precursors or the self-polymerization of hetero-
difunctional a-a-b-b or a-a-b dimers (HDDs). The first strategy  was ruled out because it was thought 
difficult to design a cyclic PAA precursor amenable to thermal or catalytic ring-opening polymeri-
zation, especially  in the case of purpose-tailored PAAs carrying reactive side-substituents, as for 
instance carboxyl groups, liable to interfere in these processes. Therefore, the preparation of HDDs, 
in particular those of the a-a-b-b type, expected to polymerize according to Scheme 2.1 A, was pre-
ferred. We focalized our investigation to these HDDs because the procedure adopted in this investi-
gation was not easily applicable to the preparation of the a-a-b ones.
constituted of molecules doubly terminated by the excess
function. There is no way, by the traditional method, to
straightforwardly obtain PAAs with controlled hetero-difunc-
tional chain terminals, that is, PAAs solely containing mole-
cules of ‘‘a!! """""" !! b’’ type. This precluded to PAAs the
access to the remarkable number of biotechnological applica-
tions, for instance liposome preparation, drug conjugation,
and protein modification, which have been so far nearly
uniquely mastered by hetero-difunctional PEGs that, how-
ever, are far to be endowed with the functional versatility of
PAAs. In the past, a PAA-albumin conjugate was prepared by
employing a large excess of doubly vinyl-terminated, low-
molecular weight PAA apt to react with the exposed protein
thiol and amine groups. However, despite tedious purifica-
tion procedures, the presence of ‘‘bridged’’ protein molecules
could not be excluded.13
Two strategies exist, in principle, for unequivocally preparing
hetero-diterminated PAAs, either the ring-opening polymer-
ization of cyclic precursors or the self-polyaddition of het-
ero-difunctional (‘‘a!!a!!b!!b’’ or ‘‘a!!a!!b’’) dimers
(HDDs). The first strategy was ruled out because it was
thought difficult to design a cyclic PAA precursor amenable
to thermal or catalytic ring-opening polymerization, espe-
cially in the case of purpose-tailored PAAs carrying reactive
side-substituents, as for instance carboxyl groups, liable to
interfere in these processes. Therefore, the preparation of
HDDs, in particular those of the ‘‘a!!a!!b!!b’’ type,
expected to polymerize according to Scheme 2, was pre-
ferred. We limited our investigation to ‘‘a!!a!!b!!b’’ type
HDDs because the procedure adopted in this investigation
was not easily applicable to the preparation of the
‘‘a!!a!!b’’ ones. A different approach would be actually
needed, hopefully to be reported in a future article.
The synthetic scope of HDDs is manifold. They can be poly-
merized to high-molecular weight PAAs without bothering
with stoichiometric balance. PAAs of controlled average mo-
lecular weight and mono-functionalized with an acrylamide-
or a sec-amine group at one end can be prepared by adding,
respectively, a controlled amount of mono-functional acryla-
mides or sec-amines, whereas the addition of multifunctional
acrylamides or amines will lead to star-like PAAs. Block PAA-
PAA or PAA-PEG copolymers with controlled structure will
be easily obtained. ‘‘Velvety-like’’ grafting of PAA chains to
properly functionalized surfaces can be achieved. PAA chains
of controlled average length can be grafted to proteins with
no risk of undesirable side reactions such as protein–protein
coupling or crosslinking. ‘‘Tadpole-like’’ PAA conjugates with
hydrophobic moieties forming in aqueous media liposomes
or nanoparticles can be prepared as functional drug carriers.
Based on this premise, the aim of this article is to report on
the preparation of some model HDDs corresponding to PAAs
extensively studied for biomedical applications and to pro-
vide selected factual examples of their synthetic potential.
EXPERIMENTAL
Materials
2,2-Bis(acrylamido)acetic acid (BAC) and 1,4-bis(acryloyl)pi-
perazine (BP) were synthesized as previously described,14,15
lithium hydroxide monohydrate (98%), piperazine hexahy-
drate (P) (99%), 2-(R, S)-methylpiperazine (MP) (95%),
1,4,8,11-tetrazacyclotetradecane (Cyclam) (98%), di-(tert-
butyl)dicarbonate (97%), thiocholesterol (TC), bovine serum
albumin (BSA) (96%), 4-acryloylmorpholine (97%), morpho-
line (99.5%), guanidine hydrochloride (98%), glacial acetic
acid, hydrochloric acid (37%), sodium hydroxide (98.5%),
sodium chloride (99%), dichloromethane (reagent grade),
trifluoroacetic acid, DOWEXVR MAC-3 ion exchange resin were
purchased from Sigma-Aldrich and used as received.
Methods
Nuclear Magnetic Resonance (NMR) Spectra
1H NMR, 13C NMR, distortionless enhanced by polarization
transfer (DEPT), 1H-1H correlation (COSY), heteronuclear
multiple bond correlation (HMBC), and heteronuclear corre-
lation (HETCOR) spectra were run at room temperature on a
Bru¨ker Advanced 400 spectrometer operating at 400.132
and 100.623 M z, respectively.
Size Exclusion Chromatograp y
Size exclusion chromatography (SEC) traces were obtained
using a Knauer Pump 1000 equipped with a Knauer Auto-
sampler 3800, TKSgel G4000 PW, and G3000 PW TosoHaas
columns connected in series, light scattering/viscometer Vis-
cotek 270 Dual Detector and a refractive index detector
Waters model 2410. The mobile phase was a 0.1 M Tris
buffer pH 8.1 6 0.05 with 0.2 M sodium chloride. The sam-
ple concentration was 2% (w/v) and the flow rate 1 mL/
min. Triple detector SEC allowed determining, besides the
molecular weight, the long chain branching (LCB) frequency
of star-like PAAs by means of the dedicated Viskotek soft-
are, which compared their Mark–Houwink plots with those
of samples of th ir l near counterpart of approximately the
same molecular weight and used common Zimm–Stockmayer
equations and methods.16
Dyn m c Light Scattering
Dynamic light scattering (DLS) analysis was performed to
evaluate the hydrodynamic radius of polymeric micelles
using a Malvern NanoZS instrument (Malvern Instruments,
Worcestershire, UK) with a laser fitted at 532 nm and fixed
SCHEME 2 Self-polymerization of the ‘‘a!!a!!b!!b’’ type
HDDs.
SCHEME 1 Traditional synthesis of linear PAAs by Michael-
type polyaddition.
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Scheme 2.1 A. Self-polymerization of the a-a-b-b type HDDs.
The synthetic scope of HDDs is manifold. They can be polymerized to high-molecular weight PAAs 
without bothering with stoichiometric balance. PAAs of controlled average molecular weight and 
mono-functionalized with an acrylamide or a sec-amine group at one end chain can be prepared by 
adding, respectively, a controlled amount of mono-functional acrylamides or se-amines, wheras the 
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addition of multifunctional acrylamides or amines will lead to star-like PAAs. Block PAA-PAA or 
PAA-PEG copolymers with controlled structure will be easily obtained. “Velvety-like” grafting of 
PAA chains to properly functionalized surface can be achieved. PAA chains of controlled average 
length can be grafted to proteins with non risk of undesirable side reactions such as protein-protein 
coupling or crosslinking. “Tadpole-like” conjugate with hydrophobic moieties forming in aqueous 
media “liposomes” or core-shell polimeric nanomicelles can be prepared as functional drug carriers. 
Based on this premise, the aim of this work is to report on the preparation of some model HDDs 
corresponding to PAAs extensively studied for biomedical applications and to provide selected fac-
tual examples of their synthetic potential.
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2.2 HYPERBRANCHED POLYAMIDOAMINES FOR THE SYNTHESIS OF HIGH-
PERFORMANCE BIOMATERIALS
PAA-based nano-sized systems have been widely studied for using in biological and biomedical 
field. For instance, PAAs have been found to be able to complex and transport  gene, siRNA, and 
proteins into different cytotypes, enabling specific delivery  of many biocative macromolecules at 
subcellular level.1 2 Furthermore, PAAs containing hydrophobic moiety as side pendant have proved 
capable to form nanoparticles with hydrophobic core able to solublise and consequently release 
several hydrophobic drugs.3 Up to now, only linear PAAs have been considered for these purposes, 
although highly branched macromolecules have proved to be more effective due to the smaller size, 
more compact shape, and high concentration of terminal groups in their surface.4 In addition, they 
generally  exhibit  much lower solution viscosity  compared with linear polymers of the same molar 
mass, a characteristic that may  help  facilitate all technological and manufacturing and medical 
processes, including the administration. To our knowledge, no clear reports on branched or hyper-
branched PAAs have been published so far, while plenty  of information are available on the struc-
turally related (but not identical) PAMAM polymers, prepared by  self-polycondensation of 2-
aminoethylacrylamide hydrochloride that, being an “AB2” type monomer, automatically  gives rise 
to hyperbranched structures. 5  On the other hand, hydrogels consisting of cross-linked PAAs are 
well known and have been studied either as scaffolds for tissue engineering or as heavy metal ions 
absorbing resins.6 7 The easiest  way for preparing crosslinked PAAs is to partially or totally substi-
tute in their polymerization recipes amines bearing three or more reactive hydrogen atoms for the 
primary monoamines or the secondary bis-amines normally employed as monomers. Theoretical 
considerations led us to suppose that by properly adjusting the reaction conditions and particularly 
the monomers’ stoichiometric ratio, branched soluble PAAs could be obtained in the same way. A 
set of experiments was performed to substantiate this assumption. The aim of this work is to report 
on the results obtained.
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2.3 POLYAMIDOAMINE-BASED MULTILAYER NANOPARTICLES AS POTENTIAL GENE 
AND PROTEIN DELIVERY SYSTEMS
Synthetic polymers are receiving increasing attention as drug and gene delivery  vehicles as rational 
design makes it possible to modify the polymer properties, and thereby to optimize the structure-
activity relationships to induce a desired pharmokinetic profile. A common mechanism to engineer 
structures is to use electrostatics, and one can envisage a situation where multilayer vehicles are 
prepared from synthetic, positively and negatively charged polymers that  also incorporate electro-
statically negatively charged biological macromolecules such as DNA or RNA.8  Delivery  of the 
cargo is effected when such nanoparticles disassemble inside the cell as a result of pH changes, and 
the DNA is then able to be transported to the nucleus.9 Due to the versatility of layer-by-layer tech-
niques, a range of structurally diverse nanoparticles with wide potential application in the field of 
gene and protein delivery is accessible from a small number of components. Further tailoring of the 
outermost layer allows for specific intracellular up-take and, potentially, more control from the de-
livery profile point of view, since interaction with a specific cytotype or an appropriate biodistribu-
tion profile can be achieved by modifying the surface of nanoparticles with peptides, antibodies and 
lipids;10 Zhang et al have made lipid-based polyplexes to alter, through hydrophobic tails, the deliv-
ery properties of the system,11 a surface modification that reduces the interaction of the nanoparti-
cles with various serum proteins that would otherwise cause aggregation or degradation of the par-
ticles, thereby improving delivery; Kim et al have modified polyethylenimine (PEI) to produce non-
toxic interpolyelectolyte complexes for use as a carrier for siRNA.12 PEGylation of the surfaces of 
nanoparticles can confer stealth-like behavior of the nanoparticles due to decreasing interaction 
with plasma proteins and reticulo-endothelial system (RES). Whilst  such approaches have had some 
success, these polymers are not totally  biodegradable or exhibit cytotoxicity in-vivo that has hin-
dered practical application.13 By contrast, PAAs are degradable and biocompatible synthetic polye-
lectrolytes. Therefore, the encapsulation of drugs, proteins or genetic material in multilayer PAA-
based nanoparticles can efficiently provide a method for assembling gene/protein delivery systems 
with appropriate biodistribution characteristics and biocompatibility. Recently, we showed that the 
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degree of ionization of each ionic group is only weakly dependent on the ionization state of the en-
tire PAA molecule and thus, the charge distribution of the polymer can be engineered through an 
appropriate choice of monomer,14 enabling a more facile and modular approach to nanoparticle de-
sign. Taking that insight as a reference for current study, the aim of this work was to investigate the 
feasibility of PAA-based multilayer nanoparticles prepared using layer-by-layer approaches as gene 
or protein delivery systems, focusing on four possible combinations of biocompatible PAAs. Ex-
perimentally, the focus has been the charge, size and localized dynamics of each particular layer 
within the nanoparticle assembly, against a background of an acceptable cytotoxicity profile.
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2.4 ISA23-BSA CONJUGATE AS ANTIMALARIAL DELIVERY SYSTEMS
Malaria is one of the main medical concerns worldwide because of the numbers of people affected, 
the severity of the disease, and the complexity of the life cycle of its causative agent, the protozoan 
Plasmodium. The arsenal of strategies deployed to hinder this infection has included chemotherapy 
by using combination of drugs and vaccination approaches, none of them being capable yet of 
claiming victory.15 The emergence of drug resistance severely  limits the arsenal of available drugs 
against protozoal pathogens.16 The development of resistance is favored in any situation in which 
parasites are exposed to a low level of antimalarial drug, for instance where a full course of treat-
ment is not completed, or where long-acting drugs are administered, which are eliminated slowly 
from the body. With the advent of nanomedicine, renewed hopes have appeared of finally obtaining 
the magic bullet against  malaria. Novel delivery formulations are likely to optimize the therapeutic 
efficacy of antimalarials. In particular, targeted nanovectors, such as liposomes, solid-lipid nanopar-
ticles, nano-/microemulsions and polymer-based nanocarriers have been receiving special attention 
in order to minimize the side effects of drug therapy and achieve the intake of doses sufficiently low 
to be innocuous for the patient but locally high enough to be lethal for the malaria parasite.17 18 The 
aim of this work was to design a prototype nanovector for the targeted delivery of antimalarial 
drugs exclusively to P. falciparum-infected red blood cells (pRBC), and capable of reaching the 
preclinical pipeline in the short term. Preliminary targeting analysis by fluorescence-assisted cell 
sorting (FACS) indicated that fluorescein-labeled ISA23 has an almost complete target specificity 
towards pRBC. Furthermore, in vitro experiments demonstrated that ionic complexes of ISA23 with 
primaquine significantly increased its activity. In the light of this, highly water-soluble ISA23/
albumin graft-copolymers, sharing the stealth-like properties of ISA23 and the drug binding ability 
of the albumin core, have been developed. Overall, the binding ability and the antimalarial activity 
were explored in order to assemble a Troyan horse “nanocapsule” targeting pRBC with complete 
specificity of delivering its antimalarial cargo inside these cells, and of eliminating detectable para-
sitemia both in P. falciparum cultures and in malaria-infected mice.
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2.5 POLYAMIDOAMINE HYDROGELS AS SCAFFOLDS FOR IN VITRO CULTURING OF 
PERIPHERAL NERVOUS SYSTEM CELLS
Hydrogels can be considered an attractive alternative to rigid hydrophobic materials for the produc-
tion of conduits for nerve regeneration, since they are biomimetic because of their high water con-
tent. 
PAAs are synthetic water soluble polymers, and most of them are endowed with physico-chemical 
and biological properties making them appealing as biomaterials. Cross-linked PAAs can be ob-
tained by  using as cross-linking agents multifunctional amines, affording to  hydrogel which absorb 
large amounts of water. In addition, PAA hydrogels arisen from biocompatible linear PAAs are usu-
ally biocompatible and biodegradable to non-toxic products. Although several PAA hydrogels were 
tested as substrate for cell culturing and conduits for peripheral nerve regeneration, actually,  neither 
of them display suitable characteristics for achieving nerve regeneration in vivo owing to their 
scarce mechanical strength.19 In view of clinical applications, this work deal with the evaluation of 
two families of PAA hydrogels, prepared by  polyaddition of piperazine and 1,2-diaminoethane as 
cross-linking agent with N,N'-methylenebisacrylamide or 1,4-bisacryloylpiperazine, as scaffolds for 
Schwann cells (SC) and dorsal root ganglia (DRG) neuron culturing. 
The aim was to obtain new hydrogel materials combinig mechanical properties with ability to pro-
mote SC and DRG cell adhesion and/or proliferation, to be used as tubular conduits for in vivo pe-
ripheral nerve regeneration. The rationale was to capitalize on the structure-forming ability of these 
PAAs as linear polymers, which might be maintained, to some extent, in the cross-linked form.
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CHAPTER 3
MATERIALS AND METHODS
3.1 MATERIALS
2,2-Bis(acrylamido)acetic acid (BAC) and 1,4-bis(acryloyl)piperazine (BP) were synthesized as 
previously  described.1 2 Lithium hydroxide monohydrate (98%), piperazine hexahydrate (P) (99%), 
1,4,8,11-tetrazacyclotetradecane (Cyclam) (98%), di-(tert-butyl)dicarbonate (97%), thiocholesterol 
(TC), bovine serum albumin (BSA) (96%), 4-acryloylmorpholine (97%), morpholine (99.5%), gua-
nidine hydrochloride (98%), glacial acetic acid, hydrochloric acid (37%), sodium hydroxide 
(98.5%), sodium chloride (99%), dichloromethane (reagent grade), trifluoroacetic acid, DOWEX 
MAC-3 ion exchange resin, deuterium oxide (99.9 atom % D), N,N’.methylenebisacrylamide 
(MBA) (99%), PBS, chlorotrimethylsilane (98%), ethanol (95%), 4-amino-TEMPO (TEMPO) 
(98%), N,N’-bis(2-hydroxyethyl)ethylenediamine (HEEDA) (98%), potassium hydroxide (99%) 
sodium dodecyl sulphate (SDS) (98%) and 1-amino-4-guanidinobutane sulphate salt (Agmatine) 
(97%), tris(hydroxymethyl)aminomethane (tris) (99%), chloroquine bisphosphate (98%), pri-
maquine bisphosphate (98%), fluorescein 5-isothiocyanate (FITC) were purchased from Sigma-
Aldrich and used as received. 1,2-diaminoethane (ethylenediamine) (99%) and 1,4-diaminobuthane 
was purcheased from Fluka and purified just before use by  distillation. Piperazine anhydrous (99%), 
2-(R, S)-methylpiperazine (MP) (95%), and trans-2,5-dimethylpiperazine (98%) were purcheased 
from Sigma-Aldrich and purified before use by sublimation.
ISA1, ISA23, AGMA1, BACEDDA were synthesized as previously  described,3 4 their salient fea-
tures are reported in Table 3.2.3 B.
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3.2 METHODS
Nuclear Magnetic Resonance (NMR) Spectra. 1H NMR, 13C NMR, distortionless enhanced by  po-
larization transfer (DEPT), 1H- 1H correlation (COSY), heteronuclear multiple bond correlation 
(HMBC), and heteronuclear correlation (HETCOR) spectra were run at room temperature on a 
Bruker Advance 400 spectrometer operating at 400.132 and 100.623 MKz, respectively. 
Electron Paramagnetic Resonance (EPR) Spectra. EPR spectra were recorded using a cw-Bruker 
EMX spectrometer (BrukerBiospin, UK) fitted with a high-sensitivity cavity (ER 4119HS) operat-
ing at X-band frequencies (9.5 GHz) at room temperature,with 100 kHz field modulation and 
10mW microwave power.
Size Exclusion Chromatography (SEC). SEC traces were obtained using a Knauer Pump 1000 
equipped with a Knauer Autosampler 3800, TKSgel G4000 PW and G3000 PW TosoHaas columns 
connected in series, using a light scattering (LS)/viscosimeter Viscotek 270 Dual Detector, coupled 
to a refractive index detector (Waters model 2410). The mobile phase was a 0.1 M Tris buffer (pH 
8.0 ± 0.05) with 0.2 M sodium chloride. The sample concentration was 2% (w/v) and the flow rate 1 
mL/min Triple detector SEC allowed determining, besides the molecular weight, the long chain 
branching (LCB) frequency of star-like PAAs by means of the dedicated Viskotech software, which 
compared their Mark-Houwink plots with those of samples of their linear counterparts of approxi-
mately the same molecular weight and used common Zimm-Stockmayer equation and methods.5 
Dynamic Light Scattering (DLS). DLS analysis was performed to evaluate the hydrodynamic di-
ameter of polymeric micelles and self-assembled nanoparticles using a Malvern NanoZS instrument 
(Malvern Instruments, Worcesterchire, UK) with a laser fitted at 532 nm and fixed 173° scattering 
angle.
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5 Zimm, B.; Stockmayer, W., H., J. Chem. Phys., 1949, 17, 1301-1314.
3.2.1 HETERO-DIFUNCTIONAL DIMERS AS BUILDING BLOCKS FOR THE SYNTHESYS 
OF POLYAMIDOAMINES WITH HETERO-DIFUNCTIONAL CHAIN TERMINALS
Synthesis of 4-N-Boc-2-(R, S)-methylpiperazine (MP-Boc). Typically, 2-(R,S)-methylpiperazine 
(MP) (21.1 g,  0.200 mol) was dissolved in tap water (1.2 L) and glacial acetic acid (12.0 g, 0.197 
mol) was added. The mixture was gently stirred for 15 minutes then cooled to 0 °C. After this time, 
a solution of di-(tert-butyl)dicarbonate (34.9 g, 0.160 mol) in methanol (150 mL) was added drop-
wise in 30 minutes to the reactive mixture. During this time the reaction was vigorously stirred and 
the temperature gradually warmed up to room temperature. The reaction was maintained under this 
condition for further 20 minutes, then the precipitated formed filtered and the pH was adjusted to 
5.5 with 1M HCl. The aqueous phase was extracted with CH2Cl2 (2x100 mL) to separate the disub-
stituted derivative then the pH was adjusted to 9.5 with 1M NaOH. The desired product was recov-
ered by repeated extraction with CH2Cl2 (5x200 mL), the organic layers collected and dried over 
anhydrous sodium sulphate. The solvent was evaporated to afford the crude solid. Yield: 90 %.
1H NMR (CDCl3, δ, ppm): 0.99 (d, HNCH2CHCH3), 1.41 (s, (CH3)3C), 1.57 (br, NHCH2CH), 2.34 
(br, axial NHCH2CH), 2.64 (m, NHCH2CH), 2.72 (m, axial NHCH2CH2NBoc), 2.90 (m, equatorial 
NHCH2CH),  2.95 (br, equatorial NHCH2CH2N). 13C NMR (D2O, δ, ppm): 19.16 (CH3CH), 28.15 
((CH3)3CO), 45.71 (HNCH2CH2N, CH3CHCH2N), 51.65 (CH3CH), 79.51 ((CH3)3CO), 154.70 
(NCO). Anal. Calcd for: C10H20N2O2: C, 59.97; H, 10.07; N, 13.99. Found: C, 59.12; H, 10.13; N, 
13.75.
Synthesis of N-Boc-Piperazine (P-Boc). P-Boc was synthesized following the same procedure 
above described for MP-Boc using piperazine hexahydrate (25.0 g, 0.129 mol), glacial acetic acid 
(7.6 g,  0.127 mol), di-(tert-butyl)dicarbonate (23.2 g, 0.103 mol) and tap  water (1.2 L).  Yield: 
87%. 
1H NMR (CDCl3, δ, ppm): 1.47 (s, (CH3)3C), 1.82 (br, NHCH2CH2NBoc), 2.81 (m, 
HNCH2CH2NBoc), 3.40 (m, NHCH2CH2NBoc). 13C NMR (D2O, δ, ppm): 28.97 ((CH3)3CO), 
45.21 (HNCH2CH2N), 79.52 ((CH3)3CO), 154.84 (NCO). Anal. Calcd for: C9H18N2O2: C, 58.04; 
H, 9.74; N, 15.04. Found: C, 56.12; H, 10.78; N, 14.46.
Synthesis of BAC-P. To a vigorously stirred solution of N-Boc-piperazine (1.3200 g, 7.042 mmol) in 
bidistilled water (15 mL) cooled at 0 °C, a solution of 2,2-bis(acrylamido)acetic acid (BAC) 
(2.8000 g, 14.084 mmol) and LiOH.H2O (0.5963 g, 14.084 mmol) in bidistilled water (30 mL) was 
added dropwise. The reaction was maintained at 0 °C and left under stirring for 2 days. After this 
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period, the crude reaction mixture was purified by ionic exchange chromatography on Dowex Mac-
3 (8x60 cm) using bidistilled water (500 mL), and then an acid concentration elution gradient pass-
ing from 10-4 M to 0.1 M  hydrochloric acid (1000 mL total). The product obtained was freeze-dried 
then dissolved in trifluoroacetic acid to obtain a 1 M  solution maintained for 3 hours under gentle 
stirring in nitrogen atmosphere. The product was precipitated by  addition of diethyl ether (10 mL), 
washed with fresh solvent (3 x 10 mL) and dried under vacuum affording a white and deliquescent 
solid. Yield: 55%. 
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Calcd for: C12H20N4O4: C, 
50.69; H, 7.09; N, 19.71.  Found: C, 49.46; H, 7.31; N, 18.83.
Synthesis of BAC-MP. The reaction and purification of BAC-MP were carried out as previously de-
scribed for BAC-P using BAC (2.8000 g, 14.084 mmol), LiOH.H2O (0.5963 g, 14.084 mmol) and 
4-N-Boc-2-methylpiperazine (1.4100 g, 7.042 mmol) as reagents. Yield: 60%.
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Calcd for: C13H22N4O4: C, 
52.34; H, 7.43; N, 18.78.   Found: C, 50.47; H, 7.62; N, 17.89.
Synthesis of MBA-P. To a solution of MBA (4.7438 g, 30.77 mmol) in bidistilled water (220 mL) a 
solution of N-Boc-piperazine (1.9297 g, 10.46 mmol) in bidistilled water (50 mL) was added drop-
wise under stirring at 0 °C.  The reaction was maintained at 0 °C for 48 hours and monitored by 
TLC using 2-propanol/water/0.15 M acetate buffer pH 5.5  = 2:2:6 (v/v) as eluant. During this time a 
precipitate was formed that was filtered off and the solution acidified at pH 3.0 using 1 M hydro-
chloric acid.  Unreacted MBA was successfully eliminated by repeated extraction with diethyl ether 
(5x100 mL) and ethyl acetate (2x150 mL). The aqueous solution was treated with 5 % hydrochloric 
acid (4.6 mL) and stirred for 24 hours. The mixture was then freeze dried and the product obtained 
as a white solid. Yield: 70%. 
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Calcd for: C11H20N4O2: C, 
54.98; H, 8.39; N, 23.32. Found: C, 49.98; H, 8.83; N, 21.14.
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Table 3.2.1 A.  Full NMR characterization (D2O, δ) of all HDDs.
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S1. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-P dimer.
a)
b)
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S2. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-MP dimer.
a)
b)
Table S1. 1H NM  and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 8.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.1 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.7 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S3. 1H NMR (panel a) and 13C NMR (panel b), (D2O)  of  MBA-P dimer.
a)
b)
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S4. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  MBA-MP dimer.
a)
b)
Figure S5. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-P dimer.
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 70.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a)
b)
Figure S6. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-MP dimer.
able S1. 1   and 13   ( 2 , , pp ) data of all s!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC- P 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
BA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
BA- P 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP- P 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a)
b)
Figure S7. 1H NMR, (D2O) of  BAC-MP-Acryloylmorpholine conjugate (BAC-MP-AM).
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 8.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a) equatorial, b) axial, c) cis, d) trans
Synthesis of MBA-MP, BP-P, BP-MP. The same procedure above described for MBA-P was fol-
lowed.
MBA-MP
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Anal. Calcd for 
C12H22N4O2: C, 56.67; H, 8.72; N, 22.03.  Found C, 51.92; H, 9.11; N, 19.74.
BP-P
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Anal. Calcd for 
C14H24N4O2: C, 59.98; H, 8.63; N, 19.98.  Found: C, 59.43; H, 8.73; N, 19.59.
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BP-MP
The full NMR characterization (D2O) is reported in Table  3.2.1 A. Anal. Anal. Calcd for 
C15H26N4O2: C, 61.20; H, 8.90; N, 19.03.  Found: C, 61.25; H, 9.02; N, 18.98.
Synthesis of BAC-MP Homopolymer (ISA23). To a solution of BAC-MP (0.4 g, 1.3408 mmol) in 
bidistilled water (450 µL) 1 M  NaOH was added dropwise until pH 9 and the reaction kept under 
stirring at room temperature for 5 days in nitrogen atmosphere After this period the mixture was 
acidified to pH 4.4-5.5 with 37% HCl, filtered through a paper filter then ultrafiltered through a 
membrane with nominal cut-off of 3000. The product was obtained after freeze-drying as a yel-
lowish solid. Yield: 79%. 
Mn = 38000, Mw = 50000, Mw/ Mn = 1.32, Rh = 7.4 nm, [η] = 0.567 dL/g, a = 0.773, logK = 
-3.855. 1H NMR (D2O, δ, ppm): 1.26 (d, CH3CH), 2.64 (m, CH2CONH), 2.85 (m, CHCH3), 3.07 
(br, NCH2 MP ring), 3.28 (br, equatorial NCH2CH2 MP ring), 3.28 (br, axial NCH2CH2N MP ring, 
NCH2CH2), 5.51, 5.45 (ds, CHCOOH and CHCOO-).
Synthesis of BP-P Homopolymer. The reaction was carried out as above reported, starting from BP-
P (0.7200 g, 5.569 mmol) dissolved in bidistilled water (1.4 mL). After 5 days under gentle stirring 
the mixture was acidified with concentrated HCl, filtered through a paper filter then ultrafiltered 
through a membrane with nominal cut-off of 3000.  The pure product was recovered after freeze-
drying. Yield: 72.5 %. 
Mn = 30900, Mw = 38000, Mw/ Mn = 1.13, Rh = 3.808 nm, [η] = 0.294 dL/g, a = 1.01, logK = 
-4.703. 1H NMR (D2O, δ, ppm): 2.58 (br, CH2CONH), 3.06 (s, NCH2 piperazine ring), 3.12 (m, 
NCH2CH2), 3.31 (br, CH2NCO piperazine ring), 3.38 (br, CH2NCO piperazine ring).
Synthesis of BAC-MP-Acryloylmofpholine Conjugate. Acryloylmorpholine (4.4 mg, 0.035 mmol) 
was dissolved in 0.1 M  sodium hydroxide (150 µL) and BAC-MP (100.0 mg, 0.335 mmol) was 
added under vigorous stirring until a clear solution was obtained. Then 1 M NaOH was dropped 
into the reaction mixture until pH 8.5 was reached, and the reaction was kept 3 days at room tem-
perature under nitrogen atmosphere. After this time the mixture was acidified at  pH 5 by the addi-
tion of 1 M HCl. The final product was obtained after freeze drying. Yield: 97%. 
Mn = 3200, Mw = 4100, Mw/ Mn = 1.28, Rh = 6.8 nm, [η] = 0.234 dL/g, a = 0.781, logK = -3.74. 
1H NMR (D2O) is reported in Table 3.2.1 B.
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Table 3.2.1 B.  1H NMR chemical shifts (δ) of BAC-MP-AM conjugate,  star-like BAC-MP-Cyclam 
(BAC-MP-Cy), star-like BP-MP-Cyclam (BP-MP-Cy) in D2O.
# 1 2 3 4 5 6/7 8 9 10 11
BP-MP-Cy 1H 3.87 a); 
3.48 b)
3.79 3.68 3.63 3.57 3.48 3.05 2.99 1.85 1.48; 
1.38
# 1 2 3 4/5/6 7 8 9 10
BAC-MP-Cy 1H 5.65 3.78 3.78a);
 3.44b)
3.44 3.16 2.82 1.96 1.45; 
1.38
# 1 2 3 4 5/6 7/8/9/10 11 12
BAC-MP-AM 1H 6.22 5.77 5.62;
 5.56
4.05 3.62 3.20 2.75 1.39
1 2 3 4 5/6 7/8/9/10 11 12
BAC-MP-AM 1H 6.2
2
5.7
7
5.62; 5.56 4.0
5
3.6
2
3.20 2.7
5
1.3
9
Figure S8. 1H NMR, (D2O) of  BAC-MP-Cyclam based star polymer (BAC-MP-C).
1 2 3 4/5/6 7 8 9 10
BAC-MP-C 1H 5.6
5
3.7
8
3.78 ax; 3.44 eq 3.44 3.1
6
2.8
2
1.9
6
1.45; 1.38
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Figure S9. 1H NMR, (D2O) of  BP-MP-Cyclam based star polymer (BP-MP-C).
# 1 2 3 4 5 6/7 8 9 10 11
BP-MP-Cy 1H 3.87 a); 
3.48 b)
3.79 3.68 3.63 3.57 3.48 3.05 2.99 1.85 1.48; 
1.38
# 1 2 3 4/5/6 7 8 9 10
BAC-MP-Cy 1H 5.65 3.78 3.78a);
 3.44b)
3.44 3.16 2.82 1.96 1.45; 
1.38
# 1 2 3 4 5/6 7/8/9/10 11 12
BAC-MP-AM 1H 6.22 5.77 5.62;
 5.56
4.05 3.62 3.20 2.75 1.39
# 1 2 3 4 5 6/7 8 9 10 11
BP-MP-Cy 1H 3.87 a); 
3.48 b)
3.79 3.68 3.63 3.57 3.48 3.05 2.99 1.85 1.48; 
1.38
# 1 2 3 4/5/6 7 8 9 10
BAC-MP-Cy 1H 5.65 3.78 3.78a);
 3.44b)
3.44 3.16 2.82 1.96 1.45; 
1.38
# 1 2 3 4 5/6 7/8/9/10 11 12
BAC-MP-AM 1H 6.22 5.77 5.6 ;
 5.56
4.05 3.62 3.20 2.75 1.39
# 1 2 3 4 5 6/7 8 9 10 11
BP-MP-Cy 1H 3.87 a); 
3.48 b)
3.79 3.68 3.63 3.57 3.48 3.05 2.99 1.85 1.48; 
1.38
# 1 2 3 4/5/6 7 8 9 10
BAC-MP-Cy 1H 5.65 3.78 3.78a);
 3.44b)
3.44 3.16 2.82 1.96 1.45; 
1.38
# 1 2 3 4 5/6 7/8/9/10 11 12
BAC-MP-AM 1H 6.22 5.77 5.62;
 5.56
4.05 3.62 3.20 2.75 1.39
a) equatorial, b) axial
Synthesis of Star-like BAC-MP. To a solution of cyclam (2.0 mg, 0.001 mmol) in 0.5 M NaOH (150 
µL), BAC-MP (100.0 mg, 0.335 mmol) was added and the reaction left  5 days at pH 8 under gentle 
stirring. After this time the mixture was freeze-dried and the dry product recovered. Yield: 98%. 
Mn = 10800, Mw = 11660, Mw/ Mn = 1.08, [η] = 0.125 dL/g, a = 0.607, logK = -3.706, branching 
frequency = 2.17. . 1H NMR (D2O) is reported in Table 3.2.1 B.
Synthesis of Star-like BP-MP. The same procedure above described was followed using cyclam 
(20.4 mg, 0.102 mmol), 0.5 M sodium hydroxide (550 µL) and BP-MP (300.0 mg, 1.020 mmol). 
The reaction was filtered through a paper filter and the crude product freeze-dried. Yield: 97%. 
Mn = 3300, Mw = 3900, Mw/ Mn = 1.21, [η] = 0.128 dL/g, a = 0.521, logK = -3.823, branching 
frequency = 2.08. . 1H NMR (D2O) is reported in Table 3.2.1 B.
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Synthesis of BAC-P-grafted-BSA. Guanidine hydrochloride (0.5056 g, 5.190 mmol) was dissolved 
in bidistilled water (5 mL), BSA (1.5065 g, 0.023 mmol) was added and the mixture was vigorously 
stirred for 10 minutes until a clear solution was obtained. BAC-P (0.3190 g, 1.122 mmol) was then 
added to the mixture and the pH was adjusted at 8.0 by the addition of solid Na2CO3. The reaction 
was kept under nitrogen atmosphere and gentle stirring for 5 days. The mixture was purified by di-
alysis against water (membrane cut-off 50000) and the pure product collected after freeze-drying. 
Yield: 72%. 
Mn = 1,01,000, Mw/ Mn = 1.07, Rh = 6.1 nm, [η] = 0.203 dL/g, a = 0.203, logK = -2.74.
Synthesis of BAC-MP-grafted-BSA. The reaction was carried out following the same procedure de-
scribed for BAC-P-grafted-BSA using guanidine hydrochloride (0.5056 mg, 5.190 mmol), BSA 
(1.5065 g, 0.023 mmol), BAC-MP (0.3347 g, 1.122 mmol). The pure product was obtain after the 
usual ultrafiltration procedure and freeze drying. Yield: 84%. 
Mn = 84,900, Mw/ Mn = 1.17, Rh = 4.11 nm, [η] = 0.053 dL/g, a = 0.265, logK = -2.58.
Synthesis of BP-P-grafted-BSA. The same procedure as in the previous case was followed using 
guanidine hydrochloride (0.5056 mg, 5.190 mmol), BSA (1.5065 g, 0.023 mmol), BP-P (0.3146 
mg, 1.122 mmol). The usual work-up afforded the pure product. Yield: 79%. 
Mn = 88,100, Mw/ Mn = 1.14, Rh = 5.90 nm, [η] = 0.083 dL/g, a = 0.163, logK = -2.04.
Synthesis of Hetero-difunctional BAC-MP-TC. To a solution of BAC-MP (103.3 mg, 0.251 mmol) 
in bidistilled water (1 mL), thiocholesterol (TC) (10.1 mg, 0.025 mmol) dissolved in diethyl ether 
(0.1 mL) was added and the formation of a macroemulsion was observed. The pH was adjusted to 
7.0 by the addition of 3 M NaOH and the mixture vigorously  stirred for 2 days. Then, 1 M NaOH 
was added until pH 9 and the reaction maintained in this condition under stirring for further 5 days. 
After this time, the mixture was acidified to pH 5 by  the addition of 1 M  HCl and purified by dialy-
sis against water (membrane cut-off 3500) for 2 hours. The crude product collected after freeze dry-
ing was suspended in diethyl ether (2 mL) to remove unreacted thiocholesterol, and dried in vac-
uum. Yield: 38%.
Anal. Calcd for (C13H22N4O4)10-(C27H46S): C, 55.69; H, 7.92, N, 16.55. Found: C, 51.98; H, 8.46, 
N, 18.15.
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Synthesis of Hetero-difunctional MBA-P-TC. The reaction was carried out following the same pro-
cedure as in the previous case using MBA-P (60.3 mg, 0.251 mmol) and TC (10.1 mg, 0.025 
mmol). Yield: 29%. 
Anal. Calcd for (C11H20N4O2)10-(C27H46S): C, 58.64; H, 8.84; N, 19.97. Found: C, 58.00; H, 8.76; 
N, 20.56.
Synthesis of Hetero-difunctional BP-P-TC. The reaction was carried out following the same proce-
dure as in the case of ISA23-TC using: BP-P (70.4 mg, 0.251 mmol) and TC (10.1 mg, 0.025 
mmol). Yield: 44%. 
Anal. Calcd for (C14H24N4O2)10-(C27H46S): C, 62.56; H,8.99; N, 17.48. Found: C, 61.42 ; H, 8.83; 
N, 18.60.
Synthesis of Hetero-difunctional BP-MP-TC. The reaction was carried out following the same pro-
cedure as in the case of ISA23-TC using: BP-MP (73.9 mg, 0.251 mmol) and TC (10.1 mg, 0.025 
mmol). Yield: 36%. 
Anal. Calcd for (C15H26N4O2)10-(C27H46S): C, 63.53; H, 9.21; N,16.74.  Found: C, 62.75; H, 9.11; 
N, 17.50.
Dynamic Light Scattering (DLS). DLS analysis was performed to evaluate the hydrodynamic di-
ameter of polymeric micelles using a Malvern NanoZS instrument (Malvern Instruments, Worces-
terchire, UK) with a laser fitted at 532 nm and fixed 173° scattering angle. DLS measurements were 
carried out  on two sets of experiments. In the first, samples were prepared in phosphate buffer solu-
tion (PBS) saline in the concentration range of 0.1-1 mg/ml and measurements were performed at 
fixed temperature (25 °C). In the second one, the sample was prepared in PBS saline with concen-
tration of 1 mg/ml, and the measures were performed varying the temperature: 20, 25, 30, 35, 40, 
45, 50, 55, and 60 °C. Before each analysis, the samples were filtered though a syringe filter (5 µm 
pore size; Watmann, UK) to remove the dust. All data were evaluated as numeral distribution of the 
hydrodynamic diameter. 
Transmission Electron Microscopy (TEM). TEM analysis of self-assembled polymeric BAC-MP-
TC micelles was captured using the negative staining technique. A solution of BAC-MP-TC (1 mg/
ml) in ultrapure water at pH 7.4 was prepared; then a 5 µl aliquot was deposited onto a Formvar-
coated Cu grid (400 Mesh). After adsorption, the grid was stained with 1% uranyl acetate solution 
(5 µl), wiped away by means of a paper filter and died at room temperature. Observation was made 
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by using a LEO 912 AB energy-filtering transmission electron microscopy (EFTEM; Carl Zeizz, 
Obercochen, Germany) operating at 80 kV. Digital images were collected by Proscan 1K slow-scan 
charge-coupled device camera (Proscan Scheuting, Germany).
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3.2.2 HYPERBRANCHED POLYAMIDOAMINES FOR THE SYNTHESIS OF HIGH-
PERFORMANCE BIOMATERIAL
Polymerization: General procedure. 
BAC series (reaction 1.1 from Table 3.2.2 A as model of synthesis). BAC (555.8 mg , 2.6250 mmol, 
purity  93.6%) was dissolved in 1.00 mL deoxygenated doubly distilled water under nitrogen atmos-
phere in the presence of lithium hydroxide (63.5 mg, 2.6250 mmol). The amines (EDA,22.8 mg, 
0.3750 mmol ; and P, 254.2 mg, 3.0000 mmol) were then added at once all together and the mixture 
gently stirred until homogeneous and maintained at 20°C under nitrogen for 7 days with intermit-
tent stirring. After this time, the reaction mixture was acidified to pH ? 4 (1M  HCl). The product, if 
soluble, was purified by  dissolving in water and ultrafiltering through a membrane with nominal 
cut-off 1000. It was finally recovered by freeze-drying and the yield determined. Characterizations 
were performed on the final product. In the case of gel formation, the gel time was estimated and 
the polymerization was then allowed to proceed as described. The final product, after acidification, 
was thoroughly extracted with water, dried, and the yield determined. The soluble extracts, if any, 
were not further characterized. The exact amounts of all reagents for each preparation are reported 
in Table 3.2.2 A and Table 3.2.2 B.
Table 3.2.2 A. Amount of reagent for the system based on 2,2’-
bisacrylamidoacetic acid and ethylenediamine.a)
!"#$%&'()#%*'+,'-.-/0(1#)23"4)&1*+)2%$12')21*'),*'%$5"4%,%*1)&1,%')#'$%$3)67,2$1+,)4'&+,+&%3')8.(8'
 
 
N° BAC 
(Mol x 10-3) 
EDA 
(Mol x 10-3)  
P  
(Molx 10-3) 
M  
(Mol x 10-3) 
1.1 2.6250 0.3750 3.0000 - 
1.2 2.4975 0.3750 3.0000 - 
1.3 3.1875 0.3750 3.0000 - 
1.4 1.6665 0.2500 2.0000 - 
1.5 4.9342 0.3750 3.0000 - 
1.6 5.1370 0.3750 3.0000 - 
1.7 5.6222 0.3750 3.0000 - 
1.8 3.9280 0.4550 3.0000 2.0000 
1.9 3.5000 1.3333 3.0000 - 
1.10 3.3333 1.3333 3.0000 - 
1.11 4.2500 1.3333 3.0000 - 
1.12 5.0000 0.8889 2.0000 - 
1.13 4.8000 1.3333 3.0000 2.0000 
'
'
)8 9:;<-.-/0(1#)23"4)&1*+)2%$12')21*='>?:<%$5"4%,%*1)&1,%='@<A1A%3)B1,%='C<&+3A5+41,%D'
'
N° BP 
(Mol x 10-3) 
EDA 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
2.1 2.6250 0.3750 3.0000 - 
2.2 2.4975 0.3750 3.0000 - 
2.3 3.1875 0.3750 3.0000 - 
2.4 1.6665 0.2500 2.0000 - 
2.5 4.9342 0.3750 3.0000 - 
2.6 5.1370 0.3750 3.0000 - 
2.7 5.6222 0.3750 3.0000 2.0000 
2.8 3.9280 0.4550 3.0000 2.0000 
2.9 3.5000 1.3333 3.0000 - 
2.10 3.3333 1.3333 3.0000 - 
2.11 4.2500 1.3333 3.0000 - 
2.12 5.0000 0.8889 2.0000 - 
2.13 4.8000 1.3333 3.0000 2.0000 
'
'
'
N° 
BAC 
(Mol x 10-3) 
Cy 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
3.1 2.6250 0.3750 3.0000 - 
3.2 2.4975 0.3750 3.0000 - 
3.3 3.1875 0.3750 3.0000 - 
3.4 1.5630 0.1250 1.0000 - 
3.5 3.3000 0.1250 1.0000 - 
3.6 3.3000 0.1250 1.0000 - 
3.7 3.9280 0.4550 3.0000 2.0000 
 
a) BAC= 2,2’-bisacrylamidoacetic acid, EDA=ethylenediamine, P=piperazine, 
M=morpholine.
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Table 3.2.2 B.  Amount of reagent for the system based on 2,2’-
bisacrylamidoacetic acid and cyclam as multifunctional monomer.a)
!"#$%&'()#%*'+,'-.-/0(1#)23"4)&1*+)2%$12')21*'),*'%$5"4%,%*1)&1,%')#'$%$3)67,2$1+,)4'&+,+&%3')8.(8'
 
 
N° BAC 
(Mol x 10-3) 
EDA 
(Mol x 10-3)  
P  
(Molx 10-3) 
M  
(Mol x 10-3) 
1.1 2.6250 0.3750 3.0000 - 
1.2 2.4975 0.3750 3.0000 - 
1.3 3.1875 0.3750 3.0000 - 
1.4 1.6665 0.2500 2.0000 - 
1.5 4.9342 0.3750 3.0000 - 
1.6 5.1370 0.3750 3.0000 - 
1.7 5.6222 0.3750 3.0000 - 
1.8 3.9280 0.4550 3.0000 2.0000 
1.9 3.5000 1.3333 3.0000 - 
1.10 3.3333 1.3333 3.0000 - 
1.11 4.2500 1.3333 3.0000 - 
1.12 5.0000 0.8889 2.0000 - 
1.13 4.8000 1.3333 3.0000 2.0000 
'
'
)8 9:;<-.-/0(1#)23"4)&1*+)2%$12')21*='>?:<%$5"4%,%*1)&1,%='@<A1A%3)B1,%='C<&+3A5+41,%D'
'
N° BP 
(Mol x 10-3) 
EDA 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
2.1 2.6250 0.3750 3.0000 - 
2.2 2.4975 0.3750 3.0000 - 
2.3 3.1875 0.3750 3.0000 - 
2.4 1.6665 0.2500 2.0000 - 
2.5 4.9342 0.3750 3.0000 - 
2.6 5.1370 0.3750 3.0000 - 
2.7 5.6222 0.3750 3.0000 2.0000 
2.8 3.9280 0.4550 3.0000 2.0000 
2.9 3.5000 1.3333 3.0000 - 
2.10 3.3333 1.3333 3.0000 - 
2.11 4.2500 1.3333 3.0000 - 
2.12 5.0000 0.8889 2.0000 - 
2.13 4.8000 1.3333 3.0000 2.0000 
'
'
'
N° 
BAC 
(Mol x 10-3) 
Cy 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
3.1 2.6250 0.3750 3.0000 - 
3.2 2.4975 0.3750 3.0000 - 
3.3 3.1875 0.3750 3.0000 - 
3.4 1.5630 0.1250 1.0000 - 
3.5 3.3000 0.1250 1.0000 - 
3.6 3.3000 0.1250 1.0000 - 
3.7 3.9280 0.4550 3.0000 2.0000 
 
a) BAC= 2,2’-bisacrylamidoacetic acid,  Cy=cyclam, P=piperazine, M=mor-
pholine.
BP series (reaction 2.1 from Table 3.2.2 C as model of synthesis). BP (509.8 mg, 2.6250 mmol) was 
dissolved in 0.9 mL deoxygenated doubly  distilled water under nitrogen atmosphere. The amines 
(EDA,22.8 mg, 0.3750 mmol ; and P, 254.2 mg, 3.0000 mmol) were then added at  once all together, 
and the mixture gently stirred until homogeneous and maintained at 20°C under nitrogen for 4 days 
with intermittent stirring. After this time, the reaction mixture was acidified to pH ? 4 (1M HCl), 
diluted and ultrafiltered through a membrane with nominal cut-off 1000. The product was finally 
recovered by  freeze-drying and characterized. In the case of gel formation the same procedure as in 
the previous case was followed. The exact amounts of all reagents for each preparation are reported 
in Table 3.2.2 C.
Table 3.2.2 C. Amount of reagent for the system based on bisacryloylpipera-
zine and ethylenediamine as multifunctional monomer.a)
!"#$%&'()#%*'+,'-.-/0(1#)23"4)&1*+)2%$12')21*'),*'%$5"4%,%*1)&1,%')#'$%$3)67,2$1+,)4'&+,+&%3')8.(8'
 
 
N° BAC 
(Mol x 10-3) 
EDA 
(Mol x 10-3)  
P  
(Molx 10-3) 
M  
(Mol x 10-3) 
1.1 2.6250 0.3750 3.0000 - 
1.2 2.4975 0.3750 3.0000 - 
1.3 3.1875 0.3750 3.0000 - 
1.4 1.6665 0.2500 2.0000 - 
1.5 4.9342 0.3750 3.0000 - 
1.6 5.1370 0.3750 3.0000 - 
1.7 5.6222 0.3750 3.0000 - 
1.8 3.9280 0.4550 3.0000 2.0000 
1.9 3.5000 1.3333 3.0000 - 
1.10 3.3333 1.3333 3.0000 - 
1.11 4.2500 1.3333 3.0000 - 
1.12 5.0000 0.8889 2.0000 - 
1.13 4.8000 1.3333 3.0000 2.0000 
'
'
)8 9:;<-.-/0(1#)23"4)&1*+)2%$12')21*='>?:<%$5"4%,%*1)&1,%='@<A1A%3)B1,%='C<&+3A5+41,%D'
'
N° BP 
(Mol x 10-3) 
EDA 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
2.1 2.6250 0.3750 3.0000 - 
2.2 2.4975 0.3750 3.0000 - 
2.3 3.1875 0.3750 3.0000 - 
2.4 1.6665 0.2500 2.0000 - 
2.5 4.9342 0.3750 3.0000 - 
2.6 5.1370 0.3750 3.0000 - 
2.7 5.6222 0.3750 3.0000 2.0000 
2.8 3.9280 0.4550 3.0000 2.0000 
2.9 3.5000 1.3333 3.0000 - 
2.10 3.3333 1.3333 3.0000 - 
2.11 4.2500 1.3333 3.0000 - 
2.12 5.0000 0.8889 2.0000 - 
2.13 4.8000 1.3333 3.0000 2.0000 
'
'
'
N° 
BAC 
(Mol x 10-3) 
Cy 
(Mol x 10-3) 
P 
(Mol x 10-3) 
M 
(Mol x 10-3) 
3.1 2.6250 0.3750 3.0000 - 
3.2 2.4975 0.3750 3.0000 - 
3.3 3.1875 0.3750 3.0000 - 
3.4 1.5630 0.1250 1.0000 - 
3.5 3.3000 0.1250 1.0000 - 
3.6 3.3000 0.1250 1.0000 - 
3.7 3.9280 0.4550 3.0000 2.0000 
 
a) BP=bisacryloylpiperazine, EDA=ethylenediamine, P=piperazine, M=mor-
pholine.
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3.2.3 POLYAMIDOAMINE-BASED MULTILAYER NANOPARTICLES AS POTENTIAL GENE 
AND PROTEIN DELIVERY SYSTEM
Synthesis of Spin-labelled PAA (ISA1-TEMPO of Table 3.2.3 A). 1,4-bis(acryloyl)piperazine (4.000 
g, 20.5952 mmol) was dissolved in water (6.6 mL) by gently  stirring. TEMPO (0.3634 g, 2.0595 
mmol), MP (0.9771 g, 9.2678 mmol) and HEEDA (1.4161 g, 9.2678 mmol) were then added to-
gether and the mixture maintained 3 days at room temperature under nitrogen with occasional stir-
ring. After this time, it was diluted with distilled water (50 mL), acidified to pH 4-4.5 with dilute 
hydrochloric acid and then ultrafiltered through a membrane with nominal molecular weight cut-off 
10000. The retained fraction was freeze-dried and the product obtained as a white powder. Yield: 
65%. The other spin-labelled polymers were obtained using stoichiometric ratio indicated in Table 
3.2.3 A. The molecular weight of the polymers are reported in Table 3.2.3 B, including the polymers 
without labelling.
Table 3.2.3 A. Reagent used in the synthesis of spin-labelled PAAs.
Tables and Figures
Reagent ISA1-TEMPO ISA23-TEMPO AGMA1-TEMPO
Water / mL 6.60 6.60 6.60
BAC / mmol - 20.08 20.08
BISPIP / mmol 20.60 - -
2-MP / mmol 9.27 18.07 -
HEEDA / mmol 9.27 - -
TEMPO / mmol 2.06 2.00 2.00
LiOH / mmol - 20.08 38.16
Agmatine / mmol - - 18.08
Table 1. Reagent used in the synthesis of spin-labelled PAA
20
Table 3.2.3 B. Molecular weight of the PAAs used for 
self-assembly experiments.
Sample Mn Mw PD
ISA1 21400 26000 1.21
ISA1-TEMPO 12000 16000 1.30
ISA23 25000 28600 1.15
ISA23-TEMPO 13700 19300 1.40
AGMA1 18400 24100 1.31
AGMA1-TEMPO 21800 25900 1.18
BACEDDA 22500 26300 1.17
Table 2. Molecular weight of PAA used for self-assembly experiments
Name Cationic polymer Anionic Polymer
NP1 ISA1 ISA23
NP2 ISA1 BACEDDA
NP3 AGMA1 ISA23
NP4 AGMA1 BACEDDA
Table  3.  Pairs  of  polymers  used  for  obtaining  nanoparticles  with  or  without  spin-
labelled probe
21
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Core Preparation. Polymeric nanoparticles, with all possible binary combinations of cationic and 
predominantly anionic PAAs, were prepared from polymer solutions at pH 7.4 (Table 3.2.3 C).
Table 3.2.3 C. Pairs of polymers used for obtainig nano-
sized cores with or without spin-labelled probe.
Sample Mn Mw PD
ISA1 21400 26000 1.21
ISA1-TEMPO 12000 16000 1.30
ISA23 25000 28600 1.15
ISA23-TEMPO 13700 19300 1.40
AGMA1 18400 24100 1.31
AGMA1-TEMPO 21800 25900 1.18
BACEDDA 22500 26300 1.17
Table 2. Molecular weight of PAA used for self-assembly experiments
Name Cationic polymer Anionic Polymer
NP1 ISA1 ISA23
NP2 ISA1 BACEDDA
NP3 AGMA1 ISA23
NP4 AGMA1 BACEDDA
Table  3.  Pairs  of  polymers  used  for  obtaining  nanoparticles  with  or  without  spin-
labelled probe
21
Briefly, stock solution  f l s (1 mg/mL) were prepared by dissolving the polymer in water, 
and then adjusting the pH to 7.4 using potassium hydroxide 2M. In order to prepare the polymeric 
core, the required amount of cationic polymer solution was transferredto a vial, and the anionic 
polymer solution added under vigorous stirring. Each pair of polymers was prepared using the 
cationic/anionic charge ratio (c/a) within a range 1:1 to 10:1. The charge/repeating unit of the poly-
mers at pH 7.4 are reported in Table 3.2.3 D.
Table 3.2.3 D.  Equivalent charge per mol of the PAAs at 
pH 7.4.
Sample
Cationic 
(charge/mol)
Anionic 
(charge/mol)
ISA1 1.020 -
AGMA1 0.529 -
ISA23 - 0.333
BACEDDA - 1.979
Table 4. Equivalent charge per mol of the polymers at pH 7.4
22
Multilayer Nanoparticle Preparation. Typically, multilayer nanoparticles were prepared following 
the same simple procedure, namely adding oppositely charged polymers, layer-by-layer, by sequen-
tial addition of the appropriate polymer solution. All nanoparticles were prepared starting witha 
core obtained using the procedure describedabove with c/a ratio of 1:5. After core formation, cati-
onic or anionic polymer was added step-by-step, waiting 5 minutes for each layer formation, to ob-
tain nanoparticles with 6 layers. 
Measurement of Core and Multilayer Stability Using DLS and Z-potential analysis. Dynamic light 
scattering measurements were carried out at 20° C, on a Malvern Zetasizerwith wavelength 488 nm. 
A scattering angle of 90° was chosen. Before analysis, the nanoparticlesolutions, at a fixed concen-
tration of 1 mg/mL, were filtered througha 5-micron pore size syringe filter (Whatman, UK). The 
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intensity autocorrelation function analysed by  the method of cumulantswas used to obtain the aver-
age diffusion coefficient  and polydispersity of the nanoparticles, and thus, the hydrodynamic diame-
ter via the Stoke-Einstein equation. ζ-potential analyses were carried out using the same instrument. 
To determine the ζ-potential samples were diluted with 0.1 mMKCl and placed in an electrophoretic 
cell, where an electric field was applied for 2 minutes. Each sample was analysed in triplicate, and 
the average mobility reported here.
Preparation of Multilayer Nanoparticles for EPR Studies. TEMPO spin-labelled nanoparticles with 
4 layers were obtained in an analogous manner, except that the spin-labelled polymer was incorpo-
rated into the nanoparticles in only one layer at a time, to obtain three different labelled nanoparti-
cles, specifically, where the label resides in the core and in the first and third layer, Table 3.2.3 E.
Table 3.2.3 E. Spin-labelled multilayer (4 layer) nanoparticles obtained at pH 
7.4 labelled in the core (NP1{n=1}), (NP2 {n=1}), (NP3{n=1}), in the first 
(NP1{n=2}), (NP2 {n=2}), (NP3{n=2}) and in the third (NP1{n=4}), (NP2 
{n=4}), (NP3{n=4}).
Sample ISA1 AGMA1 ISA23 BACEDDA
NP1{n=1} + - (+) -
NP1{n=2} + - (+) -
NP1{n=4} + - (+) -
NP2{n=1} (+) - - +
NP2{n=2} (+) - - +
NP2{n=4} (+) - - +
NP3{n=1} - (+) + -
NP3{n=2] - (+) + -
NP3{n=4} - (+) + -
NP4{n=1} - (+) - +
NP4{n=2} - (+) - +
NP4{n=4} - (+) - +
Table 5. Spin-labelled multilayer (4 layer) nanoparticles obtained at pH 7.4 labelled in 
the  core  (NP1{n=1},  NP2{n=1},  NP3{n=1},  NP4{n=1}),  in  the  first  (NP1{n=2}, 
NP2{n=2},  NP3{n=2},  NP4{n=2},)  and in  the third  (NP1{n=4},NP2{n=4},  NP3{n=4}, 
NP4{n=4}, layer. The spin-labelled probe is reported in parentheses.
23
The spin-labelled probe is reported in parentheses.
Preparation of Multilayer Nanoparticles for Toxicological Studies. The nanoparticles reported in 
Table 3.2.3 C were also prepared without spin-labelled polymers as previously  described for as-
sessment in the toxicology studies.
Preparation of Lypopolyplexes for EPR Studies. 200 mg of SDS was dissolved in water to make 
100 mL of solution (2 mg/mL). This stock solution was used to make solutions with decreasing 
concentration of SDS by serial dilution. 1 mL of these SDS solutions was added to 1 mL of spin-
labelled nanoparticles, as previously  prepared and labelled in the third layer (n=4), in order to pre-
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pare lipopolyplexes with SDS concentrations of 0.05 and 1 mg/mL. The mixture was subjected to 
vigorous stirring for 15 minutes.  
Investigation of PAA Mobility in Multilayer Nanoparticles. For each nanoparticle, the EPR analysis 
was carried out in triplicate and the spectra analysed in terms of the rotational correlation time (τr) 
of the TEMPO label, and the polarity that the probe senses. The EPR spectra of the TEMPO-
labelled PAA nanoparticles were compared with pure spin-labelled polymers in water at pH 7.4, and 
the same polymer species in SDS solutions.
Analysis of the spectra, in terms of τr,were carried out using the well-known equation,6
!
r
!6 .5x10"10 H"
o #$ HoH"1"1% (1)
where H! 0 is the linewidth of the central peak and H0 and H-1 are the intensities of the 
central  and  high  field  peak  respectively.These  values  were  evaluated  by  the 
instrument software (WinEPR, Bruker) in order to calculate the rotational correlation 
time (!r) and the hyperfine coupling constant (polarity) sensed by the probe. This type 
of analysis can be used for weakly and mildly immobilized spin-labels, as they are in 
our  case  (10-10<"r<10
-9)12.  Small  changes  in  peak  intensity  arising  due  to  slight 
changes  in  instrument  gain  were  removed  by  normalising  each  spectrum  to  the 
maximum peak intensity in each spectrum. The "rsensed by a spin-labelled ISA1-
TEMPO, AGMA1-TEMPO or ISA23-TEMPO can also be quantified by analysing its 
EPR spectrum. Changes on that environment induced by molecular interactions are 
accordingly easily detected. 
10
                                        (eq. 1)
where ΔH0 is the linewidth of the central peak and H0 and H-1 are the intensities of the central and 
high field peak respectively. These values were evaluated by  the instrument software (WinEPR, 
Bruker) in order to calculate the rotational correlation time (τr) and the hyperfine coupling constant 
(polarity) sensed by the probe. This type of analysis can be used for weakly and mildly immobilized 
spin-labels, as they are in our case (10-10<τr<10-9). Small changes in peak intensity  arising due to 
slight changes in instrument gain were removed by normalising each spectrum to the maximum 
peak intensity  in each spectrum. The τr sensed by a spin-labelled ISA1-TEMPO, AGMA1-TEMPO 
or ISA23-TEMPO can also be quantified by analysing its EPR spectrum. Chan es on that environ-
ment induced by molecular interactions are accordingly easily detected. 
Evaluation of In-vitro Toxicity. An assessment of toxicity was performed in vitro as previously 
described.7 Briefly, the nanoparticles described herein, were reconstituted in DMEM cell culture 
media to a final concentration of 5mg/mL.  Sterile flat bottomed 96-well plates were seeded with 
Vero and B16 cells, respectively, at a cell density  of 1x104 cells per well and incubated for 16 h at 
37oC in an atmosphere of 5% (v/v) CO2.  Cells were exposed to the nanoparticles using a final con-
centration range of 0.5-5 mg/mL.   After incubation for 68 hours (37oC; 5% (v/v) CO2), cell viabil-
ity  was assessed using the 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) 
assay.  MTT solution was added (5µL of a sterile 5mg/mL MTT in PBS) and incubated for a further 
4 hours (total incubation of 72h), during which time the yellow tetrazolium dye was converted to an 
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6 Griffiths P., C.; Paul, A., Heenan, R., K.; et al., J. Phys. Chem. B, 2004, 108 (12), 3810-3816.
7 Richardson, S., C., W.; Ferruti, P.; et al., J. Drug Target., 1999, 6 (6), 391-404.
insoluble blue formazan salt.  The cell culture media was removed and formazan salt crystals were 
dissolved in DMSO (100µL/well).  Plates were evaluated spectrophotometrically by measuring ab-
sorbance at 550nm and the results compared to a negative control (dextran (D1662, Sigma, Dorset 
UK); concentration range 0.5-5mg/mL) and positive control (poly(ethyleneimine) (PEI) (181978 
Sigma, Dorset, UK); concentration range 0.5-5mg/mL) respectively.  Results were recorded as per-
centage viability  measured against an untreated population of cells and expressed as a mean 
(±S.E.M.). IC50 values were calculated using the Prism software package by  Graphpad Software 
Inc., (La Jolla, CA, USA).  
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3.2.4 ISA23-BSA CONJUGATE AS ANTIMALARIAL DELIVERY SYSTEMS
Synthesis of 4-N-Boc-2-(R, S)-methylpiperazine (MP-Boc). Typically, 2-(R,S)-methylpiperazine 
(MP) (21.1 g,  0.200 mol) was dissolved in tap water (1.2 L) and glacial acetic acid (12.0 g, 0.197 
mol) was added. The mixture was gently stirred for 15 minutes then cooled to 0 °C. After this time, 
a solution of di-(tert-butyl)dicarbonate (34.9 g, 0.160 mol) in methanol (150 mL) was added drop-
wise in 30 minutes to the reactive mixture. During this time the reaction was vigorously stirred and 
the temperature gradually warmed up to room temperature. The reaction was maintained under this 
condition for further 20 minutes, then the precipitated formed filtered and the pH was adjusted to 
5.5 with 1M HCl. The aqueous phase was extracted with CH2Cl2 (2x100 mL) to separate the disub-
stituted derivative then the pH was adjusted to 9.5 with 1M NaOH. The desired product was recov-
ered by repeated extraction with CH2Cl2 (5x200 mL), the organic layers collected and dried over 
anhydrous sodium sulphate. The solvent was evaporated to afford the crude solid. Yield: 90 %.
1H NMR (CDCl3, δ, ppm): 0.99 (d, HNCH2CHCH3), 1.41 (s, (CH3)3C), 1.57 (br, NHCH2CH), 2.34 
(br, axial NHCH2CH), 2.64 (m, NHCH2CH), 2.72 (m, axial NHCH2CH2NBoc), 2.90 (m, equatorial 
NHCH2CH),  2.95 (br, equatorial NHCH2CH2N). 13C NMR (D2O, δ, ppm): 19.16 (CH3CH), 28.15 
((CH3)3CO), 45.71 (HNCH2CH2N, CH3CHCH2N), 51.65 (CH3CH), 79.51 ((CH3)3CO), 154.70 
(NCO). Anal. Calcd for: C10H20N2O2: C, 59.97; H, 10.07; N, 13.99. Found: C, 59.12; H, 10.13; N, 
13.75.
Synthesis of BAC-MP. To a vigorously stirred solution of 2,2-bis(acrylamido)acetic acid (BAC) 
(2.8000 g, 14.084 mmol) and LiOH.H2O (0.5963 g, 14.084 mmol) in bidistilled water (30 mL) 
cooled at  0 °C, a solution of N-Boc-piperazine (1.4100 g, 7.042 mmol)  in bidistilled water (15 mL) 
was added dropwise. The reaction was maintained at 0 °C and left under stirring for 2 days. After 
this period, the crude reaction mixture was purified by ionic exchange chromatography on Dowex 
Mac-3 (8x60 cm) using bidistilled water (500 mL), and then an acid concentration elution gradient 
passing from 10-4 M to 0.1 M hydrochloric acid (1000 mL total). The product obtained was freeze-
dried then dissolved in trifluoroacetic acid to obtain a 1 M solution maintained for 3 hours under 
gentle stirring in nitrogen atmosphere. The product was precipitated by addition of diethyl ether (10 
mL), washed with fresh solvent (3 x 10 mL) and dried under vacuum affording a white and deli-
quescent solid. Yield: 60%. 
The full NMR characterization (D2O) was already  reported in Table  2.2.1 A. Anal. Calcd for: 
C13H22N4O4: C, 52.34; H, 7.43; N, 18.78.   Found: C, 50.47; H, 7.62; N, 17.89.
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Synthesis of BAC-MP-grafted-BSA (ISA23-BSA conjugate). Guanidine hydrochloride (0.5056 g, 
5.190 mmol) was dissolved in bidistilled water (5 mL), BSA (1.5065 g, 0.023 mmol) was added and 
the mixture was vigorously stirred for 10 minutes until a clear solution was obtained. BAC-MP 
(0.3347 g, 1.122 mmol) was then added to the mixture and the pH was adjusted at 8.0 by the addi-
tion of solid Na2CO3. The reaction was kept under nitrogen atmosphere and gentle stirring for 5 
days. The mixture was purified by dialysis against water (membrane cut-off 50000) and the pure 
product collected after freeze-drying. Yield: 84%. 
Mn = 1,01,000, Mw/ Mn = 1.07, Rh = 6.1 nm, [η] = 0.203 dL/g, a = 0.203, logK = -2.74.
Synthesis of FITC-labelled BAC-MP-grafted-BSA (ISA23-BSA-FITC). ISA23-BSA conjugate previ-
ously synthesized (100 mg) was solubilized in bidistilled water (2 ml), and the pH was adjusted to 
8.0 by using 2 M sodium carbonate. To this mixture FITC (1 mg) were added under stirring and the 
reaction was maintained under nitrogen atmosphere for 48 h and occasionally stirred. After this 
time, it was diluted with bidistilled water (4 ml), acidied with hydrochloric acid to pH 6.5 and then 
ultrafiltered though a membrane with nominal cut-off 50,000. The fraction retained was finally 
freeze-dried and the product collected as a yellow powder. Yield 98 %.
Equilibrium dialysis test. Equilibrium dialysis was performed using Teflon dialysis chamber with 
standard membrane (millipore). Experiments were carried out in triplicate using 1 ml of the PBS 
containing chroloquine (CQ) or primaquine (PQ) against 1 ml of PBS containing ISA23-BSA con-
jugate (30 mg/ml). Equilibrium time was determined spectrophotometrically for the two drugs using 
200 ng/ml of CQ and 100 ng/ml of PQ and was found to be 4 h. Thereby, dialysis was carried out 
for 5 h in all experiments and at 25 °C. The binding of CQ and PQ was determinated within the 
range of 25-600 ng/ml. CQ and PQ were quantified by  HPLC analysis.8 Protein binding was calcu-
lated using the formula (Cc-Ct)/Cc x 100, where Cc is drug concentration in the compartment con-
taining the conjugate and Ct the concentration in PBS after dialysis.
Preparation of the ISA23-BSA/Chloroquine formulation (ISA23-BSA/CQ). The ISA23-BSA conju-
gate previously synthesized (300 mg) was dissolved in PBS (300 ml), and then chloroquine diphos-
phate (60 mg) was added into the mixture with vigorous stirring. The mixture was filtered through a 
syringe filter with pore size of 0.2 µm, freeze-dried and recovered as a yellowish solid.
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Preparation of the ISA23-BSA/Primaquine (ISA23-BSA/PQ) Formulation. This formulation was 
prepared using the same procedure previously reported for the formulation of ISA23-BSA/CQ. 
Cryo-Transmission Electron Microscopy (Cryo-TEM). The cryo-TEM of ISA23-BSA conjugate 
was prepared by punge-freezing. Briefly, a lacey carbon filmed grid was placed in a pair of weezers 
at the end of a road in a controlled-atmosphere box. One drop  of the particle-containing solution (1 
mg/ml) was applied on the grid and most of the liquid was removed by a paper filter to leave a thin 
layer covering the holes. The rod was then shot vertically to plunge the grid into a liquid ethane 
bath cooled down to -180 °C. The grid was then transferred to a cryo-holder (Oxford CT-3500) 
cooled with liquid nitrogen below 180 °C. Microscopy was performed using a Philips CM120 Bi-
oTWIN transmission electron microscope operated at 120 kV, which was equipped with an objec-
tive lens to enhance contrast.
Hemolysis Assays. RBCs were diluted in PBS to yield a solution with 3% hematocrit. 200 µl of 
RBCs from this suspension and 2 µl of each ISA23-BSA solution were added to a 96-well plate. 
After incubating for  3h, 6h, and 24h at 37 °C, samples were collected in eppendorf tubes, spun at 
16,000 g per min, and the supernatant absorbance was measured spectrophotometrically at 541 nm. 
Each assay was performed in triplicate, including positive (1% Triton X-100 from Sigma Aldrich) 
and negative (PBS) controls. 
Cytotoxicity Assays. Cytotoxicity  assays were performed using 3T3 and HUVEC cells . 5,000 
cells/well were plated in 96-well plates and after 24h at 37 °C in 5% CO2 the medium was 
substituted by 100 µl of ISA23-BSA solution obtained using culture medium without FBS, and 
incubation was resumed for 48h. 10 µl of 4-[3-(4-iodophenyl)2-(4-nitrophenyl)- 2H-5-tetrazolio]-
1,3-benzene disulfonate labeling reagent (WST-1 Sigma Aldrich) was added to each well, and the 
plate was incubated in the same condition for 3 h. After thoroughly mixing for 1 min on a shaker, 
the absorbance of the sample was measured at 400 nm using a Benchmark Plus microplete reader. 
WST-1 in the absence of cells was used as blank and were prepared in triplicate for each experi-
ments.
Immunofluorescence Assays. ISA23-BSA-FITC solutions at concentration of 0.2 and 0.5 mg/
ml were obtained in PBS and filtered through a syringe filter with pore size of 0.2 µm. Then 
polymer solutions were incubated with 3D7 P. falciparum infected  Red Blood Cells (pRBCs) 
for 90 min at  37 °C with gentle stirring. Parasite nuclei were stained with 4’-6-diamino2-
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phenylindole (DAPI by Sigma Aldrich) and the RBC membrane was labelled with wheat germ 
agglutinin (WGA)-tetramethylrhodamine conjugate (Sigma Aldrich). Samples were imaged 
with a Leica TCS SP5 laser scanning confocal microscope.
Flow Cytometry (FACS). P. falciparum cells (pRBCs) cultures at a parasitemia of 5% (5,000 
cells per test tube) were incubated in a test tube with 100 µl of ISA23-BSA-FITC (0.5 mg/ml) 
for 90 min at 37 °C with gentle stirring. Parasite nuclei were stained with Hoetch reagent 
(Sigma Aldrich), and then samples were analyzed using a Gallios multi-color flow cytometry 
instrument. 
Plasmodium Falciparum Growth Inhibition Assay. Parasitemia of P. falciparum 3D7 cultures 
was adjusted to 1.5% with more than 90% of parasites at ring stage after sorbitol synchroniza-
tion. 100 µl of this culture was plated in 96-well plates and incubated for 48 h at 37 °C, under a gas 
mixture of 92% N2, 5% CO2, and 3% O2, in the presence of ISA23-BSA/PQ or ISA23-BSA/CQ so-
lutions at different concentration. Parasitemia was determined after incubation by microscopic 
counting of blood smears, or by fluorescence-assisted cell sorting (FACS). The ratio of infected ver-
sus non-infected RBCs was also determied by microscopic analysis. The average of Plasmodium 
growth inhibition with free drug or drug formulation was expressed as percentage of reduction re-
spective to the parasitemia of controls.
In vivo Toxicity of  ISA23-BSA conjugate. ISA23-BSA conjugate was diluted in PBS in order to 
obtain a solution at concentration of 0.5 mg/ml. This solution was injected in tail’s mice to yield a 
dose within 10-200 mg/Kg. Each dose was tested on three mouse with different weight. The acute 
toxicity was evaluated as percentage of death caused after polymer administration.
In vivo Antimalarial Activity of ISA23-BSA/PQ. The in vivo antimalarial activity of ISA23-BSA/
PQ formulation was evaluated by comparison with plane primaquine using the 4-days suppressive 
test. Biefly, 2x105 RBCs from the rodent malaria parasite Plasmodium yoelii yoelii 17XL (PyL) 
MRA-267 were inoculated in mice by  intraperitoneal injection (i.p.). Two therapeutic regimen were 
chosen to establish the dose-dependence. In the first group, three mouse were treated with a dose 
equivalent to 12.5 mg/Kg of primaquine, whereas in the second one a dose of 6.25 mg/Kg was ap-
plied. The chemotherapy treatment started 2 h later (day 0) by  an i.p. injection of formulation solu-
tion in PBS followed by identical dose of primaquine for the following 3 days. The negative and 
positive control groups received saline and the same dose of plane primaquine bisphosfate in PBS 
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respectively. Parasitemia was monitored daily  by microscopic examination of Wright’s-stained thin-
blood smears.
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3.2.5 POLYAMIDOAMINE HYDROGELS AS SCAFFOLDS FOR IN VITRO CULTURING OF 
PERIPHERAL NERVOUS SYSTEM CELLS
Linear PAAs from N-N’-methylenebisacrylamide and Piperazine (MBA-P). N,N’-
methylenebisacrylamide (2.600 g, 16.696 mmol) was dissolved in ethylene glycol (5.6 mL) by gen-
tly  heating at 80°C. Piperazine hexahydrate (3.276 g, 16.696 mmol) was then added and the mixture 
maintained 3 days at room temperature under nitrogen with occasional stirring. After this time, it 
was diluted with distilled water (30 mL), acidified to pH 4-4.5 with dilute hydrochloric acid and 
then ultrafiltered though a membrane with nominal molecular weight cut-off 10000. The retained 
fraction was freeze-dried and the product obtained as a white powder. Yield: 90%.
1H NMR (D2O): δ (ppm) 2.64 (t, NHCOCH2), 3.24 (br, NHCOCH2CH2), 3.26 (br, NCH2CH2N), 
4.51 (s, NHCH2NH). 13C NMR (D2O): δ (ppm) 30.21 (NHCOCH2), 44.36 (NHCH2NH), 49.70 
(NCH2CH2N), 52.41 (NHCOCH2CH2), 172.14 (NHCOCH2). 
Molecular weight: Mn=1,09,500, Mw=171000, PD=1.56.
Linear PAAs from N,N’-methylenebisacrylamide and 2-methylpiperazine (MBA-MP) or trans-2,5-
dimethylpiperazine (MBA-DMP). N,N’-methylenebisacrylamide (2.600 g, 16.696 mmol) was dis-
solved in water (5.6 mL) by gently heating at 80°C. 2-Methylpiperazine (1.724 g, 16.696 mmol) or 
(trans-2,5-dimethylpiperazine (1.945 g, 16.696 mmol) was then added and the mixtures processed 
as in the previous case. Yields: 65% (MBA-MP) and 70% (MBA-DMP). 
1H NMR (D2O) (MBA-MP): δ (ppm) 1.32 (d, CH3CH), 2.63 (br, NHCOCH2), 2.88 (br, NCH2), 3.08 
(br, br, NCH2), 3.38 (br, NCH), 3.59 (br, NHCOCH2CH2), 4.51 (s, NHCH2NH). 13C NMR (D2O) 
(MBA-MP): δ (ppm) 13.79 (CH3CH), 29.68 (NHCOCH2), 44.39 (NHCH2NH), 48.33 
(NHCOCH2CH2), 52.54 (NCH2CH2N), 54.83 (NCHCH2N), 56.22 (CH3CH), 172.14 (NHCOCH2). 
1H NMR (D2O) (MBA-DMP): δ (ppm) 1.32 (d, CH3CH), 2.69 (br, NHCOCH2), 2.94 (br, NCH2), 
3.15 (br, NCH2), 3.38 (br, NCH), 3.55 (br, NHCOCH2CH2), 4.51 (s,  NHCH2NH). 13C NMR (D2O) 
(MBA-DMP): δ (ppm) 13.98 (CH3CH), 29.59 (NHCOCH2), 44.39 (NHCH2NH), 48.35 
(NHCOCH2CH2), 53.55 (NCH2CHN), 56.07 (CH3CH), 172.15 (NHCOCH2). 
Molecular weights: MBA-MP: Mn=38,500, Mw=48,900 PD = 1.27; MBA-DMP: Mn=37,200, 
Mw=52,400, PD=1.41.
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Linear PAA from 1,4-Bis(acryloyl)piperazine and piperazine (BP-P). 1,4-Bis(acryloyl)piperazine 
(2.500 g, 12.871 mmol) was dissolved in water (4.2 mL) at room temperature and piperazine hexa-
hydrate (2.525 g, 12.871 mmol) was added under stirring. After about 5 minutes, the formed 
oligomers crystallized out. The system became homogeneous on heating at 60-70 °C and at this 
temperature the reaction proceeded to some extent, as apparent from the viscosity increasing. Even-
tually, however, the polymer precipitated again. It was retrieved by lyophilization of the whole reac-
tion mixture.
Linear PAA from 1,4-Bis(acryloyl)piperazine and 2-methylpiperazine (BP-MP) or trans-2,5-
dimethylpiperazine (BP-DMP). 1,4-Bis(acryloyl)piperazine (2.500 g, 12.871 mmol) was dissolved 
in water (4.2 mL) by  stirring and then 2-methylpiperazine (1.359 g, 12.871 mmol) or trans-2,5-
dimethylpiperazine (1.500 g, 12.871 mmol) was added. The reaction was maintained at r.t. under 
nitrogen atmosphere for 3 days with gentile stirring. After this time the reaction was treated as in 
the case of MBA-P. Yield: 65%
1H NMR (D2O) (BP-MP): δ (ppm) 1.30 (d, CH3CH), 2.82 (br, NHCOCH2), 2.88 (br, NCH2), 3.07 
(br, NCH2), 3.25 (br, NCH), 3.51 (br, NHCOCH2CH2) 3.56, 3.63 (m, NCH2CH2N). 13C NMR 
(D2O) (BP-MP): δ (ppm) 14.48 (CH3CH), 27.90 (NHCOCH2), 41.61 (NCH2CH2N), 44.67 
(NHCOCH2CH2), 45.29 (NCH2CH2N), 50.75 (NCHCH2N), 56.09 (CH3CH), 170.94 , 170.88 
(NHCOCH2).
1H NMR (D2O) (BP-DMP): δ (ppm) 1.29 (d, CH3CH), 2.84 (m, NHCOCH2, NCH2 ax.), 3.09 (br, 
NCH), 3.24 (br, NCH2 eq.), 3.49 (br, NHCOCH2CH2), 3.56, 3.62 (m,  NCH2CH2N). 13C NMR 
(D2O): δ (ppm) 14.41, 15,22 (CH3CH), 27.82 (NHCOCH2), 41.61 (NCH2CH2N), 44.64 
(NHCOCH2CH2), 48.41 (NCH2CHN), 55.11, 56.01 (CH3CH), 170.94, 170.88 (NHCOCH2). 
Molecular weight: BP-MP: Mn=22,200, Mw=29,100 PD = 1.31; BP-DMP: Mn=17,100, Mw= 
23,000, PD =1.35.
Mold Preparation. As a rule, the hydrogels were prepared in the form of sheets using molds consist-
ing of two silanized glass plates of size 10 x 10 x 0.2 cm, with a 1 mm-thick silicone spacer. The 
glass plates were rendered non-adhesive by soaking 5 hrs in aqua regia at room temperature, then 
washing several times with water, drying and exposing to chlorotrimethylsilane vapors for 3 days in 
a closed chamber. The plates were then soaked in toluene (20 mL), ethanol (2 × 20 mL) and water 
(3 × 20 mL). Finally, they were gently wiped with soft paper and used immediately. Hydrogels in 
the form of solid cylinders were obtained using thin glass tubes as molds. They were treated in the 
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same way as plates, but often the final product could be recovered only by carefully breaking the 
mold. Hydrogels in the form of hollow tubes were obtained with molds consisting of polystyrene 
cylinders with coaxial wires of graphite. No previous treatment was required in this case, since both 
materials are intrinsically non-adhesive towards PAA hydrogels.
MBA-P Hydrogels: a Model of Synthesis (MBA-P10 of Table 3.2.5 A). N,N’-
methylenebisacrylamide (2.600 g, 16.696 mmol) was dissolved in water (5.6 mL) at 80 °C and 
stirred until a homogeneous solution was obtained. Piperazine hexahydrate (2.948 g, 15.026 mmol) 
and 1,2-diaminoethane (0.0507 g, 0.835 mmol) were then added under the same conditions. The 
solution was then injected into the mold, and placed in an oven at constant temperature (25 °C). Ge-
lation occurred after about 30 h, but the reaction time was extended to 5 days. After this time, the 
glass plates were separated and the product recovered as a transparent, flexible hydrogel, which was 
purified from soluble impurities by first  extracting with ethanol (200 mL) for 16 h and then with 
water (200 mL) for 3 h. This extraction cycle was repeated three times. 
BP-P Hydrogels: a Model of Synthesis (BP-P25 of Table 3.2.5 A). Bisacryloylpiperazine (3.2440 g, 
16.696 mmol) was dissolved in water (5.6 mL) at room temperature and stirred until a homogene-
ous solution was obtained. Piperazine hexahydrate (2.4567 g, 12.522 mmol) and 1,2-diaminoethane 
(0.1261 g, 2.087 mmol) were then added with vigorous stirring for 3 minutes. The solution was then 
injected into the mold, and placed in an oven at  constant temperature (25 °C). Gelation occurred 
after about 12 h, but the reaction time was extended to 3 days. After this time, the glass plates were 
separated and the product recovered as a transparent, flexible hydrogel, with naked-eye visible 
opaque microdomain, which was purified from soluble impurities by  first extracting with ethanol 
(200 mL) for 16 h and then with water (200 mL) for 3 h. This extraction cycle was repeated three 
times.
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Other Hydrogels. The preparaion recipes of all other hydrogels considered in this work are reported 
in Table 3.2.5 A.
Table 3.2.5 A. Reagents used in the synthesis of PAA hydrogels.
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Figure 11. Cytocompatibility and proliferation of SC grown onto BP-P25 (panel A), BP-P30 
(panel B) and BP-P40 (panel C) respectively, at 3, 5  and 10 div. Scale bar 20 µm. 
 
Figure 12. Quantitative proliferation rate by MTS analysis of SC grown onto MBA-P10, 
MBA-P15, MBA-P30 (panel A) and onto BP-P25, BP-P30, BP-P40 (panel B). Data are 
compared to SC grown onto TCPS PLL-coated dishes used as control. Data analyzed at 1, 3, 
5, 7, 10 div were the mean ± SEM of experiments in triplicate. Panel A: TCPS (!), MBA-P10 
(!), MBA-P15 (!) and MBA-P30 ("). Panel B: TCPS (!), BP-P25 (!), BP-P30 (!) and BP-
P40 ("). 
 
 
Figure 13. Cytocompatibility and proliferation of DRG neurons  grown onto BP-P25 (panel 
B), BP-P30 (panel C) and BP-P40 (panel D) at 3, 5 and 7 div. DRG neurite growth was 
compared to cells grown onto TCPS lamini-coated dishes and used as control (panel A). Scale 
bar 20 µm. 
 
 
Figure 14. Immunofluorescence of DRG neurons in culture on BP-P30 at 5 and 7 div. The use 
of an anti-β   -tubulin antibody revealed a typical morphology with strong neurite 
sprouting and intact soma neurons. Scale bar 20 µm. 
 
 
Scheme 1. Synthesis of MBA-P and BP-P hydrogels.  
 
 
 
 
 
 
 
 
Table 1. Reagents used in the synthesis of  PAA hydrogels.  
 
Hydrogel Water 
[mL] 
MBA 
[mmol] 
BP 
[mmol] 
P 
[mmol] 
EDA 
[mmol] 
MBA-P10 5.60 16.70  15.00 0.80 
MBA-P15 5.60 16.70  14.20 1.30 
MBA-P30 5.60 16.70  11.70 2.50 
BP-P25 5.60 - 16.70 12.53 2.09 
BP-P30 5.60 - 16.70 11.69 2.51 
BP-P40 5.60 - 16.70 10.02 3.34 
 
 
 
 
 
Solid-state Infrared Spectroscopy (FT-IR ATR). FT-IR ATR spectra were obtained using a Spectrum 
100 FT-IR scpectrometer connected with universal ATR sampling accessory  produced by Perki-
nElmer.
Differential Scanning Calorimetry (DSC) Analysis. DSC analyses were performed using METTLER 
TOLEDO DSC 823 instrument. DSC measures were performed on BP-P polymer and BPP-base 
hydrogels in an atmosphere of nitrogen (flow 20 mL · min−1), using about 15 mg of sample con-
tained in open aluminum crucible. The heating rate applied was: 25 - 110 °C, 20 °C · min−1; 110 
°C, 4 min; 110 - 320 °C, 10 °C · min−1.
Swelling Kinetics in Differet Media. Swelling experiments were performed in water, ethanol and 
phosphate buffer solution (PBS) pH 7.4 on hydrogel discs 1 mm in thickness and with a base di-
ameter of 18 mm. All samples were dried to constant weight at 25 °C and 0.1 Tor before undergoing 
swelling experiments. Each disc was put into a test  tube containing 40 mL of the swelling medium 
and maintained at 25 °C. At regular intervals the disc was retrieved, gently  wiped with soft filter 
paper, weighed and reintroduced into the test tube. Maximum swelling was observed after about 1 
h. The extent of swelling, SW%, was determined using the following equation: where Wo is the 
weight of the dry disc and Wt is the weight of the swollen disc at any time. In all tests the percent 
mean variation coefficient, CV%, was lower than 5%. The reported values were the average of 6 
experiments.
Swelling in aqueuos media at different pH. These experiments were performed as described previ-
ously, using a starting aqueous solutions with pH in the range 1-11. After the incubation of the hy-
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drogels with the aqueous medium, the external solution was equilibrated at the fixed pH by adding 
2 M sodium hydroxide or 2 M hydrochloric acid dropwise. The CV% was lower than 5%. 
Degradation Kinetics. Degradation was monitored by following the weight loss of the hydrogel 
samples maintained at 37 °C in PBS pH 7.4 for prolonged time. The percent residual weight, Wr%, 
was calculated according to the equation: 
    
 - 9 - 
where Wo is the weight of the dry disc and Wt is the weight of the swollen disc at any time. In 
all tests the percent mean variation coefficient, CV%, was lower than 5%. The reported values 
were the average of 6 experiments. 
 
Swelling in aqueous media at different pH  
These experiments were performed as described previously, using a starting aqueous solutions 
with pH in the range 1-11. After the incubation of the hydrogels with the aqueous medium, 
the external solution was equilibrated at the fixed pH by adding  2 M sodium hydroxide or 2 
M hydrochloric acid dropwise. The CV% was lower than 5%.  
 
Degradation kinetics  
Degradation was monitored by following the weight loss of the hydrogel samples maintained 
at 37 °C in PBS pH 7.4 for prolonged time. The percent residual weight, Wr%, was calculated 
according to the equation: 
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where Wo is the weight of the dry disc at initial time, and Wtd is the weight of the dried disc at 
time t. All experiments were performed in triplicate. In all tests the mean CV% was !5%. The 
degradation was also indirectly monitored by measuring under the same conditions the trend 
of SW% on time. 
 
Accelerated degradation test  
These experiments were carried out as indicated in the previous case. The degradation was 
evaluated at 60 °C until a complete degradation was observed. 
 
Rheological measurements  
                                       eq. 3.2.5 A
where Wo is the weight of the dry disc at initial time, and Wtd is the weight of the dried disc at time 
t. All experiments were performed in triplicate. In all tests the mean CV% was ≤5%. The degrada-
tion was also indirectly monitored by  measuring under the same conditions the trend of SW% on 
time.
Accelerated Degradation Test. These experiments were carried out as indicated in the previous 
case. The degradation was evaluated at 60 °C until a complete degradation was observed.
Rheological Test. Rheological measurements were performed using an ARES strain controlled 
rheometer (Rheometric Scientific). All tests were carried out at  25 °C using a parallel plate geome-
try (d = 25 mm). The linear viscoelastic zone was measured by applying a shear strain ramp from 
0.05 to 10% at frequency of 6.28 rad/s (1 Hz). The frequency sweep tests were performed at strain 
of 0.1% over a frequency range from 0.1 to 10 rad/s. A different compressive force of 0.2, 0.5 and 
1.0 N were applied to hydrogels during the measurements. To prevent dehydratation during rheo-
logical measurements, a thin layer of silicon oil was placed on the peripheral surface of the hydro-
gel held between the plates. Each measurement was performed at least twice on different disc 
specimens of the same hydrogels sample.
Schwann Cells (SC) Culture. SC were isolated from Sprague–Dawley 3-day-old rats (Charles River, 
Calco, Italy) accordingly to institutional guidelines and in compliance with the policy on the use of 
animals approved by the European Communities Council Directive (86/609/EEC). Sciatic nerves 
explanted were digested with 1% collagenase and 0.25% trypsin (Sigma, Milan, Italy) then filtered 
through a 30 µm nylon membrane and centrifuged 10 min at 280 x g. Pellets were solubilized in 
Dulbecco's modified Eagle's medium (DMEM) (Serotec, Oxford, UK) supplemented with 10% fetal 
calf serum (FCS; Invitrogen, Monza, Italy) and plated onto 35 mm Petri dishes coated with poly-L-
Lysine (PLL; Sigma). 24 h after plating, the medium was supplemented with 10 µM arabinoside C 
(Sigma) then after 48 h the cultures were treated with a stream of cold DMEM-FCS 10%. The re-
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maining cells were plated in DMEM-FCS 10 vol.% supplemented with 10 µM forskolin (Sigma) 
and bovine pituitary extract 200 µg · mL−1 (Invitrogen). Cells became confluent in 10 days. Im-
munopanning for final purification was carried out incubating the cells for 30 min with mouse anti 
rat Thy1.1 antibody (Serotec) followed by 500 µL of baby rabbit complement (Cedarlane, Ontario, 
Canada). The cell suspension (3 x 105) was seeded on 6 cm Petri dishes and grown in presence of 2 
µM forskolin and bovine pituitary extract 200 µg · mL−1. At the third passage in vitro SC cultures 
were trypsinized and cell suspension used for hydrogel experimentation. Tissue culture polystyrene 
(TCPS) PLL-coated dishes were used as a positive control and empty disks were used as negative 
control for comparisons. The SC purity  (more than 98%) was assessed by immunocytochemistry 
with a specific antibody against the SC markers protein S100 and glycoprotein P0,9 10 analyzed by 
fluorescence microscopy by Axiovert 2000 microscope (Zeiss, Gottingen, Germany) and the images 
processed using Adobe Photoshop 5.0.2. 
Dorsal Root Ganglia (DRG) Neuron Culture. DRG were harvested from adult rat of Spra-
gue–Dawley  (Charles River) accordingly  to institutional guidelines (86/609/EEC). DRG were dis-
sociated in 0.125% collagenase type IV (Worthington, Lakewood, NJ, USA) in F12 medium (Invi-
trogen) for 1 h x 2 and then incubated in 0.25% trypsin (Worthington) in F12 medium for 30 min. 
Trypsin was inactivated by the addition of 10 vol.% foetal bovine serum (Invitrogen) in F12 me-
dium. The DRG were then washed three times in F12 medium to remove all traces of serum and 
were mechanically dissociated by  gentle trituration, filtered and centrifuged (200 g x 5 min). Cells 
were resuspended in F12 medium and centrifuged (600 g x 10 min) with 15% bovine serum albu-
min (BSA; Sigma). The cells debris supernatant was removed leaving the bolus of dissociated neu-
rons. The neurons were re-suspended in modified Bottenstein and Sato’s medium (BS medium) 
containing 0.1 mg · mL−1 transferrin, 20 nM progesterone, 100 µM putrescine, 30 nM sodium se-
lenite, 1 mg · mL−1 BSA, 0.01 mM cytosine arabinoside, 10 pM insulin (all Sigma). Finally  the 
neurons were plated on hydrogels. Neurons seeded onto TCPS dishes pre-coated with 2 µg · mL−1 
laminin-1 (Sigma) were used as positive control. After 2 h, 150 ng · mL−1 NGF (Sigma) was added 
to allow neurons to develop neurites for 7 days.
Application of SC and DRG neuron to hydrogel scaffolds. Under sterile conditions hydrogel round 
scaffolds (diameter 12 mm) were transferred into 12-well plate (smooth side faces upwards). The 
Materials and Methods
98
9 Magnaghi, V.; Conte, V.; Procacci, P.; Pivato, G.; Cortese, P.; Cavalli, E.; Pajardi, G.; Ranucci, E.; Fenili, F.; Manfredi, A.; Ferruti, P., J. Biomed. 
Mater. Res. Part A, 2011, 98A, 19.
10 Magnaghi, V.; Balabbio, M.; Cavarretta, I., T., C.; Froestl, W.; Lambert, J., J.; Zucchi, I.; Melcagni, R., C., Eur. J. Neurosci, 2004, 19, 2641.
SC or DRG neuron suspension was then seeded onto the hydrogels at proper concentrations: 5 x 
104 cells/well in DMEM-FCS 10 vol.% plus 2 µM forskolin for SC and 2 x 104 cells/well in BS 
medium for DRG neurons. The cells were grown in a tissue incubator at 37 °C in a humidified at-
mosphere with 5% CO2 for a period of 1, 3, 5, 7, 10 days of cell culture, and analyzed at each time 
point by contrast phase light  microscopy using a Zeiss inverted microscope Axioskop  2000 or proc-
essed for MTS assay of cell proliferation.
Cell proliferation. The cell proliferation on the scaffolds were determined using the colorimetric 
MTS assay  (CellTiter 96 AQueous One solution; Promega, Madison, WI, USA). The reduction of 
yellow tetrazolium salt  in MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy  -phenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) to form purple formazan crystals by the dehydrogenase enzymes se-
creted by mitochondria of metabolically  active cells forms the basis principle of this assay. The 
formazan dye shows absorbance at 490 nm and the amount of formazan crystals formed is directly 
proportional to the number of cells. To process for MTS assay, the samples were rinsed with PBS to 
remove unattached cells and incubated with 20 vol.% MTS reagent for a period of 3 h at 37 °C. Ab-
sorbance of the obtained dye was measured at 490 nm using a spectrophotometric plate reader 
(ELx800 Absorbance Microplate Reader; BioTek USA)
DRG neuron immunocytochemistry. DRG neuron were fixed in 4% paraformaldehyde r.t. for 30 
min, then rinsed 1h with PB-0.25% BSA and incubated overnight (4 °C) with primary antibodies 
for β-tubulin (1:500, mouse monoclonal; Abcam, Milan, Italy). The cells were then incubated for 2 
h FITC-coniugated mouse anti-β-tubulin (1:200; GE Healthcare Europe GmbH, Milan, Italy). The 
slides were mounted with VectashieldTM mounting medium for fluorescence containing DAPI (4′,
6-diamidino-2-phenylindole) for nuclear staining (Vector Laboratories, Peterborough, UK) and ex-
amined under a fluorescence Zeiss inverted microscope Axioskop 2000.
Statistical Analysis. All the biological data presented in this work were plotted and best-fit growth 
curve constructed (GraphPad Prism, GraphPad Software, San Diego, CA, USA).
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CHAPTER 4
RESULTS AND DISCUSSION
4.1 HETERO-DIFUNCTIONAL DIMERS AS BUILDING BLOCKS FOR THE SYNTHESIS OF 
POLYAMIDOAMINES WITH HETERO-DIFUNCTIONAL CHAIN TERMINALS
The aim of this work was to prepare hetero-diterminated PAAs as well as some novel PAA deriva-
tives not previously obtained by simple methods. Hetero-difunctional dimers (HDDs) were the sim-
plest building blocks capable of exactly reproducing the same sequence of amide-and tert-amine 
groups along the polymer chain of PAAs, while unequivocally ensuring hetero-difunctional chain 
terminals. As mentioned in Introduction, linear PAAs can be prepared by the stepwise polyaddition 
of bisacrylamides and either prim-monoamines or sec-bisamines, which yields PAAs with different 
chain structures. The investigation reported in this work concerned only HDDs leading to PAAs 
with "aabb" sequence of amide- and amine groups along the polymer chain, that is, HDDs 
obtained by the mono-addition of bis-sec-amines to bisacrylamides (Scheme 4.1 A). 
constituted of molecules doubly terminated by the excess
function. There is no way, by the traditional method, to
straightforwardly obtain PAAs with controlled hetero-difunc-
tional chain terminals, that is, PAAs solely containing mole-
cules of ‘‘a!! """""" !! b’’ type. This precluded to PAAs the
access to the remarkable number of biotechnological applica-
tions, for instance liposome preparation, drug conjugation,
and protein modification, which have been so far nearly
uniquely mastered by hetero-difunctional PEGs that, how-
ever, are far to be endowed with the functional versatility of
PAAs. In the past, a PAA-albumin conjugate was prepared by
employing a large excess of doubly vinyl-terminated, low-
molecular weight PAA apt to react with the exposed protein
thiol and amine groups. However, despite tedious purifica-
tion procedures, the presence of ‘‘bridged’’ protein molecules
could not be excluded.13
Two strategies exist, in principle, for unequivocally preparing
hetero-diterminated PAAs, either the ring-opening polymer-
ization of cyclic precursors or the self-polyaddition of het-
ero-difunctional (‘‘a!!a!!b!!b’’ or ‘‘a!!a!!b’’) dimers
(HDDs). The first strategy was ruled out because it was
thought difficult to design a cyclic PAA precursor amenable
to thermal or catalytic ring-opening polymerization, espe-
cially in the case of purpose-tailored PAAs carrying reactive
side-substituents, as for instance carboxyl groups, liable to
interfere in these processes. Therefore, the preparation of
HDDs, in particular those of the ‘‘a!!a!!b!!b’’ type,
expected to polymerize according to Scheme 2, was pre-
ferred. We limited our investigation to ‘‘a!!a!!b!!b’’ type
HDDs because the procedure adopted in this investigation
was not easily applicable to the preparation of the
‘‘a!!a!!b’’ ones. A different approach would be actually
needed, hopefully to be reported in a future article.
The synthetic scope of HDDs is manifold. They can be poly-
merized to high-molecular weight PAAs without bothering
with stoichiometric balance. PAAs of controlled average mo-
lecular weight and mono-functionalized with an acrylam de-
or a sec-amine group at one end can be prepared by adding,
respectively, a controlled amount of mono-functional acryla-
mides or sec-amines, whereas the addition of multifunctional
acrylamides or amines will lead to star-like PAAs. Block PAA-
PAA or PAA-PEG copolymers with controlled structure will
be easily obtained. ‘‘Velvety-like’’ grafting of PAA chains to
properly functionalized surfaces can be achieved. PAA chains
of controlled average length can be grafted to proteins with
no risk of undesirable side reactions such as protein–protein
coupling or crosslinking. ‘‘Tadpole-like’’ PAA conjugates with
hydrophobic moieties forming in aqueous media liposomes
or nanoparticles can be prepared as functional drug carriers.
Based on this premise, the aim of this article is to report on
the preparation of some model HDDs corresponding to PAAs
extensively studied for biomedical applications and to pro-
vide selected factual examples of their synthetic potential.
EXPERIMENTAL
Materials
2,2-Bis(acrylamido)acetic acid (BAC) and 1,4-bis(acryloyl)pi-
perazine (BP) were synthesized as previously described,14,15
lithium hydroxide monohydrate (98%), piperazine hexahy-
drate (P) (99%), 2-(R, S)-methylpiperazine (MP) (95%),
1,4,8,11-tetrazacyclotetradecane (Cyclam) (98%), di-(tert-
butyl)dicarbonate (97%), thiocholesterol (TC), bovine serum
albumin (BSA) (96%), 4-acryloylmorpholine (97%), morpho-
line (99.5%), guanidine hydrochloride (98%), glacial acetic
acid, hydrochloric acid (37%), sodium hydroxide (98.5%),
sodium chloride (99%), dichloromethane (reagent grade),
trifluoroacetic acid, DOWEXVR MAC-3 ion exchange resin were
purchased from Sigma-Aldrich and used as received.
Methods
Nuclear Magnetic Resonance (NMR) Spectra
1H NMR, 13C NMR, distortionless enhanced by polarization
transfer (DEPT), 1H-1H correlation (COSY), heteronuclear
multiple bond correlation (HMBC), and heteronuclear corre-
lation (HETCOR) spectra were run at room temperature on a
Bru¨ker Advanced 400 spectrometer operating at 400.132
and 100.623 MHz, respectively.
Size Exclusion Chromatography
Size exclusion chromatography (SEC) traces were obtained
using a Knauer Pump 1000 equipped with a Knauer Auto-
sampler 3800, TKSgel G4000 PW, and G3000 PW TosoHaas
columns connected in series, light scattering/viscometer Vis-
cotek 270 Dual Detector and a refractive index detector
Waters model 2410. The mobile phase was a 0.1 M Tris
buffer pH 8.1 6 0.05 with 0.2 M sodium chloride. The sam-
ple concentration was 2% (w/v) and the flow rate 1 mL/
min. Triple detector SEC allowed determining, besides the
molecular weight, the long chain branching (LCB) frequency
of star-like PAAs by means of the dedicated Viskotek soft-
ware, which compared their Mark–Houwink plots with those
of samples of their linear c unterpart of approximately the
same molecular weight and used common Zimm–Stockmayer
equations and methods.16
Dynamic Light Scattering
Dynamic light scattering (DLS) analysis was performed to
evaluate the hydrodynamic radius of polymeric micelles
using a Malvern NanoZS instrument (Malvern Instruments,
Worcestershire, UK) with a laser fitted at 532 nm and fixed
SCHEME 2 Self-polymerization of the ‘‘a!!a!!b!!b’’ type
HDDs.
SCHEME 1 Traditional synthesis of linear PAAs by Michael-
type polyaddition.
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Scheme 4.1 A. Self-polyaddition of "aabb" type HDDs.
Six HDDs were prepared starting from 2,2-bisacrylamidoacetic acid (BAC), 1,4-
bisacryloylpiperazine (BP) and N,N’-methylenebisacrylamide (MBA) as bisacrylamides and 
piperazine (P) and 2-methylpiperazine (MP) as amines. BAC was selected because, in combination 
with MP, it gives ISA23, the highly  biocompatible “stealth-like” amphoteric PAA mentioned in In-
troduction. BP and MBA were chosen because with P and MP they give PAAs extensively studied 
as components of bioactive hydrogels (data not shown). Moreover, P and MP are endowed with 
high reactivity towards Michael polyaddition, coupled with limited basicity leading, as a rule, to 
good biocompatibility of the resultant PAAs.1 2 3 4 5 
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The six HDDs obtained by combining the above building blocks were named BAC-P, BAC-MP, 
BP-P, BP-MP, MBA-P and MBA-MP after their parent compounds. Their structures are reported in 
Figure 4.1A.
Synthesis of Hetero-difunctional BAC-MP-TC
To a solution of BAC-MP (103.3 mg, 0.251 mmol) in bidis-
tilled water (1 mL), TC (10.1 mg, 0.025 mmol) dissolved in
diethyl ether (0.1 mL) was added, and the formation of a
macroemulsion was observed. The pH was adjusted to 7.0
by the addition of 3 M NaOH, and the mixture vigorously
stirred for 2 days. Then, 1 M NaOH was added until pH 9
and the reaction maintained in this condition under stirring
for further 5 days. After this time, the mixture was acidified
to pH 5 by the addition of 1 M HCl and purified by dialysis
against water (membrane cut-off 3500) for 2 h. The crude
product collected after freeze drying was suspended in
diethyl ether (2 mL) to remove unreacted TC, and dried in
vacuum. Yield: 38%.
Anal. Calcd for (C13H22N4O4)10-(C27H46S): C, 55.69; H, 7.92,
N, 16.55. Found: C, 51.98; H, 8.46, N, 18.15.
Synthesis of Hetero-difunctional MBA-P-TC
The reaction was performed following the same procedure
as in the previous case using MBA-P (60.3 mg, 0.251 mmol)
and TC (10.1 mg, 0.025 mmol). Yield: 29%.
Anal. Calcd for (C11H20N4O2)10-(C27H46S): C, 58.64; H, 8.84;
N, 19.97. Found: C, 58.00; H, 8.76; N, 20.56.
Synthesis of Hetero-difunctional BP-P-TC
The reaction was performed following the same procedure
as in the case of ISA23-TC using: BP-P (70.4 mg, 0.251
mmol) and TC (10.1 mg, 0.025 mmol). Yield: 44%.
Anal. Calcd for (C14H24N4O2)10-(C27H46S): C, 62.56; H, 8.99;
N, 17.48. Found: C, 61.42; H, 8.83; N, 18.60.
Synthesis of Hetero-difunctional BPMP-TC
The reaction was performed following the same procedure
as in the case of ISA23-TC using: BP-MP (73.9 mg, 0.251
mmol) and TC (10.1 mg, 0.025 mmol). Yield: 36%.
Anal. Calcd for (C15H26N4O2)10-(C27H46S): C, 63.53; H, 9.21;
N, 16.74. Found: C, 62.75; H, 9.11; N, 17.50.
RESULTS AND DISCUSSION
The aim of this work was to prepare hetero-diterminated
PAAs as well as some novel PAA derivatives not previously
obtained by simple methods. HDDs were the simplest build-
ing blocks capable of exactly reproducing the same sequence
of amide-and tert-amine groups along the polymer chain of
PAAs, while unequivocally ensuring hetero-difunctional chain
terminals. As mentioned in Introduction, linear PAAs can be
prepared by the stepwise polyaddition of bisacrylamides and
either prim-monoamines or sec-bisamines, which yields PAAs
with different chain structures. The investigation reported in
this paper concerned only HDDs leading to PAAs with
‘‘a!!a!!b!!b’’ sequence of amide- and amine groups
along the polymer chain, that is, HDDs obtained by the
mono-addition of bis-sec-amines to bisacrylamides (Scheme
2). Six HDDs were prepared starting from 2,2-bisacrylamido-
acetic acid (BAC), 1,4-bisacryloylpiperazine (BP), and N,N0-
methylenebisacrylamide (MBA) as bisacrylamides and piper-
azine (P) and 2-methylpiperazine (MP) as amines. BAC was
selected because, in combination with MP, it gives ISA23, the
highly biocompatible ‘‘stealth-like’’ amphoteric PAA men-
tioned in Introduction. BP and MBA were chosen because
with P and MP they give PAAs extensively studied as compo-
nents of bioactive hydrogels (data not shown). Moreover, P
and MP are endowed with high reactivity toward Michael
polyaddition, coupled with limited basicity leading, as a rule,
to good biocompatibility of the resultant PAAs.1,5,6,7,14 The
six HDDs obtained by combining the above building blocks
were named BAC-P, BAC-MP, BP-P, BP-MP, MBA-P, and MBA-
MP after their parent compounds. Their structures, together
with some relevant characterizations, are reported in Figure 1
and Table 1.
FIGURE 1 Structures of the HDDs synthesized.
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Figure 4.1 A. Structures of the HDDs synthesyzed.
The general synthetic procedure adopte  f r preparing HDDs is depicted in Scheme 4.1 B. It  in-
volved the synthesis of mono-Boc-protected P and MP [Step (a)] followed by  reaction with moder-
ate excess bisacrylamide, isolation and purification of the mono-addition produc , and cleavage of 
the protecting group [Step (b)]. Both steps deserve comm nts. 
The general synthetic procedure adopted for preparing
HDDs is depicted in Scheme 3. It involved the synthesis of
mono-Boc-protected P and MP [Step (a)] followed by reac-
tion with moderate excess bisacrylamide, isolation and puri-
fication of the mono-addition product, and cleavage of the
protecting group [Step (b)].
Both steps deserve comments. In Step (a), Boc-P and Boc-MP
were prepared from quasi-stoichiometric amounts of di-(tert-
butyl)dicarbonate and mono-protonated P and MP, in turn
obtained by in situ adding acetic acid to the amine in 1:1
molar ratio. Only a slight excess of amine mono-acetate was
required to maximize the yield of the mono-substituted pro -
ucts, since the two pKa values of both amines differ by ! four
orders of magnitude,17 and under the conditions adopted the
amount of doubly protonated molecules and, correspondingly,
of uncharged molecules amenable to react twice was minimal.
In Step (b), the addition reactions of Boc-P and Boc-MP to
BAC, BP, and MBA were performed for 2 days in water a
0 "C, using two- to threefold excess bisacrylamide. Under
these conditions, the double addition to the same bisacryla-
mide molecule was minimized. It may be noticed that the
excess bisacrylamide required to achieve this result was sig-
nificantly lower than expected from purely statistical calcula-
tions. It would appear that at 0 "C the amine addition to one
of the two double bonds biased the reactivity of the other
notwithstanding the fairly long distance between them. How-
ever, at room temperature and with the same stoichiometric
ratios, significant amounts of the double-addition products
were formed. The product work-up depended on the bisacry-
lamide used. In the case of BAC, the reaction mixtures con-
tained excess BAC, protected BAC-P (or BAC-MP) and small
amounts of di-addition products, that is, di-protected trimers
of the ‘‘b##b##a##a##b##b’’ type. All these products
were highly polar and hardly extractable from water ith o -
ganic solvents. Therefore, they were isolated by ion-exchange
chromatography using a weakly acid (carboxylated) resin and
following a two-step elution protocol. The first step was
performed with bidistilled water as eluent, the second step
with an acid concentration elution gradient passing from
10#4 M to 0.1 M hydrochloric acid (see Fig. 2). Unreacted
BAC was eluted in the first step. In the second step, the
mono-addition products were eluted first, followe by the di-
substituted products, which were discarded. The combined
fractions containing the mono-addition products were then ly-
ophilized and pure BAC-P and BAC-MP finally obtained by
deprotection with trifluoroacetic acid.
The addition reactions of MBA or BP with Boc-P or Boc-MP
gave protected MBA-P, MBA-MP, BP-P, and BP-MP, respec-
tively. The reaction mixtures, containing dimers and residual
bisacrylamide, were acidified to pH 3 and the bisacrylamides
fractionally extracted with organic solvents. Under these con-
ditions, the protected dimers, being ionized, remained in the
aqueous phase and were retrieved by freeze-drying. As the
products were insoluble in TFA, the deprotection step was
performed with 5% hydrochloric acid.
All protected HDDs were characterized by 1H NMR. All
deprotected HDDs were fully characterized by elemental
analysis, 1H NMR, 13C NMR, DEPT, 1H-1H COSY, HMBC, and
HETCOR (see Experimental and Supporting Information, Ta-
ble S1). The results of these characterizations were in agree-
ment with the proposed structures. C/N ratios by elemental
analysis are reported in Table 1. As all HDDs were isolated
as trifluoroacetates or hydrochlorides and vacuum dried or
lyophilized, some loss of acid was inevitable and, therefore,
the absolute values of elemental analyses were not fully reli-
able. However, the C/N ratios were not liable to be signifi-
cantly affected by the isolation procedures and provided a
reliable confirmation that the product structures were as
expected.
All HDDs, as either hydrochlorides or trifluoroacetates, could
be stored for a long time at 0–5 "C, if protected from mois-
ture and did not polymerize at room temperature. In aque-
ous solution, polymerization was triggered by rising pH
above 7.5 with bases inert toward Michael addition, such as
inorganic hydroxides or tertiary amines. The molecular
weights of the resultant polymers were usually high and
TABLE 1 C/N Ratio of HDDs
HDD
C/N Ratio
Calculated Found
BAC-P 2.57 2.63
BAC-MP 2.79 2.82
MBA-P 2.35 2.36
MBA-MP 2.57 2.63
BP-P 3.00 3.04
BP-MP 3.22 3.23
SCHEME 3 General synthetic pathway for the prep r tion of
HDDs. Step (a): synthesis of mo o-Boc-protected P and MP.
Step (b): Michael-type reaction with bisacrylamide, and cleav-
age of the protecting group.
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Scheme 4.1 B. General synthetic pathway for the preparation of HDDs. Step (a): synthesis of mono-Boc-protected P 
and MP. Step (b): Michael-type reaction with bisacrylamide, and cleavage of the protecting group.
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In step (a), Boc-P and Boc-MP were prepared from quasi-stoichiometric amounts of di-(tert-
butyl)dicarbonate and mono-protonated P and MP, in turn obtained by  in situ adding acetic acid to 
the amine in 1:1 molar ratio. Only  a slight excess of amine mono-acetate was required to maximize 
the yield of the mono-substituted products, since the two pKa values of both amines differ by ap-
proximately four orders of magnitude, and under the conditions adopted the amount of doubly-
protonated molecules and, correspondingly, of uncharged molecules amenable to react twice was 
minimal. In step (b), the addition reactions of Boc-P and Boc-MP to BAC, BP and MBA were car-
ried out for two days in water at 0 °C, using 2- to 3-fold excess bisacrylamide. Under these condi-
tions, the double addition to the same bisacrylamide molecule was minimized. It may be noticed 
that the excess bisacrylamide required to achieve this result was significantly lower than expected 
from purely statistical calculations. It would appear that at  0 °C the amine addition to one of the two 
double bonds biased the reactivity of the other notwithstanding the fairly  long distance between 
them. However, at room temperature and with the same stoichiometric ratios significant amounts of 
the double-addition products were formed. The product work-up depended on the bisacrylamide 
employed. In the case of BAC, the reaction mixtures contained excess BAC, protected BAC-P (or 
BAC-MP) and small amounts of di-addition products, that is, di-protected trimers of the 
“bbaabb” type. All these products were highly polar and hardly extractable from water 
with organic solvents. Therefore, they were isolated by  ion-exchange chromatography employing a 
weakly  acid (carboxylated) resin and following a two-step  elution protocol. The first step was car-
ried out with bidistilled water as eluant, the second step with an acid concentration elution gradient 
passing from 10-4 M  to 0.1 M hydrochloric acid (Figure 4.1 B). Unreacted BAC was eluted in the 
first step. In the second step, the mono-addition products were eluted first, followed by  the di-
substituted products, which were discarded. The combined fractions containing the mono-addition 
products were then lyophilized and pure BAC-P and BAC-MP finally obtained by de-protection 
with trifluoroacetic acid.
The addition reactions of MBA or BP with Boc-P or Boc-MP gave protected MBA-P, MBA-MP, 
BP-P and BP-MP, respectively. The reaction mixtures, containing dimers and residual bisacrylam-
ide, were acidified to pH 3 and the bisacrylamides fractionally  extracted with organic solvents. Un-
der these conditions, the protected dimers, being ionized, remained in the aqueous phase and were 
retrieved by freeze-drying. Since the products were insoluble in TFA, the de-protection step was 
carried out with 5% hydrochloric acid. 
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Dowex Mac 3
Column
Fractions at different pH
pH<5      pH=5      pH>5
1
2
HCl 10-4 M
HCl 10-1 M B
C
A
Figure 4.1 B. Equipment adopted to obtain the hydrochloric acid gradient used in the second elution step of BAC-P and 
BAC-MP purification. Column C was connected through Valve 1 to Flask B containing 10-4 M hydrochloric acid, in 
turn connected through Valve 2 to Flask A containing 10-1 M hydrochloric acid.  Each drop flowing out the column drew 
a drop from Flask B, immediately replaced by a drop from Flask A, thus obtaining the desired acid concentration gradi-
ent. 
All protected HDDs were characterized by 1H NMR. All de-protected HDDs were fully character-
ized by  elemental analysis, 1H NMR, 13C NMR (Figures S4.1 A-F), distortionless enhanced by po-
larization transfer (DEPT), 1H-1H correlation (COSY), heteronuclear multiple bond correlation 
(HMBC) and heteronuclear correlation (HETCOR) (Table 4.1 A). The results of these characteriza-
tions were in agreement with the proposed structures. C/N ratios by elemental analysis are reported 
in Table 4.1 B. Since all HDDs were isolated as trifluoroacetates or hydrochlorides and vacuum 
dried or lyophilized, some loss of acid was inevitable and, therefore, the absolute values of elemen-
tal analyses were not  fully reliable. However, the C/N ratios were not liable to be significantly af-
fected by the isolation procedures and provided a reliable confirmation that the product structures 
were as expected. All HDDs, as either hydrochlorides or trifluoroacetates, could be stored for a long 
time at 0÷5 °C, if protected from moisture, and did not polymerize at room temperature. In aqueous 
solution, polymerization was triggered by rising pH above 7.5 with bases inert towards Michael ad-
dition, such as inorganic hydroxides or tertiary amines. The molecular weights of the resultant 
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polymers were usually  high and obviously  related to the reaction time, whereas all practical diffi-
culties to achieve a precise balance among the reactant functions were got round.
Table 4.1 A.  Full NMR characterization (D2O, δ) of all HDDs.
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S1. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-P dimer.
a)
b)
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S2. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-MP dimer.
a)
b)
Table S1. 1H NM  and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 8.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.1 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.7 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S3. 1H NMR (panel a) and 13C NMR (panel b), (D2O)  of  MBA-P dimer.
a)
b)
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
Figure S4. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  MBA-MP dimer.
a)
b)
Figure S5. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-P dimer.
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 70.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a)
b)
Figure S6. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-MP dimer.
able S1. 1   and 13   ( 2 , , pp ) data of all s!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC- P 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
BA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
BA- P 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 48.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP- P 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a)
b)
Figure S7. 1H NMR, (D2O) of  BAC-MP-Acryloylmorpholine conjugate (BAC-MP-AM).
Table S1. 1H NMR and 13C NMR (D2O, , ppm) data of all HDDs!
1 2 3 4 5 6 7 8 9 10 11 12 13
BAC-P 1H 3.49 3.49 3.49 3.49 3.49 2.74 5.73 5.68 6.13
13C 48.56 48.56 52.62 52.62 41.39 28.81 170.79 56.61 168.15 170.79 128.75 129.10
BAC-MP 1H 3.24 3.40a)
3.78b)
3.40 3.63 3.63 2.81 5.78 6.21 5.75 1.43
13C 57.38 46.43 49.00 48.14 40.30 29.23 170.75 57.41 168.40 170.75 129.74 129.53 13.97
MBA-P 1H 3.58 3.58 3.58 3.58 3.47 2.73 4.58 5.71 6.14
13C 45.7 45.7 49.89 49.89 42.09 29.22 171.68 53.60 171.68 128.42 129.75
MBA-MP 1H 3.19 3.38a)
3.71b)
3.38 3.60 3.38 2.72 4.60 5.74 6.19 1.40
13C 58.12 46.23 48.94 8.15 40.29 29.17 171.79 53.58 171.79 128.45 129.56 13.85
BP-P 1H 3.61 3.61 3.61 3.01 - 3.61 3.61 - 5.79 6.14c)
6.67d)
13C 48.95 53.11 44.53 27.42 169.73 40.70 41.33 169.73 127.35 129.02
BP-MP 1H 3.87 3.44a)
3.77b)
3.42 3.77 3.56 2.98 3.58 3.65 5.75 6.08c)
6.64d)
1.47
13C 56.76 45.26 47.83 45.06 44.85 27.59 169.64 40.04 41.37 169.64 127.23 128.97 13.49
     a) equatorial; b) axial; c) cis; d) trans
a) equatorial, b) axial, c) cis, d) trans 
Table 4.1 B. C/N Ratio of all HDDs synthesized.
The general synthetic procedure adopted for preparing
HDDs is depicted in Scheme 3. It involved the synthesis of
mono-Boc-protected P and MP [Step (a)] followed by reac-
tion with moderate excess bisacrylamide, isolation and puri-
fication of the mono-addition product, and cleavage of the
protecting group [Step (b)].
Both steps deserve comments. In Step (a), Boc-P and Boc-MP
were prepared from quasi-stoichiometric amounts of di-(tert-
butyl)dicarbonate and mono-protonated P and MP, in turn
obtained by in situ adding acetic acid to the amine in 1:1
molar ratio. Only a slight excess of amine mono-acetate was
required to maximize the yield of the mono-substituted prod-
ucts, since the two pKa values of both amines differ by ! four
orders of magnitude,17 and under the conditions adopted the
amount of doubly protonated molecules and, correspondingly,
of uncharged molecules amenable to react twice was minimal.
In Step (b), the addition reactions of Boc-P and Boc-MP to
BAC, BP, and MBA were performed for 2 days in water at
0 "C, using two- to threefold excess bisacrylamide. Under
these conditions, the double addition to the same bisacryla-
mide molecule was minimized. It may be noticed that the
excess bisacrylamide required to achieve this result was sig-
nificantly lower than expected from purely statistical calcula-
tions. It would appear that at 0 "C the amine addition to one
of the two double bonds biased the reactivity of the other
notwithstanding the fairly long distance between them. How-
ever, at room temperature and with the same stoichiometric
ratios, significant amounts of the double-addition products
were formed. The product work-up depended on the bisacry-
lamide used. In the case of BAC, the reaction mixtures con-
tained excess BAC, protected BAC-P (or BAC-MP) and small
amounts of di-addition products, that is, di-protected trimers
of the ‘‘b##b##a##a##b##b’’ type. All these products
were highly polar and hardly extractable from water with or-
ganic solvents. Therefore, they were isolated by ion-exchange
chromatography using a weakly acid (carboxylated) resin and
following a two-step elution protocol. The first step was
performed with bidistilled water as eluent, the second step
with an acid concentration elution gradient passing from
10#4 M to 0.1 M hydrochloric acid (see Fig. 2). Unreacted
BAC was eluted in the first step. In the second step, the
mono-addition products were eluted first, followed by the di-
substituted products, which were discarded. The combined
fractions containing the mono-addition products were then ly-
ophilized and pure BAC-P and BAC-MP finally obtained by
deprotection with trifluoroacetic acid.
The addition reactions of MBA or BP with Boc-P or Boc-MP
gave protected MBA-P, MBA-MP, BP-P, and BP-MP, respec-
tively. The reaction mixtures, containing dimers and residual
bisacrylamide, were acidified to pH 3 and the bisacrylamides
fractionally extracted with organic solvents. Under these con-
ditions, the protected dimers, being ionized, remained in the
aqueous phase and were retrieved by freeze-drying. As the
products were insoluble in TFA, the deprotection step was
performed with 5% hydrochloric acid.
All protected HDDs were characterized by 1H NMR. All
deprotected HDDs were fully characterized by elemental
analysis, 1H NMR, 13C NMR, DEPT, 1H-1H COSY, HMBC, and
HETCOR (see Experimental and Supporting Information, Ta-
ble S1). The results of these characterizations were in agree-
ment with the proposed structures. C/N ratios by elemental
analysis are reported in Table 1. As all HDDs were isolated
as trifluoroacetates or hydrochlorides and vacuum dried or
lyophilized, some loss of acid was inevitable and, therefore,
the absolute values of elemental analyses were not fully reli-
able. However, the C/N ratios were not liable to be signifi-
cantly affected by the isolation procedures and provided a
reliable confirmation that the product structures were as
expected.
All HDDs, as either hydrochlorides or trifluoroacetates, could
be stored for a long time at 0–5 "C, if protected from mois-
ture and did not polymerize at room temperature. In aque-
ous solution, polymerization was triggered by rising pH
above 7.5 with bases inert toward Michael addition, such as
inorganic hydroxides or tertiary amines. The molecular
weights of the resultant polymers were usually high and
TABLE 1 C/N Ratio of HD s
HDD
C/N Ratio
Calculated Found
BAC-P 2.57 2.63
BAC-MP 2.79 2.82
MBA-P 2.35 2.36
MBA-MP 2.57 2.63
BP-P 3.00 3.04
BP-MP 3.22 3.23
SCHEME 3 General synthetic pathway for the preparation of
HDDs. Step (a): synthesis of mono-Boc-protected P and MP.
Step (b): Michael-type reaction with bisacrylamide, and cleav-
age of the protecting group.
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The synthetic potential of HDDs was assessed by performing model reactions, namely  self-
polyaddition, preparation of monofunctional PAA oligomers with controlled molecular weight, of 
star-like PAA architectures, of protein-PAA conjugates and of tadpole-like PAA-cholesterol amphi-
philes. The aim was to test the general aptitude of HDDs to be employed for these reactions and 
was limited to a few examples involving only some of the prepared dimers at a time. It may be no-
ticed that most of the reaction products were hardly obtainable by the traditional PAA preparation 
method. 
The self-polyadditions of BAC-MP and BP-P were carried out as model syntheses of PAAs via the 
corresponding HDDs. The reaction progress was monitored by 1H NMR until signals at 5.78, 6.13 
and 6.67 ppm, relative to the acrylic hydrogens, fell below the detection threshold of the instrument. 
The products had, respectively, Mn 38000 and 30900, with Mw/Mn 1.32 and 1.13. These molecular 
weight values were significantly higher than those of the corresponding PAAs obtained by the tradi-
tional methods after the same reaction times, with lower polydispersities. 
The polymerization of HDD mixtures with either monofunctional acrylamides or amines with ap-
proximately the same reactivity as the corresponding function present in HDDs, leads at 100% con-
version to an average polymerization degree equal to:
obviously related to the reaction time, whereas all practical
difficulties to achieve a precise balance among the reactant
functions were got round.
The synthetic potential of HDDs was assessed by performing
model reactions, namely self-polyaddition, preparation of
monofunctional PAA oligomers with controlled molecular
weight, of star-like PAA architectures, of protein-PAA conju-
gates and of tadpole-like PAA-cholesterol amphiphiles. The
aim was to test the general aptitude of HDDs to be used for
these reactions and was limited to a few examples involving
only some of the prepared dimers at a time. It may be
noticed that most of the reaction products were hardly
obtainable by the traditional PAA preparation method.
The self-polyadditions of BAC-MP and BP-P were performed as
model syntheses of PAAs via the corresponding HDDs. The reac-
tion progress was monitored by 1H NMR until signals at 5.78,
6.13, and 6.67 ppm, relative to the acrylic hydrogens, fell below
the detection threshold of the instrument. The products had,
respectively, Mn 38,000 and 30,900, with Mw/Mn 1.32 and 1.13.
These molecula weight values w re significantly higher than
those of the corresponding PAAs obtained by the traditional meth-
ods after the same reaction times, with lower polydispersities.
The polymerization of HDD mixtures with either monofunc-
tional acrylamides or amines with approximately the same
reactivity as the corresponding function pr sent in HDDs,
leads at 100% conversion to an average polymerization
degree equal to:
Xn ¼ NHDD;0Nmonofunctional;0 (1)
where NHDD,0 is the initial number of HDD molecules and
Nmonofunctional,0 is the initial number of mono-functional com-
pound. Obviously, Mn is given by the product of Xn times the
molecular weight of the HDD used, added by the molecular
weight of the mono-functional compound. The resultant
polymer will be terminated at one terminus with the unreac-
tive group and at the opposite terminus with the excess re-
active function. The preparation of an ISA23 oligomer mono-
functionalized at one terminus with an activated double
bond by polymerization of BAC-MP in the presence of
4-acryloylmorpholine is reported in Scheme 4.
The reaction was performed adopting a 10/1 BAC-MP/
4-acryloylmorpholine molar ratio. The reaction progress was
monitored by 1H NMR by comparing the signals at 6.22 and
5.62 ppm, relative to the end-chain acrylic group and the
CH-COO" hydrogen of BAC, respectively (see Supporting Infor-
mation Fig. S7). The reaction was stopped when in the NMR
spectrum, the ratio of the reference peaks’ integrals remained
constant with time and was consistent with the presence of a
double bond every 10 BAC-MP units, that is, the reaction yield
had approached 100%. The Mn of the product was 3200, with
Mw/Mn 1.28. This molecular weight value was very close to
the expected value of 3150, as calculated from eq 1.
The same derivative, as well as the cholesteryl-terminated
PAA (see below) could be also prepared by reacting 4-acryl-
oylmorpholine and TC with presynthesized HDDS polymers.
However, the direct polymerization of HDDs in presence of
the same monofunctional compounds presented two distinct
advantages: it could be performed in one-pot, one step reac-
tion; moreover, both 4-acryloylmorpholine and TC acted in
the mean time as chain regulators.
FIGURE 2 Equipment adopted to obtain the hydrochloric acid
gradient used in the second elution step of BAC-P and BAC-MP
isolation. Column C was connected through Valve 1 to Flask B
containing 10"4 M hydrochloric acid, in turn connected through
Valve 2 to Flask A containing 10"1 M hydrochloric acid. Each
drop flowing out the column drew a drop from flask B, imme-
diately replaced by a drop from flask A, thus obtaining the
desired acid concentration gradient.
SCHEME 4 Synthesis of the mono-functionalized ISA23 oligomer by polymerization of BAC-MP in the presence of 4-
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                                               eq. 4.1 A
Where NHDD,0 is the initial number of HDD molecules and Nmonofunctional,0 is the initial number of 
mono-functional compound. Obviously, Mn is given by the product of  times the molecular 
weight of the HDD employed, added by the molecular weight of the mono-fu ctional compound. 
The resultant polymer will be terminated at one terminus with the unreactive group  and at the oppo-
site terminus with the excess reactive function.  
obviously related to the reaction time, whereas all practical
difficulties to achieve a precise balance among the reactant
functions were got round.
The synthetic potential of HDDs was assessed by performing
model reactions, namely self-polyaddition, preparation of
monofunctional PAA oligomers with controlled molecular
weight, of star-like PAA architectures, of protein-PAA conju-
gates and of tadpole-like PAA-cholesterol amphiphiles. The
aim was to test the general aptitude of HDDs to be used for
these reactions and was limited to a few examples involving
only some of the prepared dimers at a time. It may be
noticed that most of the reaction products were hardly
obtainable by the traditional PAA preparation method.
The self-polyadditions of BAC-MP and BP-P were performed as
model syntheses of PAAs via the corresponding HDDs. The reac-
tion progress was monitored by 1H NMR until signals at 5.78,
6.13, and 6.67 ppm, relative to the acrylic hydrogens, fell below
the detection threshold of the instrument. The products had,
respectively, Mn 38,000 and 30,900, with Mw/Mn 1.32 and 1.13.
These molecular weight values were significantly higher than
those of the corresponding PAAs obtained by the traditional meth-
ods after the same reaction times, with lower polydispersities.
The polymerization of HDD mixtures with either monofunc-
tional acrylamides or amines with approximately the same
reactivity as the corresponding function present in HDDs,
leads at 100% conversion to an average polymerization
degree equal to:
Xn ¼ NHDD;0Nmonofunctional;0 (1)
where NHDD,0 is the initial number of HDD molecules and
Nmonofunctional,0 is the initial number of mono-functional com-
pound. Obviously, Mn is given by the product of Xn times the
molecular weight of the HDD used, added by the molecular
weight of the mono-functional compound. The resultant
polymer will be terminated at one terminus with the unreac-
tive group and at the opposite terminus with t excess re-
active function. The preparation of an ISA23 oligomer mono-
functionalized at one terminus with an activated double
bond by polymerization of BAC-MP in the presence of
4-acryloylmorpholine is reported in Scheme 4.
The reaction was performed adopting a 10/1 BAC-MP/
4-acryloylmorpholine molar ratio. The reaction progress was
monitored by 1H NMR by comparing the signals at 6.22 and
5.62 ppm, relative to the end-chain acrylic group and the
CH-COO" hydrogen of BAC, respectively (see Supporting Infor-
mati n Fig. S7). The reaction was stopped w en in the NMR
spectrum, the ratio of the reference peaks’ integrals remained
constant with time and was consistent with the presence of a
double bond every 10 BAC-MP units, that is, the reaction yield
had approached 100%. The Mn of the product was 3200, with
Mw/Mn 1.28. This molecular weight value was very close to
the expected value of 3150, as calculated from eq 1.
The same derivative, as well as the cholesteryl-terminated
PAA (see below) could b also prepared by reacting 4-acryl-
oylmorpholine and TC with presynthesized HDDS polymers.
However, the direct polymerization of HDDs in presence of
the same monofunctional compounds presented two distinct
advantages: it could be per ormed in one-pot, one step reac-
i ; moreover, both 4-acryloylmorpholine and TC acted in
he mea time as c ain r gulators.
FIGURE 2 Equipment adopted to obtain the hydrochloric acid
gradient used in the second elution step of BAC-P and BAC-MP
isolation. Column C was connected through Valve 1 to Flask B
containing 10"4 M hydrochloric acid, in turn connected through
Valve 2 to Flask A con aining 10"1 M hydrochloric acid. Each
drop flowing out the column drew a drop from flask B, imme-
diately replaced by a drop from flask A, thus obtaining the
desired acid concentration gradient.
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Scheme 4.1 C. Synthesis of the mono-functionalized IS 23 oligomer b  polymerization of BAC-MP in the presence of 
4-acryloylmorpholine.
The preparation of an ISA23 oligomer mono-functionalized at  one terminus with an activated dou-
ble bond by  p lymerization of BAC-MP in the presence of 4-acryloylmorpholine is reported in 
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Scheme 4.1 C. The reaction was carried out adopting a 10/1 BAC-MP/4-acryloylmorpholine molar 
ratio. The reaction progress was monitored by 1H NMR by comparing the signals at 6.22 and 5.62 
ppm, relative to the end-chain acrylic group and the CH-COO- hydrogen of BAC, respectively 
(Figure 4.1 C). 
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Figure 4.1 C. 1H NMR of BAC-MP-4-acryloylmorpholine conjugate (BAC-MP-AM).
The reaction was stopped when in the NMR spectrum the ratio of the reference peaks’ integrals re-
mained constant with time and was consistent with the presence of a double bond every 10 BAC-
MP units, that is, the reaction yield had approached 100%. 
The Mn of the product was 3200, with Mw/ Mn 1.28. This molecular weight value was very  close to 
the expected value of 3150, as calculated from Eq. 4.1 A.
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Four-arm star-like PAAs (BP-MP-C and BAC-MP-C) were synthesized from BP-MP and BAC-MP 
and 1,4,8,11-tetraazacyclotetradecane (cyclam) (Scheme 4.1 D). The polymerization reactions were 
performed, as usual, in aqueous solution at pH 9 and monitored by 1H NMR (Figures S4.1 G and 
H). The products were isolated when the signals attributed to the double bond hydrogens fell below 
the instrument’s detection threshold.
Four-arm star-like PAAs (BP-MP-C and BAC-MP-C) were
synthesized from BP-MP and BAC-MP and 1,4,8,11-tetraa-
zacyclotetradecane (cyclam; Scheme 5). The polymeriza-
tion reactions were performed, as usual, in aqueous solu-
tion at pH 9 and monitored by 1H NMR. The products
were isolated when the signals attributed to the double
bond hydrogens fell below the instrument’s detection
threshold.
In the case of BP-MP-C, the adopted HDD/cyclam molar ratio
was 10. The Mn of the product was 3300, with Mw/Mn 1.21.
These values were in close agreement with the values of
3400 and 1.29 calculated from the classic literature’s formu-
las18,19 extrapolated for p ¼ 1 (eqs 2 and 3):
!Xn ¼ ðfrpþ 1$ rpÞð1$ rpÞ (2)
!Xw
!Xn
¼ 1þ frpðfrpþ 1$ rpÞ2 (3)
where f is the number of reactive functions of the multifunc-
tional monomer (four for cyclam), r ¼ NaNb þf Nb0 , Na ¼ Nb is the
molar amount of HDD and Nb’ is the molar amount of the
multifunctional monomer. In the case of BAC-MP-C, the
adopted HDD/cyclam molar ratio was 34.2. The product had
Mn 10,800 with Mw/Mn 1.08, to be compared with the calcu-
lated values of 10,700 and 1.26. It may be observed that Mn
was in excellent agreement with the expected value, whereas
the Mw/Mn ratio was remarkably lower. In fact, the product
obtained was quasi-monodisperse. Interestingly, this effect
was not observed with BP-MP, suggesting that the zwitterionic
nature of BAC-MP was largely responsible for it. Possibly,
BAC-MP reversibly interacted with cyclam, resulting in a local
catalytic activity of the latter favoring the growth of the
chains attached to it over that of ‘‘free’’ molecular species.
Thus, the behavior of the BAC-MP/cyclam system as regards
the molecular weight distribution of the resultant polymer
approached that of a cyclic monomer growing on a multifunc-
tional center. The LCB frequency of BP-MP-C and BAC-MP-C
was determined by SEC connected in series with refractive
index (RI), light scattering, and viscometric detectors (see Ex-
perimental) and found in both cases of & two side chains per
macromolecule. This LCB frequency value was consistent with
the expected four-arm architecture originating from a cyclam
core.
BAC-P, BAC-MP, BP-P, and BSA were chosen as model HDDs
and protein for the preparation of PAA-protein graft copoly-
mers. This was simply achieved by triggering the HDD poly-
merization in aqueous medium in the presence of BSA that
participated in the polymerization through its exposed NH2
and SH groups. To give an example, the synthesis of BAC-
MP-g-BSA is reported in Scheme 6.
The occurrence of PAA grafting onto BSA was evaluated by
SEC connected in series with RI, light scattering, and visco-
metric detectors. The data, reported in Table 2, provided clear
evidence of the increasing of the molecular weight of copoly-
mers with respect to native BSA, always accompanied by low
polydispersities and higher values of the Mark–Houwink con-
stants, hence higher hydrodynamic radii. A further
SCHEME 5 Synthesis of four-arm star-like PAAs from BP-MP
and BAC-MP and cyclam.
SCHEME 6 Synthesis of BAC-MP-g-BSA by polymerization of BAC-MP in the presence of BSA.
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Scheme 4.1 C. Synthesis of four-arm star-like PAAs from BP-MP and BAC-MP and cyclam.
In the case of BP-MP-C, the adopted HDD/cyclam molar ratio was 10. The Mn of the product was 
3300, with Mw/ Mn 1.21. These values were in close agreement with the values of 3400 and 1.29 
calculated from the classic literature’s formulas6 7 extrapolated for p = 1 (Eq.s 4.1 B and C):
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multifunctional monomer. In the case of BAC-MP-C, the
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and protein for the preparation of PAA-protein graft copoly-
mers. This was simply achieved by triggering the HDD poly-
merization in aqueous medium in the presence of BSA that
participated in the polymerization through its exposed NH2
and SH groups. To give an example, the synthesis of BAC-
MP-g-BSA is report d in Scheme 6.
The occurrence of PAA grafting onto BSA was evaluated by
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mers with respect to native BSA, always accompanied by low
polydispersities and higher values of the Mark–Houwink con-
stants, hence higher hydrodynamic radii. A further
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                                             Eq. 4.1 B
     
Four-arm star-like PAAs (BP-MP-C and BAC-MP-C) were
synthesized from BP-MP and BAC-MP and 1,4,8,11-tetraa-
zacyclotetradecane (cyclam; Scheme 5). The polymeriza-
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Where f is the number of reactive functions of the multifunctional monomer (four f r cyclam),  = 
Na/(Nb + f Nb’ ), Na = Nb is the molar amount of HDD and Nb’ is the molar amount  t e multi-
functional monomer. In the case of BAC-MP-C the adopted HDD/cyclam molar ratio was 34.2. The 
product had Mn 10800 with Mw/ Mn 1.08, to be compared with the calculated values of 10700 and 
1.26. It  may be observed that Mn was in excellent agreement with the expected value, whereas the 
Mw/ Mn ratio was remarkably lower. In fact, the product obtained was quasi-monodisperse. Inter-
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6 Khalili, F.; Henni, A.; East, A., L., L., J. Chem. Eng. Data, 2009, 54, 2914-2917.
7 Peebles, L., H. Eds., In Molecular Weight Sistribution in Polymers, Wiley Interscience, New York, 1971.
estingly, this effect  was not observed with BP-MP, suggesting that  the zwitterionic nature of BAC-
MP was largely responsible for it. Possibly, BAC-MP reversibly interacted with cyclam, resulting in 
a local catalytic activity of the latter favoring the growth of the chains attached to it over that of 
“free” molecular species. Thus, the behavior of the BAC-MP/ cyclam system as regards the mo-
lecular weight distribution of the resultant polymer approached that of a cyclic monomer growing 
on a multifunctional center. The long chain branching (LCB) frequency  of BP-MP-C and BAC-MP-
C was determined by  SEC connected in series with RI, light scattering and viscometric detectors 
(see Experimental) and found in both cases of approximately  2 side chains per macromolecule. This 
LCB frequency  value was consistent with the expected four-arm architecture originating from a cy-
clam core. 
BAC-P, BAC-MP, BP-P and BSA were chosen as model HDDs and protein for the preparation of 
PAA-protein graft copolymers. This was simply achieved by triggering the HDD polymerization in 
aqueous medium in the presence of BSA that participated in the polymerization through its exposed 
NH2 and SH groups. To give an example, the synthesis of BAC-MP-g-BSA is reported in Scheme 
4.1 E. The occurrence of PAA grafting onto BSA was evaluated by SEC connected in series with 
RI, light scattering and viscometric detectors. 
Four-arm star-like PAAs (BP-MP-C and BAC-MP-C) were
synthesized from BP-MP and BAC-MP and 1,4,8,11-tetraa-
zacyclotetradecane (cyclam; Scheme 5). The polymeriza-
tion reactions were performed, as usual, in aqueous solu-
tion at pH 9 and monitored by 1H NMR. The products
were isolated when the signals attributed to the double
bond hydrogens fell below the instrument’s detection
threshold.
In the case of BP-MP-C, the adopted HDD/cyclam molar ratio
was 10. The Mn of the product was 3300, with Mw/Mn 1.21.
These values were in close agreement with the values of
3400 and 1.29 calculated from the classic literature’s formu-
las18,19 extrapolated for p ¼ 1 (eqs 2 and 3):
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where f is the number of reactive functions of the multifunc-
tional monomer (four for cyclam), r ¼ NaNb þf Nb0 , Na ¼ Nb is the
molar amount of HDD and Nb’ is the molar amount of the
multifunctional monomer. In the case of BAC-MP-C, the
adopted HDD/cyclam molar ratio was 34.2. The product had
Mn 10,800 with Mw/Mn 1.08, to be compared with the calcu-
lated values of 10,700 and 1.26. It may be observed that Mn
was in excellent agreement with the expected value, whereas
the Mw/Mn ratio was remarkably lower. In fact, the product
obtained was quasi-monodisperse. Interestingly, this effect
was not observed wit BP-MP, suggesting that the zwitterionic
nature of BAC-MP was largely responsible for it. Possibly,
BAC-MP eversibly interacted wi cyclam, resulting a local
catalytic activity of the latter favoring the growth of the
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tional center. The LCB frequency of BP-MP-C and BAC-MP-C
was determined by SEC connected in series with refractive
index (RI), light scattering, and viscometric detectors (see Ex-
perimental) and found in both cases of & two side chains per
macromolecule. This LCB frequency value was consistent with
the expected four-arm architecture originating from a cyclam
core.
BAC-P, BAC-MP, BP-P, and BSA were chosen as model HDDs
and protein for the preparation of PAA-protein graft copoly-
mers. This was simply achieved by triggering the HDD poly-
merization in aqueous medium in the presence of BSA that
participated in the polymerization through its exposed NH2
and SH groups. To give an example, the synthesis of BAC-
MP-g-BSA is reported in Scheme 6.
The occurrence of PAA grafting onto BSA was evaluated by
SEC connected in series with RI, light scattering, and visco-
metric detectors. The data, reported in Table 2, provided clear
evidence of the increasing of the molecular weight of copoly-
mers with respect to native BSA, always accompanied by low
polydispersities and higher values of the Mark–Houwink con-
stants, hence higher hydrodynamic radii. A further
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Scheme 4.1 E. Synthesis of BAC-MP-g-BSA by polymerization of BAC-MP in the presence of BSA.
The data, reported in Table 4.1 C, provided clear evidence of the increasing of the molecular weight 
of copolymers with respect to native BSA, always accompanied by low polydisperisities and higher 
values of the Mark-Houwink constants, hence higher hydrodynamic radii. A further confirmation 
was provided by the far higher solubility  in aqueous media of the copolymers compared with virgin 
BSA.
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Table 4.1 C. Molecular weight and viscosimetric data of PAA-g-BSA samples 
compared with BSA.
confirmation was provided by the far higher solubility in
aqueous media of the copolymers compared with virgin BSA.
The BP-P-g-BSA copolymer was further characterized by
comparing the tracing of its potentiometric titrations with
those of virgin BSA/linear BP-P mixtures of known composi-
tion (Fig. 3), as previously reported.13 The titration curves of
the copolymer and of the BSA/BP-P mixtures exhibited two
evident inflections at pH values close to the inflections of the
BP-P titration curve, whereas the BSA curve was character-
ized by a semicontinuous decrease of pH on acid addition
without clearly detectable inflections. Considering that the
amine character of the albumin ANH2 groups involved in the
grafting reaction is preserved, we may reasonably suppose
that PAA/BSA mixtures are good models for PAA-grafted al-
bumin, as far as titration is concerned. Therefore, from the
family of titration curves reported in Figure 3, the PAA con-
tent in the grafted product can be determined as ! 20% by
weight. This value was consistent with the molecular weight
difference of the BP-P-g-BSA copolymer with respect that of
BSA (calculated 18,000, experimentally found 21,100).
Assuming that no BP-P was present, as the copolymer had
been extensively ultrafiltered through a membrane with mo-
lecular weight cut-off 50,000, this correspondence confirmed
that grafting reaction occurred as expected. No titration
experiments were performed with BAC-MP-g-BSA and BAC-
P-g-BSA as the acid–base properties of BAC-MP and BAC-P
are close to those of BSA.
‘‘Tadpole-like’’ PAA-cholesterol amphiphiles were obtained by
performing the polymerization of HDDs in the presence of
TC, which participates in the Michael polyaddition through
its SH group (Scheme 7).
These reaction systems closely resembled the preparation of
mono-functional PAAs by copolymerization of HDDs with
monofunctional amines or acrylamides, as the SH group
reacts with activated double bonds in the same way as the
amine groups.20,21 Being TC insoluble in water, the prepara-
tions of HDD-TC conjugates were performed in a diethy-
lether/water slurry. TC resided in the former solvent and the
HDDs in the latter. The two solutions were vigorously stirred
under nitrogen at room temperature in a closed vessel until
the signals due to the acrylic hydrogens of bisacrylamides
were no longer detectable in the 1H NMR spectra of the
aqueous phases. The feasibility of this process was ascer-
tained with BAC-MP, MBA-P, BP-P, and BP-MP. A 10:1 HDD/
TC molar ratio was used for obtaining polymers with 10
repeating units of HDD per TC molecule. This value was cho-
sen because literature data22,23 suggested it as leading to a
suitable hydrophilic/lipophilic balance to form and hydro-
phobically stabilize polyelectrolyte emulsions. In the case of
BAC-MP-TC and MBA-P-TC, their amphiphilic nature led to
phase segregation both in aqueous media and organic sol-
vents. Consequently, their 1H NMR spectra showed neither
traces of the PAA backbone in deuterated water, nor of the
cholesterol moiety in deuterated chloroform, as expected.
BP-P turned to be hardly soluble in both solvents, probably
due to the tendency of the BP-P chain to crystallize (data not
shown). Only in the case of BP-MP-TC both components were
soluble in deuterated chloroform. This allowed obtaining
clear homogeneous solutions and running 1H NMR spectra in
this solvent. These spectra did not significantly differ from
those of a previously synthesized BP-MP PAA carrying pendant
TC moieties24 and showed the presence of the diagnostic peaks
of both components. The calculated and experimentally
FIGURE 3 Potentiometric titration curves of BP-P-g-BSA copol-
ymer and of BSA/linear BP-P mixtures of known composition.
TABLE 2 Molecular Weight and Viscometric Data of
PAA-Grafted BSA Samples Compared with BSA
Sample Mn
a Mw/Mn
b
[g]c
(dL/g) ad log Ke
Rh
f
(nm)
BSA 67,000 1.04 0.054 0.034 "1.45 3.92
BAC-MP-g-BSA 1,01,000 1.07 0.067 0.203 "2.74 6.1
BAC-P-g-BSA 84,900 1.17 0.053 0.265 "2.58 4.11
BP-P-g-BSA 88,100 1.14 0.083 0.163 "2.04 5.90
a Number average molecular weight.
b Polydispersity index.
c Intrinsic viscosity.
d,e Mark–Houwink constants.
f Hydrodynamic radius.
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a Number average molecular weight; b Polydispersity index; c Intrinsic vis-
cosity; d,e Mark-Houwink constants; f Hydrodynamic radius.
The BP-P-g-BSA copolymer was further characterized by comparing the tracing of its potentiomet-
ric titrations with those of virgin BSA/linear BP-P mixtures of known composition (Figure 4.1 D), 
as previously  reported.13 The titration curves of the copolymer and of the BSA/BP-P mixtures ex-
hibited two evident inflections at pH values close to the inflections of the BP-P titration curve, 
whereas the BSA curve was characterized by a emi-continuous decrease of pH upon acid addition 
without clearly detectable inflections. 
confirmation was provided by the far higher solubility in
aqueous media of the copolymers compared with virgin BSA.
The BP-P-g-BSA copolymer was further characterized by
comparing the tracing of its potentiometric titrations with
those of virgin BSA/linear BP-P mixtures of known composi-
tion (Fig. 3), as previously reported.13 The titration curves of
the copolymer and of the BSA/BP-P mixtures exhibited two
evident inflections at pH values close to the inflections of the
BP-P titration curve, whereas the BSA curve was character-
ized by a semicontinuous decrease of pH on acid addition
without clearly detectable inflections. Considering that the
amine character of the albumin ANH2 groups involved in the
grafting reaction is preserved, we may reasonably suppose
that PAA/BSA mixtures are good models for PAA-grafted al-
bumin, as far as titration is concerned. Therefore, from the
family of titration curves reported in Figure 3, the PAA con-
tent in the grafted product can be determined as ! 20% by
weight. This value was consistent with the molecular weight
difference of the BP-P-g-BSA copolymer with respect that of
BSA (calculated 18,000, experimentally found 21,100).
Assuming that no BP-P was present, as the copolymer had
been extensively ultrafiltered through a membrane with mo-
lecular weight cut-off 50,000, this correspondence confirmed
that grafting reaction occurred as expected. No titration
experiments were performed with BAC-MP-g-BSA and BAC-
P-g-BSA as the acid–base properties of BAC-MP and BAC-P
are close to those of BSA.
‘‘Tadpole-like’’ PAA-cholesterol amphiphiles were obtained by
performing the polymerization of HDDs in the presence of
TC, which participates in the Michael polyaddition through
its SH group (Scheme 7).
These reaction syst ms closely resembled the preparation of
mono-functional PAAs by c olymerization of HDDs with
mon functional amines or acrylamides, as the SH group
reacts with activated double bonds in the same way as the
amine groups.20,21 Being TC insoluble in water, the prepara-
tions of HDD-TC conjugates were performed in a diethy-
lether/water slurry. TC resided in the former solvent and the
HDDs in the latter. The two solutions were vigorously stirred
under nitrogen at room temperature in a closed vessel until
the signals due to the acrylic hydrogens of bisacrylamides
were no longer detectable in the 1H NMR spectra of the
aqueous phases. The feasibility of this process was ascer-
tained with BAC-MP, MBA-P, BP-P, and BP-MP. A 10:1 HDD/
TC molar ratio was used for obtaining polymers with 10
repeating units of HDD per TC molecule. This value was cho-
sen because literature data22,23 suggested it as leading to a
suitable hydrophilic/lipophilic balance to form and hydro-
phobically stabilize polyelectrolyte emulsions. In the case of
BAC-MP-TC and MBA-P-TC, their amphiphilic nature led to
phase segregation both in aqueous media and organic sol-
vents. Consequently, their 1H NMR spectra showed neither
traces of the PAA backbone in deuterated water, nor of the
cholesterol moiety in deuterated chloroform, as expected.
BP-P turned to be hardly soluble in both solvents, probably
due to the tendency of the BP-P chain to crystallize (data not
shown). Only in the case of BP-MP-TC both components were
soluble in deuterated chloroform. This allowed obtaining
clear homogeneous solutions and running 1H NMR spectra in
this solvent. These spectra did not significantly differ from
those of a previously synthesized BP-MP PAA carrying pendant
TC moieties24 and showed the presence of the diagnostic peaks
of both components. The calculated and experimentally
FIGURE 3 Potentiometric titration curves of BP-P-g-BSA copol-
ymer and of BSA/linear BP-P mixtures of known composition.
TABLE 2 Molecular Weight and Viscometric Data of
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Figure 4.1 D. Potentiom tric titration curves  BP-P-g-BSA copolymer and of BSA/linear BP-P mixtures of known 
composition.
Considering that the amine character of the albumin -NH2 groups involved in the grafting reaction 
is preserved, we may reasonably suppose that PAA/BSA mixtures are good models for PAA-grafted 
albumin, as far as titrati n is concerned. Theref re, rom the family of titrati n curves reported in 
Figure 4.1 D, the PAA content in the grafted product can be determined as approximately 20% by 
weight. This value was consistent with the mol cular weight difference of the BP-P-g-BSA co-
polymer with respect that of BSA (calculated 18000, experimentally found 21100). Assuming that 
Results and Discussion
110
no BP-P was present, since the copolymer had been extensively ultrafiltered through a membrane 
with molecular weight cut-off 50000, this correspondence confirmed that grafting reaction occurred 
as expected. No titration experiments were carried out  with BAC-MP-g-BSA and BAC-P-g-BSA 
since the acid-base properties of BAC-MP and BAC-P are close to those of BSA. 
“Tadpole-like” PAA-cholesterol amphiphiles were obtained by carrying out the polymerization of 
HDDs in the presence of thiocholesterol (TC), which participates in the Michael polyaddition 
through its SH group (Scheme 4.1 F). 
confirmation was provided by the far higher solubility in
aqueous media of the copolymers compared with virgin BSA.
The BP-P-g-BSA copolymer was further characterized by
comparing the tracing of its potentiometric titrations with
those of virgin BSA/linear BP-P mixtures of known composi-
tion (Fig. 3), as previously reported.13 The titration curves of
the copolymer and of the BSA/BP-P mixtures exhibited two
evident inflections at pH values close to the inflections of the
BP-P titration curve, whereas the BSA curve was character-
ized by a semicontinuous decrease of pH on acid addition
without clearly detectable inflections. Considering that the
amine character of the albumin ANH2 groups involved in the
grafting reaction is preserved, we may reasonably suppose
that PAA/BSA mixtures are good models for PAA-grafted al-
bumin, as far as titration is concerned. Therefore, from the
family of titration curves reported in Figure 3, the PAA con-
tent in the grafted product can be determined as ! 20% by
weight. This value was consistent with the molecular weight
difference of the BP-P-g-BSA copolymer with respect that of
BSA (calculated 18,000, experimentally found 21,100).
Assuming that no BP-P was present, as the copolymer had
been extensively ultrafiltered through a membrane with mo-
lecular weight cut-off 50,000, this correspondence confirmed
that grafting reaction occurred as expected. No titration
experiments were performed with BAC-MP-g-BSA and BAC-
P-g-BSA as the acid–base properties of BAC-MP and BAC-P
are close to those of BSA.
‘‘Tadpole-like’’ PAA-cholesterol amphiphiles were obtained by
performing the polymerization of HDDs in the presence of
TC, which participates in the Michael polyaddition through
its SH group (Scheme 7).
These reaction systems closely resembled the preparation of
mono-functional PAAs by copolymerization of HDDs with
monofunctional amines or acrylamides, as the SH group
reacts with activated double bonds in the same way as the
amine groups.20,21 Being TC insoluble in water, the prepara-
tions of HDD-TC conjugates were performed in a diethy-
lether/water slurry. TC resided in the former solvent and the
HDDs in the latter. The two solutions were vigorously stirred
under nitrogen at room temperature in a closed vessel until
the signals due to the acrylic hydrogens of bisacrylamides
were no longer detectable in the 1H NMR spectra of the
aqueous phases. The feasibility of this process was ascer-
tained with BAC-MP, MBA-P, BP-P, and BP-MP. A 10:1 HDD/
TC molar ratio was used for obtaining polymers with 10
repeating units of HDD per TC molecule. This value was cho-
sen because literature data22,23 suggested it as leading to a
suitable hydrophilic/lipophilic balance to form and hydro-
phobically stabilize polyelectrolyte emulsions. In the case of
BAC-MP-TC and MBA-P-TC, their amphiphilic nature led to
phase segregation both in aqueous media and organic sol-
vents. Consequently, their 1H NMR spectra showed neither
traces of the PAA backbone in deuterated water, nor of the
cholesterol moiety in deuterated chloroform, as expected.
BP-P turned to be hardly soluble in both solvents, probably
due to the tendency of the BP-P chain to crystallize (data not
shown). Only in the case of BP-MP-TC both components were
soluble in deuterated chloroform. This allowed obtaining
clear homogeneous solutions and running 1H NMR spectra in
this solvent. These spectra did not significantly differ from
those of a previously synthesized BP-MP PAA carrying pendant
TC moieties24 and showed the presence of the diagnostic peaks
of both components. The calculated and experimentally
FIGURE 3 Potentiometric titration curves of BP-P-g-BSA copol-
ymer and of BSA/linear BP-P mixtures of known composition.
TABLE 2 Molecular Weight and Viscometric Data of
PAA-Grafted BSA Samples Compared with BSA
Sample Mn
a Mw/Mn
b
[g]c
(dL/g) ad log Ke
Rh
f
(nm)
BSA 67,000 1.04 0.054 0.034 "1.45 3.92
BAC-MP-g-BSA 1,01,000 1.07 0.067 0.203 "2.74 6.1
BAC-P-g-BSA 84,900 1.17 0.053 0.265 "2.58 4.11
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b Polydispersity index.
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Scheme 4.1 F. Synthesis of “tadpole-like” PAA-Cholesterol amphiphiles by polymerization of HDDs in the presence of 
thiocholesterol (TC).
These reaction systems closely resembled the preparation of mono-functional PAAs by copolymeri-
zation of HDDs with monofunctional amines or acrylamides, since the SH group reacts with acti-
vated double bonds in the same way as the amine groups.8  Being thiocholesterol insoluble in water, 
the preparations of HDD-TC conjugates were carried out in a diethylether/water slurry. Thiocholes-
terol resided in the former solvent and the HDDs in the latter. The two solutions were vigorously 
stirred under nitrogen at room temperature in a closed vessel until the signals due to the acrylic hy-
drogens of bisacrylamides were no longer detectable in the 1H NMR spectra of the aqueous phases. 
The feasibility of this process was ascertained with BAC-MP, MBA-P, BP-P and BP-MP. A 10:1 
HDD/TC molar ratio was employed for obtaining polymers with 10 repeating units of HDD per TC 
molecule. 
This value was chosen because literature data9  10  suggest it as leading to a suitable hydrophilic/
lipophilic balance for micelle formation in aqueous media. In the case of BAC-MP-TC and MBA-
P-TC, their amphiphilic nature led to phase segregation both in aqueous media and organic sol-
vents. Consequently, their 1H NMR spectra showed neither traces of the PAA backbone in deuter-
ated water, nor of the cholesterol moiety in deuterated chloroform, as expected. BP-P turned to be 
hardly  soluble in both solvents, probably due to the tendency of the BP-P chain to crystallize (data 
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9 Ranucci, E.; Ferruti, P., Macromolecules, 1991, 24, 3747-3752.
10 Perrin, P.; Monfreux, N.; Lafruma, M., Colloid Polym. Sci., 1999, 277, 89-94.
not shown). Only  in the case of BP-MP-TC both components were soluble in deuterated chloro-
form. This allowed obtaining clear homogeneous solutions and running 1H NMR spectra in this sol-
vent. These spectra did not  significantly differ from those of a previously  synthesized BP-MP PAA 
carrying pendant TC moieties,11 and showed the presence of the diagnostic peaks of both compo-
nents. The calculated and experimentally determined C/N ratios for all the PAA-TC polymers syn-
thesized are reported in Table 4.1 D. 
Table 4.1 D. C/N Ratio of “Tadpole-like” PAA-Cholesterol Amphiphiles
determined C/N ratios for all the PAA-TC polymers synthesized
are reported in Table 3. It may be observed that the experi-
mental values were invariably lower than the theoretical ones,
pointing to cholesterol content somewhat lower than expected,
doubtless due to the heterogeneous reaction conditions
adopted. All PAA-TC samples formed nanoparticles in aqueous
media, as confirmed by DLS and TEM analyses. As an example,
the DLS curves of BAC-MP-TC are reported in Figure 4.
It may be noticed that the correlogram [Fig. 4(a)] is consist-
ent with a neat homogeneous monomodal size distribution.
The other PAA-TC samples gave similar results. The average
PAA-TC nanoparticle sizes in PBS solution pH 7.4 as a func-
tion of concentration and temperature are reported in
Figures 5 and 6, respectively.
It may be observed that particle formation at 25 !C in PBS
started at concentrations in the range 0.15–0.60 mg/mL,
their size increased sharply, reached a maximum at about
twice these values, then remained approximately constant
and finally decreased for concentrations higher than 1 mg/
mL. Consequently, the critical micelle concentration (CMC)
deduced from the graphs varied from 0.16 to 0.7 mg/mL, fol-
lowing the trend BP-P < BP-MP " MBA-P << BAC-MP. This
trend is consistent with the relative hydrophilicities of the
PAA portions. The apparent exception provided by BP-P-TC
can be explained by the previously mentioned structure-
forming tendency of its PAA portion. Nanoparticle average
sizes at 1 mg/mL concentration varied in the range 13–28
nm and, not surprisingly, followed the same trend as the
CMC, the most hydrophilic ones giving larger nanoparticles.
The temperature dependence of nanoparticle average size in
the range 25–60 !C are reported in Figure 6. All curves, leav-
ing apart BAC-MP, show qualitatively the same trend. The av-
erage size initially decreased until about 30 !C, remained
approximately constant in the range 30–45 !C and then
increased until the maximum tested temperature of 60 !C. In
the case of BAC-MP, the trend was initially the same and the
average size decreased until about 30 !C, but immediately af-
ter started to increase until 60 !C. TEM analysis showed a
quasispherical shape with no evidence of dual distribution,
as for example in the case of BAC-MP reported in Figure 7.
TABLE 3 C/ Ratio of ‘‘Tadpole-like’’ PAA-Cholesterol
Amphiphiles
Sample C/Na C/Nb HDD/TCc
BAC-MP-TC 3.21 2.98 4.52
MBA-P-TC 2.94 2.82 7.97
BP-P-TC 3.58 3.30 5.17
BP-MP-TC 3.80 3.59 6.61
a Calculated.
b Found.
c Molar ratio between the HDD repeat unit and the TC moiety as calcu-
lated from C/N found values, to be compared with a 10:1 HDD/TC molar
ratio in the reaction feeding.
FIGURE 4 DLS analysis of BAC-MP-TC nanoparticles in PBS (1
mg/mL) at 25 !C. Panel (a): correlogram; panel (b): number
size-distribution.
FIGURE 5 PAA-TC nanoparticle diameters in PBS solution pH
7.4 at 25 !C as a function of concentration: BAC-MP ( );
MBA-P ( ); BP-P ( ); BP-MP ( ).
FIGURE 6 PAA-TC nanoparticle diameters in PBS solution pH
7.4 (1 mg/mL concentration) as a function of temperature: BAC-
MP ( ); MBA-P ( ); BP-P ( ); BP-MP ( ).
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a Calculated; b Found; c Molar ratio between the HDD repeat unit and the TC 
moiety as calculated from C/N found values, to be compared with a 10:1 
HDD/TC molar ratio in the reaction feeding.
It may be observed that the experimental values were invariably lower than the theoretical ones, 
pointing to cholesterol content somewhat lower than expected, doubtless due to the heterogeneous 
reaction conditions adopted. All PAA-TC samples formed nanoparticles in aqueous media, as con-
firmed by dynamic light scattering (DLS) and TEM analyses. As example, the DLS curv s of BAC-
MP-TC and the TEM analysis are reported in Figure 4.1 E. It may be noticed that the correlogram is 
consistent with a neat homogeneous monomodal size distribution. Furthermore, TEM analysis 
showed a quasi-spherical shape of these nanoparticles. The other PAA-TC samples gave similar re-
sults. 
The average PAA-TC nanoparticle sizes in PBS solution pH 7.4 as a function of concentration and 
temperature are reported in Figures 4.1 F and 4.1 G, respectively. It  may  be observed that particle 
formation at 25 °C in PBS s arted at concentrations in the range 0.15-0.60 mg/mL, their size in-
creased sharply, reached a maximum at about twice these values, then remained approximately con-
stant and finally decreased for concentrations higher than 1 mg/mL. Consequently, the critical mi-
celle concentration (CMC) deduced from the graphs varied from 0.16 to 0.7 mg/mL, following the 
trend BP-P<BP-MP≤ MBA-P<<BAC-MP. This trend is consistent with the relative hydrophilicities 
of the PAA portions. The apparent exception provided by  BP-P-TC can be explained by the previ-
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ously mentioned structure-forming tendency of its PAA portion. Nanoparticle average sizes at 1 mg/
mL concentration varied in the range 13–28 nm and, not surprisingly, followed the same trend as 
the CMC, the most hydrophilic ones giving larger nanoparticles.
determined C/N ratios for all the PAA-TC polymers synthesized
are reported in Table 3. It may be observed that the experi-
mental values were invariably lower than the theoretical ones,
pointing to cholesterol content somewhat lower than expected,
doubtless due to the heterogeneous reaction conditions
adopted. All PAA-TC samples formed nanoparticles in aqueous
media, as confirmed by DLS and TEM analyses. As an example,
the DLS curves of BAC-MP-TC are reported in Figure 4.
It may be noticed that the correlogram [Fig. 4(a)] is consist-
ent with a neat homogeneous monomodal size distribution.
The other PAA-TC samples gave similar results. The average
PAA-TC nanoparticle sizes in PBS solution pH 7.4 as a func-
tion of concentration and temperature are reported in
Figures 5 and 6, respectively.
It may be obser ed that particle formation at 25 !C in PBS
started at concentrations in the range 0.15–0.60 mg/mL,
their size increased sharply, reached a maximum at about
twice these values, then remained approximately constant
and finally decreased for concentrations higher than 1 mg/
mL. Consequently, the critical micelle concentration (CMC)
deduced from the graphs varied from 0.16 to 0.7 mg/mL, fol-
lowing the trend BP-P < BP-MP " MBA-P << BAC-MP. This
trend is consistent with the relative hydrophilicities of the
PAA portions. The apparent exception provided by BP-P-TC
can be explained by the previously mentioned structure-
forming tendency of its PAA portion. Nanoparticle average
sizes at 1 mg/mL concentration varied in the range 13–28
nm and, not surprisingly, followed the same trend as the
CMC, the most hydrophilic ones giving larger nanoparticles.
The temperature d pendenc of nanoparticle average size in
the range 25–60 !C are reported in Figure 6. All curves, leav-
ing apart BAC-MP, show qualitatively the same trend. The av-
erage size initially decreased until about 30 !C, remained
approximately constant in the range 30–45 !C and then
increased until the maximum tested temperature of 60 !C. In
the case of BAC-MP, the trend was initially the same and the
average size decreased until about 30 !C, but immediately af-
ter started to increase until 60 !C. TEM analysis showed a
quasispherical shape with no evidence of dual distribution,
as for example in the case of BAC-MP reported in Figure 7.
TABLE 3 C/N Ratio of ‘‘Tadpole-like’’ PAA-Cholesterol
Amphiphiles
Sample C/Na C/Nb HDD/TCc
BAC-MP-TC 3.21 2.98 4.52
MBA-P-TC 2.94 2.82 7.97
BP-P-TC 3.58 3.30 5.17
BP-MP-TC 3.80 3.59 6.61
a Calculated.
b Found.
c Molar ratio between the HDD repeat unit and the TC moiety as calcu-
lated from C/N found values, to be compared with a 10:1 HDD/TC molar
ratio in the reaction feeding.
FIGURE 4 DLS analysis of BAC-MP-TC nanoparticles in PBS (1
mg/mL) at 25 !C. Panel (a): correlogram; panel (b): number
size-distribution.
FIGURE 5 PAA-TC nanoparticle diameters in PBS solution pH
7.4 at 25 !C as a function of concentration: BAC-MP ( );
MBA-P ( ); BP-P ( ); BP-MP ( ).
FIGURE 6 PAA-TC nanoparticle diameters in PBS solution pH
7.4 (1 mg/mL concentration) as a function of temperature: BAC-
MP ( ); MBA-P ( ); BP-P ( ); BP-MP ( ).
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CONCLUSIONS
Up to now, there was no simple method to straightforwardly
prepare PAAs with differently functionalized chain termini,
that is, PAAs solely containing molecules of a!! """""" !! b type.
This precluded to PAAs the access to a number of derivatives,
such as for instance PAAs of controlled average molecular
weight and mono-functionalized with an acrylamide- or a sec-
amine group at one end, PAAs with a star-like molecular
architecture, graft-PAA-protein conjugates, ‘‘tadpole-like’’ PAA
conjugates with hydrophobic moieties able to self-assemble
into nanoparticles in aqueous media. The devised strategy to
overcome this problem was to prepare HDDs of
‘‘a!!a!!b!!b’’ type, that is, the mono-addition products of
a bis-sec-amine to a bisacrylamide, which as strong acid salts
could be indefinitely kept dormant in the dry state at 0–5 #C
but polymerized in aqueous media at pH > 7.5. In this article,
we report on the preparation of a selected number of HDDs
and provide evidence of their synthetic potential by perform-
ing model reactions following the above cited lines. It should
be noticed that the specificity of the Michael addition of
amines to bisacrylamides in aqueous media, shared only by
thiols under the PAA preparation conditions, allowed prepar-
ing most of the above derivatives by simply performing the
polymerization of HDDs in the presence of the substrates of
interest with no need of presynthesizing PAAs mono-function-
alized at one end with an activated double bond. This greatly
simplified the synthetic processes negligibly affecting the
products’ characteristics. On the whole, it can be concluded
that the aim of this research has been adequately fulfilled,
thus demonstrating the wide synthetic potential of HDDs.
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FIGURE 7 TEM micrograph of BAC-MP-TC conjugate obtained
by negative staining microscopy using uranyl acetate.
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a)
b)
c)
Figure 4.1 E. DLS an TEM analyses of BAC-MP-TC nanoparticles in PBS (1 mg/ml) at 25 °C. Panel ( ): orrelogram; 
panel (b): number size-distribution. Panel (c): TEM micrograph obtained by negative staining microscopy using uranyl 
acetate.
determined C/N ratios for all the PAA-TC polymers synthesized
are reported in Table 3. It may be observed that the experi-
mental values were invariably lower than the theoretical ones,
pointing to cholesterol content somewhat lower than expected,
doubtless due to the heterogeneous reaction conditions
adopted. All PAA-TC samples formed nanoparticles in aqueous
media, as confirmed by DLS and TEM analyses. As an example,
the DLS curves of BAC-MP-TC are reported in Figure 4.
It may be noticed that the correlogram [Fig. 4(a)] is consist-
ent with a neat homogeneous monomodal size distribution.
The other PAA-TC samples gave similar results. The average
PAA-TC nanoparticle sizes in PBS solution pH 7.4 as a func-
tion of concentration and temperature are reported in
Figures 5 and 6, respectively.
It may be observed that particle formation at 25 !C in PBS
started at concentrations in the range 0.15–0.60 mg/mL,
their size increased sharply, reached a maxi um at about
twice these values, then remained approximately constant
and finally decreased for concentrations higher than 1 mg/
mL. Consequently, the critical micelle concentration (CMC)
deduced from the graphs varied from 0.16 to 0.7 mg/mL, fol-
lowing the trend BP-P < BP-MP " MBA-P << BAC-MP. This
trend is consistent with the relative hydrophilicities of the
PAA portions. The apparent exception provided by BP-P-TC
can be explained by the previously mentioned structure-
forming tendency of its PAA portion. Nanoparticle average
sizes at 1 mg/mL concentration varied in the range 13–28
nm and, not surprisingly, followed the same trend as the
CMC, the most hydrophilic ones giving larger nanoparticles.
The temperature dependence of nanoparticle average size in
the range 25–60 !C are reported in Figure 6. All curves, leav-
ing apart BAC-MP, show qualitatively the same trend. The av-
erage size initially decreased until about 30 !C, remained
approximately constant in the range 30–45 !C and then
increased until the maximum tested temperature of 60 !C. In
the case of BAC-MP, the trend was initially the same and the
average size decreased until about 30 !C, but immediately af-
ter started to increase until 60 !C. TEM analysis showed a
quasispherical shape with no evidence of dual distribution,
as for example in the case of BAC-MP reported in Figure 7.
TABLE 3 C/N Ratio of ‘‘Tadpole-like’’ PAA-Cholesterol
Amphiphiles
Sample C/Na C/Nb HDD/TCc
BAC-MP-TC 3.21 2.98 4.52
MBA-P-TC 2.94 2.82 7.97
BP-P-TC 3.58 3.30 5.17
BP-MP-TC 3.80 3.59 6.61
a Calculated.
b Found.
c Molar ratio between the HDD repeat unit and the TC moiety as calcu-
lated from C/N found values, to be compared with a 10:1 HDD/TC molar
ratio in the reaction feeding.
FIGURE 4 DLS analysis of BAC-MP-TC nanoparticles in PBS (1
mg/mL) at 25 !C. Panel (a): correlogram; panel (b): number
size-distribution.
FIGURE 5 PAA-TC nanoparticle diameters in PBS solution pH
7.4 at 25 !C as a function of concentration: BAC-MP ( );
MBA-P ( ); BP-P ( ); BP-MP ( ).
FIGURE 6 PAA-TC nanoparticle diameters in PBS solution pH
7.4 (1 mg/mL concentration) as a function of temperature: BAC-
MP ( ); MBA-P ( ); BP-P ( ); BP-MP ( ).
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Figure 4.1 F. Hydrodynamic diameter of PAA-Cholesterol micelles in PBS at 25 °C as function of polymer concentra-
tion: BAC-MP-TC (--◊--); MBA-P-TC (--?--); BP-P-TC (--○--); BP-MP-TC (--⋇--).
The t mperature depend nce of anoparticle average size in the range 25-60 °C are reported in Fig-
ure 4.1 G. All curves, leaving apart BAC-MP, show qualitatively the same trend. 
The average size initially  dec eased until about 30 °C, remained approximately constant in the 
range 30-45 °C and then increased until the maximum tested temperature of 60 °C. In the case of 
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BAC-MP the trend was initially the same and the average size decreased until about 30 °C, but im-
mediately after started to increase until 60 °C.
determined C/N ratios for all the PAA-TC polymers synthesized
are reported in Table 3. It may be observed that the experi-
mental values were invariably lower than the theoretical ones,
pointing to cholesterol content somewhat lower than expected,
doubtless due to the heterogeneous reaction conditions
adopted. All PAA-TC samples formed nanoparticles in aqueous
media, as confirmed by DLS and TEM analyses. As an example,
the DLS curves of BAC-MP-TC are reported in Figure 4.
It may be noticed that the correlogram [Fig. 4(a)] is consist-
ent with a neat homogeneous monomodal size distribution.
The other PAA-TC samples gave similar results. The average
PAA-TC nanoparticle sizes in PBS solution pH 7.4 as a func-
tion of concentration and temperature are reported in
Figures 5 and 6, respectively.
It may be observed that particle formation at 25 !C in PBS
started at concentrations in the range 0.15–0.60 mg/mL,
their size increased sharply, reached a maximum at about
twice these values, then remained approximately constant
and finally decreased for concentrations higher than 1 mg/
mL. Consequently, the critical micelle concentration (CMC)
deduced from the graphs varied from 0.16 to 0.7 mg/mL, fol-
lowing the trend BP-P < BP-MP " MBA-P << BAC-MP. This
trend is consistent with the relative hydrophilicities of the
PAA portions. The apparent exception provided by BP-P-TC
can be explained by the previously mentioned structure-
forming tendency of its PAA portion. Nanoparticle average
sizes at 1 mg/mL concentration varied in the range 13–28
nm and, not surprisingly, followed the same trend as the
CMC, the most hydrophilic ones giving larger nanoparticles.
The temperature dependence of nanoparticle average size in
the range 25–60 !C are reported in Figure 6. All curves, leav-
ing apart BAC-MP, show qualitatively the same trend. The av-
erage size initially decreased until about 30 !C, remained
approximately constant in the range 30–45 !C and then
increased until the maximum tested temperature of 60 !C. In
the case of BAC-MP, the trend was initially the same and the
average size decreased until about 30 !C, but immediately af-
ter started to increase until 60 !C. TEM analysis showed a
quasispherical shape with no evidence of dual distribution,
as for example in the case of BAC-MP reported in Figure 7.
TABLE 3 C/N Ratio of ‘‘Tadpole-like’’ PAA-Cholesterol
Amphiphiles
Sample C/Na C/Nb HDD/TCc
BAC-MP-TC 3.21 2.98 4.52
MBA-P-TC 2.94 2.82 7.97
BP-P-TC 3.58 3.30 5.17
BP-MP-TC 3.80 3.59 6.61
a Calculated.
b Found.
c Molar ratio between the HDD repeat unit and the TC moiety as calcu-
lated from C/N found values, to be compared with a 10:1 HDD/TC molar
ratio in the reaction feeding.
FIGURE 4 DLS analysis of BAC-MP-TC nanoparticles in PBS (1
mg/mL) at 25 !C. Panel (a): correlogram; panel (b): number
size-distribution.
FIGURE 5 PAA-TC nanoparticle diameters in PBS solution pH
7.4 at 25 !C as a function of concentration: BAC-MP ( );
MBA-P ( ); BP-P ( ); BP-MP ( ).
FIGURE 6 PAA-TC nanoparticle diameters in PBS solution pH
7.4 (1 mg/mL concentration) as a function of temperature: BAC-
MP ( ); MBA-P ( ); BP-P ( ); BP-MP ( ).
ARTICLE WWW.POLYMERCHEMISTRY.ORG
JOURNAL OF
POLYMER SCIENCE
10 JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY 2012, 000, 000–000
Figure 4.1 G. Hydrodynamic diameter of PAA-Cholesterol micelles in PBS at concentration of 1 mg/ml as function of 
temperature: BAC-MP-TC (--◊--); MBA-P-TC (--?--); BP-P-TC (--○--); BP-MP-TC (--⋇--).
Results and Discussion
114
Supplementary Figures.
Figure S1. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-P dimer.
a)
b)
Figure S4.1 A. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of BAC-P dimer.
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Figure S2. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BAC-MP dimer.
a)
b)
Figure S4.1 B. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of BAC-MP dimer.
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Figure S3. 1H NMR (panel a) and 13C NMR (panel b), (D2O)  of  MBA-P dimer.
a)
b)
Figure S4.1 C. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of MBA-P dimer.
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Figure S4. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  MBA-MP dimer.
a)
b)
Figure S4.1 D. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of MBA-MP dimer.
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Figure S5. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-P dimer.
a)
b)
Figure S4.1 E. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of BP-P dimer.
Results and Discussion
119
Figure S6. 1H NMR (panel a) and 13C NMR (panel b), (D2O) of  BP-MP dimer.
a)
b)
Figure 
S4.1 F. 1H (Panel a) and 13C (Panel b) NMR spectra (D2O, ppm) of BP-MP dimer.
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Figure S8. 1H NMR, (D2O) of  BAC-MP-Cyclam based star polymer (BAC-MP-C).
# 1 2 3 4/5/6 7 8 9 10
BAC-MP-Cy 1H 5.65 3.78 3.78; 
3.44
3.44 3.16 2.82 1.96 1.45; 
1.38
Figure S4.1 G. 1H NMR spectrum (D2O, ppm) of BAC-MP-Cyclam star-like polymer.
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Figure S9. 1H NMR, (D2O) of  BP-MP-Cyclam based star polymer (BP-MP-Cy).
# 1 2 3 4 5 6/7 8 9 10 11
BP-MP-Cy 1H 3.87;
3.48 
3.79 3.68 3.63 3.57 3.48 3.05 2.99 1.85 1.48; 
1.38
Figure S4.1 H. 1H NMR spectrum (D2O, ppm) of BP-MP-Cyclam star-like polymer.
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4.2 HYPERBRANCHED POLYAMIDOAMINES FOR THE SYNTHESIS OF HIGH-
PERFORMANCE BIOMATERIAL
Theoretical considerations. It is commonplace that in polycondensations involving monomers car-
rying separately two types of complementary functions "a” (for instance, reactive hydrogens) and 
"b” (for instance, activated double bonds) of which the minority  function is by convention "a", the 
ruling parameters are the initial stoichiometric ratio "r"  and the conversion degree "p", defined as in 
Eq.s 4.2. A and 4.2. B, respectively:
r = Na0/Nb0                                                        (Eq. 4.2. A)
Where Na0 and Nb0 are the number of a and b functions initially present 
p =(Na0 – Na)/ Na0                                               (Eq. 4.2. B)
Where Na is the number of a functions present at the observation time. 
It is apparent that by definition, both r and p are ≤1. Polycondensations involving monomers bear-
ing more than two functional groups (multi- or polyfunctional polycondensations) lead to insoluble 
cross-linked products at p values higher than a particular value called "critical advancement de-
gree", "pc". For p > pc the system looses its mobility, and for this reason pc is also called "gel point". 
When only  one polyfunctional monomer is present, the critical advancement degree pc is predicted 
by the Flory-Stockmayer formula ( Eq. 4.2 C) 
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Where ! is the fraction of functions belonging to the monomer with functionality >2 with respect to 
the total amount of the functions of the same type initially present in the system, f is the number of 
functions of the poly functional monomer and r is defined as above. It is worth noticing that in Eq. 
3 the pc value depends solely on stoichiometric parameters.
In Eq. (3), pc and r are related. In particular, it exists a “critical stoichiometric ratio”, which we sign 
rc, under which the system is unable to gel and yields branched, but still soluble polymers. Since p 
(and therefore also pc) cannot by definition be > 1, the theoretical rc value is obtained from Eq. (1) 
by putting pc = 1 and solving for r. Then we have: 
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If !  1  ) +  that is, the multifunctional monomer is the only one with this type of function, Eq. (4) 
reduces to:
                                                  (Eq. 4.2 C)
Where ρ is the fraction of functions belonging to the monomer with functionality >2 with resp ct to 
the otal amount of the functions of the same type init ally present i  the system, f is the number of 
functions of the poly functional monomer and r is defin d as above. It is worth noticing that in Eq. 
4.2 C the pc value depends solely on stoichiometric parameters. In Eq. (4.2 C), pc and r are related. 
In particular, it exists a “critical stoichiometric ratio”, which we sign rc, under which the system is 
unable to gel and yields branched, but  still soluble polymers. Since p (and therefore also pc) cannot 
by definition be > 1, the theoretical rc value is obtained from Eq. (4.2 A) by putting pc = 1 and solv-
ing for r. 
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Then we have: 
It is commonplace that in polycondensations involving monomers carrying separately two types of 
complementary functions  "a”  (for instance, reactive hydrogens) and  "b”  (for instance, activated 
double bonds) of which the minority function is by convention "a", the ruling parameters are the 
initial  stoichiometric  ratio  "r" and  the  conversion  degree  "p",  defined  as  in  Eq.s  1  and  2, 
respectively:
r = Na0/Nb0 (1)
Where Na0 and Nb0 are the number of a and b functions initially present 
p =(Na0 – Na)/ Na0 (2)
Where Na is the number of a functions present at the observation time. 
It is apparent that by definition, both r and p are !1. 
Polycondensations  involving  monomers  bearing  more  than  two  functional  groups  (multi-  or 
polyfunctional polycondensations) leed to insoluble cross-linked products at p values higher than a 
particular value called "critical advancement degree", "pc". For p > pc the system looses its mobility, 
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the critical advancement degree pc is predicted by the Flory-Stockmayer formula (3) 
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If !  1  ) +  that is, the multifunctional monomer is the only one with this type of function, Eq. (4) 
reduces to:
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If ρ= 1,  that is, the multifunctional monomer is the only one with this type of function, Eq. (4.2 D) 
reduces to:
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Eq. (3) is not valid in the presence of mono functional compounds. These systems obey to Eq. (6):  
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Where  fW,A  and fW,B are the weight average of the monomers functionalities, including the mono 
functional ones (Eq. 7):
'
'
"
jAjA
jAjA
AW
Nf
Nf
f
,,
,
2
,
,    ;   
'
'
"
jBjB
jBjB
BW
Nf
Nf
f
,,
,
2
,
, (7)
Where  “fA,j”  and  “fB,j”  represent  the  functionality  of  each  monomer  of  type  "A"  and  "B", 
respectively, and where NAj and NBj  are the corresponding moles number in the system. 
Also in this case it is possible to define a critical ratio, rmc, below which the system cannot settle 
into a gel. This will be determined by putting in Eq. 7  pc = 1 and resolving for  r. The resultant 
equation is: 
 (
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In these systems there are two main ways for preparing branched, but completely soluble stepwise 
polymers, namely employing recipes with r > rc, but stopping the reaction at p < pc, or employing 
recipes with r < rc and pushing the reaction to p ! 1. The former method has received attention REF, 
but is of rather difficult application, in that the necessary conditions for rendering it reproducible is 
the  perfect  knowledge  of  the  polymerization  kinetics  coupled  with  the  thorough control  of  all 
reaction parameters. These conditions, once adjusted for a given system, are hardly extensible to 
other systems. By contrast, the latter method involves only the reagents’ stoichiometric control in 
the  polymerization  recipe,  which  is  far  easier,  and  in  principle  can  be  extended  to  all  similar 
systems. Therefore, this method was the only considered in this investigation. 
Systems adopted 
According to Flory, the equations reported in the previous paragraph are expected to hold if all the 
functions of the same type present in the system have equal reactivity. We supposed that for the 
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In these systems there are two main ways for preparing branched, but completely soluble stepwise 
polymers, namely employing recipes with r > rc, but stopping the reaction at p < pc, or employing 
recipes with r < rc and pushing the reaction to p ! 1. The former method has received attention REF, 
but is of rather difficult application, in that the necessary conditions for rendering it reproducible is 
the  perfect  knowledge  of  the  polymerization  kinetics  coupled  with  the  thorough control  of  all 
reaction parameters. These conditions, once adjusted for a given system, are hardly extensible to 
other systems. By contrast, the latter method involves only the reagents’ stoichiometric control in 
the  polymerization  recipe,  which  is  far  easier,  and  in  principle  can  be  extended  to  all  similar 
systems. Therefore, this method was the only considered in this investigation. 
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According to Flory, the equations reported in the previous paragraph are expected to hold if all the 
functions of the same type present in the system have equal reactivity. We supposed that for the 
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In these systems there are two main ways fo  preparing branched, but completely soluble ste wise 
polymers, namely  employing recipes with r > rc, but stopping the reaction at p < pc, or employing 
recipes with r < rc and pushing the reaction to p ≈ 1. The former method has received attention,12 13 
but is of rather difficult a plication, in that the nece sary  cond tions for rendering it reproducible is 
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12 Stockmayer, W., H., J. Chem. Phys., 1943, 11, 45; J. Polym. Soc., 1952, 9, 69.
13 Flory, P., J.; J. Am. Chem. Soc., 1939, 61, 3334; 1941, 63, 3083-3096.
the perfect knowledge of the polymerization kinetics coupled with the thorough control of all reac-
tion parameters. These conditions, once adjusted for a given system, are hardly  extensible to other 
systems. By contrast, the latter method involves only the reagents’ stoichiometric control in the po-
lymerization recipe, which is far easier, and in principle can be extended to all similar systems. 
Therefore, this method was the only considered in this investigation.
Systems adopted. According to Flory, the equations reported in the previous paragraph are expected 
to hold if all the functions of the same type present in the system have equal reactivity. We supposed 
that for the Michael-type additions leading to PAAs this condition was approached by employing 
from one side symmetrical bisacrylamides, owing the relatively long distance between the activated 
double bonds, and from the other side symmetrical bis-sec-amines and symmetrical macrocyclic 
polyamines. In particular, we chose a model system (System A) consisting of 2,2-bis-
acrylamidoacetic acid as bisacrylamides, piperazine as difunctional amine, 1,4,8,12-
tetraazacyclotetradecane as tetra functional amine and, when opportune, morpholine as monofunc-
tional amine. In both cases we performed six polymerization reactions: two with r > rc and excess 
amine hydrogens, one with r > rc  and excess double bonds, one with r < rc and excess mobile hy-
drogens, one with r < rc with excess activated double bonds, and one starting from r > rc, but  driven 
to rm < rmc by the addition of morpholine. The reaction conditions were the same in all cases and 
according to previous experience should allow reaching p values close to 1.
For comparison purposes, we also studied a parallel a system (System B) in which 1,4,8,12-
tetraazacyclotetradecane was replaced by 1, 2-diamonoethane (ethylenediamine), all other reagents 
being equal. The two systems are not equivalent  in that the four mobile hydrogen atoms of ethyle-
nediamine are not expected to be equally  reactive towards Michael addition. In fact, the reaction 
constants of the two hydrogen atoms of primary amines with model acrylamides are known to differ 
by at least one order of magnitude.14 Nevertheless, ethylenediamine had been often employed in the 
past as cross-linking agent for preparing PAA hydrogels.15 16
Compliance with the theory. The results obtained for the system A employed BAC as bisacrylamide 
are reported in Table 4.2.A. 
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14 Mather, B., D; Viswanathan, K.; Miller, K., M.; Long, T., E., Progress Polym. Sci., 2006, 31, 487-531.
15 Ferruti, P., Salamone J., C. Eds, CRC Press Inc.: Boca Ranton, FL, 1996; Vol. 5, pp 3334-3359.
16 Ferruti, P.; Marchisio, M., A.; Duncan, R., Macromol. Rapid. Commun., 2002, 23, 332-355.
Table 4.2 A. Results obtained for the system A. (a), (e)
N° BAC
Mol 10-3
CY
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3
Mw
10-3
3.1 2.6250 0.3750 3.0000 - H 0.714 0.7 -0.014 4.7 6.1
3.2 2.4975 0.3750 3.0000 - H 0.714 0.667 -0.047 3.9 5.7
3.3 3.1875 0.3750 3.0000 - H 0.714 0.85 +0.136 -(b) -(b)
3.4 1.5630 0.1250 1.0000 - = 0.714 0.800 +0.086 -(b) -(b)
3.5 1.0004 0.1250 1.0000 - H 0.714 0.800 +0.086 -(b) -(b)
3.6 1.7863 0.1250 1.0000 - = 0.714 0.709 -0.005 3.7 9.1
3.7 3.9280 0.4550 3.0000 2.0000 H 0.857(d) 0.800 -0.057 3.4 4.6
Considerando CY come tetrafunzionale
N° BAC
Mol 10-3
CY
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3
Mw
10-3
3.1 2.6250 0.3750 3.0000 - H 0.864 0.737 -0.127 4.7 6.1
3.2 2.4975 0.3750 3.0000 - H 0.864 0.701 -0.163 3.9 5.7
3.3 3.1875 0.3750 3.0000 - H 0.864 0.895 0.031 -(b) -(b)
3.4 1.5630 0.1250 1.0000 - = 0.864 0.760 -0.104 -(b) -(b)
3.5 1.0004 0.1250 1.0000 - H 0.864 0.842 -0.022 -(b) -(b)
3.6 1.7863 0.1250 1.0000 - = 0.864 0.665 -0.199 3.7 9.1
3.7 3.9280 0.4550 3.0000 2.0000 H 1.000(d) 0.839 -0.161 3.4 4.6
Considerando CY come trifunzionale 
(a)BAC=2,2’-bisacrylamidoacetic acid, CY=cyclam, P=piperazine,  M=morpholine; (b)Formation of microgels 
was observed after about 7 hrs; (c)Theoretical rc (d) rmc  value (e) All experiments were performed in triple
The polyaddition experiments with excess double bonds and r > rc (3.4 of Table 4.2 A) ultimately 
gave a gel. Apparently, the polyaddition experiment with excess mobile hydrogens and r > rc (3.3 
and 3.5 of Table 4.2 A) did not gel, as expected, but DLS analysis revealed that it contained micro-
gels, a behavior already observed for widely  different systems where the principle of equal reactiv-
ity  was not strictly obeyed. This result suggests that  three of the four hydrogens of 1,4,8,12-
tetraazacyclotetradecane are significantly more reactive than the fourth one. All polyaddition sys-
tems with r < rc (3.1, 3.2 and 3.6 of Table 4.2 A) did not gel irrespective of the nature of the excess 
function, including 3.7 of Table 4.2 A,  in which the addition of morpholine brought to non-gelling 
conditions a system that otherwise would have gelled. DLS analysis excluded in all of these sys-
tems the presence of micro-or nanogels. 
The results obtained with System B are reported in Table 4.2 B. In this case, two different bi-
sacrylamides, namely BAC and BP, were used. Conflicting results were obtained among the poly-
addition experiments performed with excess amine hydrogens (1.1-1.4, 1.8-1.11, 1.13, 2.1-2.4, 
2.8-2.11, 2.13 of Table 4.2 B) and those with excess double bonds (1.5-1.7, 1.12, 2.5-2.7, 2.12 of 
Table 4.2 B). In the former case, when r > rc the substitution of ethylenediamine for 1,4,8,12-
tetraazacyclotetradecane, with the exception of the reactions 1.3, 1.11, 2.3 and 2.11, led to reaction 
mixtures that neither gelled, nor contained microgels.
Results and Discussion
126
Table 4.2.2. Results obtained for the system B.(a), (e)
N° BAC
Mol 10-3
EDA
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3 
Mw
10-3
1.1 2.6250 0.3750 3.0000 - H 0.714 0.700 -0.014 4.3 6.8
1.2 2.4975 0.3750 3.0000 - H 0.714 0.667 -0.047 3.9 5.7
1.3 3.1875 0.3750 3.0000 - H 0.714 0.850 +0.136 -(b) -(b)
1.4 1.6665 0.2500 2.0000 - H 0.714 0.667 -0.047 2.8 4.3
1.5 4.9342 0.3750 3.0000 - = 0.714 0.760 +0.046 -(b) -(b)
1.6 5.1370 0.3750 3.0000 - = 0.714 0.730 +0.016 -(b) -(b)
1.7 5.6222 0.3750 3.0000 - = 0.714 0.667 -0.047 2.2 3.5
1.8 3.9280 0.4550 3.0000 2.0000 H 0.857(d) 0.800 -0.057 3.4 4.6
1.9 3.5000 1.3333 3.0000 - H 0.515 0.618 +0.103 3.4 5.3
1.10 3.3333 1.3333 3.0000 - H 0.515 0.588 +0.073 2.9 4.7
1.11 4.2500 1.3333 3.0000 - H 0.515 0.750 +0.235 -(b) -(b)
1.12 5.0000 0.8889 2.0000 - = 0.515 0.756 +0.241 -(b) -(b)
1.13 4.8000 1.3333 3.0000 2.0000 H 0.606(d) 0.720 +0.114 3.1 4.2
N° BP
Mol 10-3
EDA
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3 
Mw
10-3
2.1 2.625 0.3750 3.0000 - H 0.714 0.700 -0.014 5.1 7.9
2.2 2.4975 0.3750 3.0000 - H 0.714 0.667 -0.047 4.2 6.5
2.3 3.1875 0.3750 3.0000 - H 0.714 0.850 +0.136 -(b) -(b)
2.4 1.6665 0.2500 2.0000 - H 0.714 0.667 -0.047 3.3 4.9
2.5 4.9342 0.3750 3.0000 - = 0.714 0.760 +0.046 -(b) -(b)
2.6 5.1370 0.3750 3.0000 - = 0.714 0.730 +0.016 -(b) -(b)
2.7 5.6222 0.3750 3.0000 - = 0.714 0.667 -0.047 2.5 3.9
2.8 3.928 0.4550 3.0000 2.0000 H 0.857(d) 0.800 -0.057 3.1 4.2
2.9 3.5000 1.3333 3.0000 - H 0.515 0.618 +0.103 3.4 5.3
2.10 3.3333 1.3333 3.0000 - H 0.515 0.588 +0.073 2.9 4.7
2.11 4.2500 1.3333 3.0000 - H 0.515 0.750 +0.235 -(b) -(b)
2.12 5.0000 0.8889 2.0000 - = 0.515 0.756 +0.241 -(b) -(b)
2.13 4.8000 1.3333 3.0000 2.0000 H 0.606(d) 0.720 0.114 2.9 3.8
Considerando EDA come tetrafunzionale 
(a)BAC=2,2’-bisacrylamidoacetic acid, EDA=ethylenediamine, P=piperazine, M=morpholine; (b)Formation of 
microgels was observed after about 7 hrs; (c)Theoretical rc (d) rmc  value (e) All experiments were performed in tri-
ple
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By contrast, the results of the polyadditions performed with excess double bonds gelled, in full 
agreement with the theory. Perhaps, in the latter case considerable excess of double bonds provides 
a suitable environment to make possible the reaction of all four amine hydrogens without signifi-
cant difference in reactivity.  The r and rc values reported in 4.2 A and 4.2 B were calculated by put-
ting forward as a hypothesis that both 1,4,8,12-tetraazacyclotetradecane and ethylenediamine carry 
four reactive hydrogens, that is, they react as tetrafunctional monomers. In Tables 4.2 C and 4.2 D, 
the same results of Tables 4.2 A and 4.2 B are correlated with r and rc values calculated by hypothe-
sizing that the same amines react as trifunctional monomers. 
Table 4.2 C. Results obtained for system A considering cyclam as trifuntional monomers. (a), (e)
N° BAC
Mol 10-3
CY
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc r r - rc Mn
10-3
Mw
10-3
3.1 2.6250 0.3750 3.0000 - H 0.714 0.7 -0.014 4.7 6.1
3.2 2.4975 0.3750 3.0000 - H 0.714 0.667 -0.047 3.9 5.7
3.3 3.1875 0.3750 3.0000 - H 0.714 0.85 +0.136 - -
3.4 1.5630 0.1250 1.0000 - = 0.714 0.800 +0.086 - -
3.5 1.0004 0.1250 1.0000 - H 0.714 0.800 +0.086 - -
3.6 1.7863 0.1250 1.0000 - = 0.714 0.709 -0.005 3.7 9.1
3.7 3.9280 0.4550 3.0000 2.0000 H (M) 0.857 0.800 -0.057 3.4 4.6
Consideran o CY come tetrafunzionale
N° BAC
Mol 10-3
CY
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc r r - rc Mn
10-3
Mw
10-3
3.1 2.6250 0.3750 3.0000 - H 0.864 0.737 -0.127 4.7 6.1
3.2 2.4975 0.3750 3.0000 - H 0.864 0.701 -0.163 3.9 5.7
3.3 3.1875 0.3750 3.0000 - H 0.864 0.895 0.031 - -
3.4 1.5630 0.1250 1.0000 - = 0.864 0.760 -0.104 - -
3.5 1.0004 0.1250 1.0000 - H 0.864 0.842 -0.022 - -
3.6 1.7863 0.1250 1.0000 - = 0.864 0.665 -0.199 3.7 9.1
3.7 3.9280 0.4550 3.0000 2.0000 H 1.000 0.839 -0.161 3.4 4.6
Considerando CY come trifunzionale 
(a)BAC=2,2’-bisacrylamidoacetic acid, CY=cyclam, P=piperazine,  M=morpholine; (b)Formation of microgels 
was observed after about 7 hrs; (c)Theoretical rc (d) rmc  value (e) All experiments were performed in triple
It is immediately apparent that as regards gelling 1,4,8,12-tetraazacyclotetradecane does not fit into 
this hypothesis and reasonably follows the theory  only as tetrafuctional monomer. Ethylenediamine 
reacts as tetrafunctional monomer only  with excess double bonds, while with excess hydrogens it 
follows the theory  only as trifunctional monomer, with the additional qualification that even as such 
it has a tendency to form microgels instead of gelling completely (1.8 of Table 4.2 D). Apparently, 
two out of the four hydrogens, of ethylenediamine (one per nitrogen) are significantly  more reactive 
than the third one, which in turn is more reactive than the fourth one. In other words, the experi-
mental data suggest that  ethylenediamine contains three kinds of amine hydrogens of unequal reac-
tivity. The first two belong to primary amines and can be reasonably expected to be highly reactive. 
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Table 4.2 D. Results obtained for system B considering EDA as trifuntional monomers. (a), (e)
N° BAC
Mol 10-3
EDA
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3 
Mw
10-3
1.1 2.6250 0.3750 3.0000 - H 0.864 0.737 -0.127 4.3 6.8
1.2 2.4975 0.3750 3.0000 - H 0.864 0.701 -0.163 3.9 5.7
1.3 3.1875 0.3750 3.0000 - H 0.864 0.895 +0.031 -(b) -(b)
1.4 1.6665 0.2500 2.0000 - H 0.864 0.701 -0.163 2.8 4.3
1.5 4.9342 0.3750 3.0000 - = 0.864 0.736 -0.128 -(b) -(b)
1.6 5.1370 0.3750 3.0000 - = 0.864 0.693 -0.161 -(b) -(b)
1.7 5.6222 0.3750 3.0000 - = 0.864 0.634 -0.230 2.2 3.5
1.8 3.9280 0.4550 3.0000 2.0000 H 1.000(d) 0.839 -0.161 3.4 4.6
1.9 3.5000 1.3333 3.0000 - H 0.714 0.7000 -0.014 3.4 5.3
1.10 3.3333 1.3333 3.0000 - H 0.714 0.6666 -0.047 2.9 4.7
1.11 4.2500 1.3333 3.0000 - H 0.714 0.8500 +0.136 -(b) -(b)
1.12 5.0000 0.8889 2.0000 - = 0.714 0.6666 -0.048 -(b) -(b)
1.13 4.8000 1.3333 3.0000 2.0000 H 0.857(d) 0.8000 -0.057 3.1 4.2
N° BP
Mol 10-3
EDA
Mol 10-3
P
Mol 10-3
M
Mol 10-3
Excess rc
(c)
r r - rc Mn
10-3 
Mw
10-3
2.1 2.625 0.3750 3.0000 - H 0.864 0.737 -0.127 5.1 7.9
2.2 2.4975 0.3750 3.0000 - H 0.864 0.701 -0.163 4.2 6.5
2.3 3.1875 0.3750 3.0000 - H 0.864 0.895 +0.031 -(b) -(b)
2.4 1.6665 0.2500 2.0000 - H 0.864 0.702 -0.163 3.3 4.9
2.5 4.9342 0.3750 3.0000 - = 0.864 0.736 -0.128 -(b) -(b)
2.6 5.1370 0.3750 3.0000 - = 0.864 0.693 -0.161 -(b) -(b)
2.7 5.6222 0.3750 3.0000 - = 0.864 0.634 -0.230 2.5 3.9
2.8 3.928 0.4550 3.0000 2.0000 H 1.000(d) 0.839 -0.161 3.0 3.9
2.9 3.5000 1.3333 3.0000 - H 0.714 0.7000 -0.014 3.4 5.3
2.10 3.3333 1.3333 3.0000 - H 0.714 0.6666 -0.047 2.9 4.7
2.11 4.2500 1.3333 3.0000 - H 0.714 0.8500 +0.136 -(b) -(b)
2.12 5.0000 0.8889 2.0000 - = 0.714 0.6666 -0.048 -(b) -(b)
2.13 4.8000 1.3333 3.0000 2.0000 H 0.857(d) 0.8000 -0.057 2.9 3.8
Considerando EDA come trifunzionale
(a)BAC=2,2’-bisacrylamidoacetic acid, EDA=ethylenediamine, P=piperazine, M=morpholine; (b)Formation of 
microgels was observed after about 7 hrs; (c)Theoretical rc (d) rmc  value (e) All experiments were performed in tri-
ple
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The remaining two belong to already  reacted amine groups and according to previous findings are 
expected to be significantly less reactive. Moreover, when one of them has reacted, the remaining 
one probably reacts even more sluggishly owing to the steric hindrance provided by the double sub-
stitution to the neighboring nitrogen, which in this sense is probably more effective if inserted in a 
branched molecular context. Then, reaction systems containing excess amine hydrogens cannot be-
have in the same way as those containing excess double bonds. In the former case, the more reac-
tive hydrogens react first leaving little or no double bonds available for the last one that under these 
conditions does not act as structure-forming, but rather as structure-breaking group. This explains 
why ethylenediamine follows the theory as a trifunctional monomer as regards gelling. On the op-
posite, with excess double bonds all hydrogens are ultimately forced to react  and contribute to 
structure formation irrespective of their relative reactivities. Consequently, ethylenediamine fully 
displays its potential as tetrafunctional monomer and complies with the theory as such.
Properties of the polymers. According to theory,17 the branched PAAs obtained under non-gelling 
conditions should have a modest average polymerization degree (Xn ≈ 4), coupled with high poly-
dispersity  (Xw ≈ 10). We did not endeavor to study  in detail the compliance with theory  of our sys-
tems up to the point of molecular weight distribution. Instead, we aimed at  establishing a synthetic 
protocol for preparing branched PAAs with reasonably  high molecular weight  and narrow- to mod-
erate molecular weight distribution. To this purpose, we had to resort to fractionation techniques. 
The crude products were ultrafiltered through a membrane with theoretical cut-off 1000 and the re-
tained fraction recovered by lyophilization. The molecular weights of the resultant products were 
then determined by SEC-LALS. The results are reported in Tables 4.2 A and 4.2 B. The reaction 
yield for all reactions was whitin 45-55 %. It may  be observed that, in agreement with the theory, 
the final products were obtained in relatively  low yields and with molecular weights in the order of 
a few thousands, that is, significantly lower that those usually  achieved by  linear PAAs. In front of 
this, each polymer molecule had multiple chain ends carrying only  one type of reactive function, 
either amine or activated double bond according to the excess function present in the polymeriza-
tion recipe. This opens the way to further functionalization useful for the synthesis of tailor-made 
polymers.
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17 Odian, G., Principles of polymerization, Wiley Intersci., New York, 2004, p 106.
4.3 POLYAMIDOAMINE-BASED MULTILAYER NANOPARTICLES AS POTENTIAL GENE 
AND PROTEIN DELIVERY SYSTEM 
The investigation reported in this section concerned PAAs affording to multilayer nanoparticles via 
their layer-by-layer self-assembling in aqueous solutions at pH 7.4. Four PAAs, named ISA1, AG-
MA1, ISA23 and BACEDDA,18 19 were synthesized, with or without spin label (TEMPO), as pre-
viously described in order to obtain four couple of oppositely charged polyelectrolytes, namely 
ISA1/ISA23, ISA1/BACEDDA, AGMA1/ISA23 and AGMA1/BACEDDA, able to form nanoparti-
cles when mixed at proper charge ratio. Their salient characteristics are shown in Table 4.3 A. 
Table 4.3 A. Equivalent charge per mol of the PAAs at 
pH 7.4.
Sample
Cationic 
(charge/mol)
Anionic 
(charge/mol)
ISA1 1.020 -
AGMA1 0.529 -
ISA23 - 0.333
BACEDDA - 1.979
Table 4. Equivalent charge per mol of the polymers at pH 7.4
22
Briefly, ISA1 and BACEDDA are purely cationic and purely  anionic, respectively; whereas ISA23 
and AGMA1 are amphoteric polyelectrolytes able to change their average charge as function of the 
pH. In particular, at pH 7.4 ISA23 is prevailingly anionic and AGMA1 is prevailingly  cationic. 
Among PAAs, these were chosen because of their widely assessed high biocompatibility.
Core formation at different charge ratios (pH 7.4). Attempts were performed to prepare different 
nanoparticles from the four PAAs at different cationic/anionic mole ratio, for screening the best 
conditions in which stable and small cores could be made. At pH 7.4, ISA1 bears a full positive 
charge per monomer unit, whereas ISA23 is negatively charged, but less so, -0.33/monomer unit 
(Table 4.3 A). When used to prepare the core for subsequent particles, these two polymers form 
structures that are circa 1.0 (± 0.2) µm in diameter, with a surface charge of -20.0 (± 7.0) mV, with 
no obvious correlation of these properties on cationic to anionic monomer mole ratio ([cat]/[an]), 
Figure 4.3 A. For the ISA1/BACEDDA pair, where the latter polymer is anionic but bears twice as 
much charge/monomer as the cationic component ISA1 (-1/monomer), the complexes formed from 
these two polymers are much smaller than the ISA1/ISA23 pair, namely 0.5 (±0.1) µm in diameter, 
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18 Richardson, S.; Ferruti, P.; Duncan, R., J. Drug Targeting, 1999, 6, 391-404.
19 Ranucci, E.; Ferruti, P.; Lattanzio, E.; Manfredi, A.; Rossi, M. Mussini, P.; et al., J. Polym. Sci.: Part A:Polym. Chem., 2009, 47, 6977-6991.
with a surface charge that increases from -40.0 (± 5.0) to +10 (± 5.0) mV with increasing cationic/
anionic mole ratio, Figure 4.3 B.
37 
 
Cation/anion molar ratio
0.1 1 10
!
-p
o
te
n
ti
a
l 
/ 
m
V
-30
-20
-10
0
10
P
a
rt
ic
le
 s
iz
e
 /
 n
m
0
250
500
750
1000
1250
!-potential / mV 
Particle size /nm 
 
Figure S1a; !-potential and particle size for nanoparticles formed from NP1 (ISA1/ISA23) as a 
function of mole ratio. 
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Figure 4.3 A. ζ-potential and particle size for nanoparticles formed from NP1 (ISA1/ISA23) as a function of mole ratio.
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Figure S1b; !-potential and particle size for nanoparticles formed from NP2 (ISA1/BACEDDA) 
as a function of mole ratio. 
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Figure 4.3 B. ζ-potential and particle size for nanoparticles formed from NP2 (ISA1/BACEDDA) as a function of mole 
ratio.
The particle size goes through a minimum around [cat]/[an] = 0.4. Similarly, the AGMA1/ISA23 
pair show a pronounced dependence of size and surface charge on composition, with the size in-
creasing from 200 to 600 (± 50.0) nm and the charge -15 to +3 (± 5.0) mV, reflecting the relative 
charges on the AGMA1 (+0.5/monomer) and ISA23 (-0.33/monomer) units, Figure 4.3 C. For this 
system, the minimum in particle size is shifted towards lower [cat]/[an] = 0.2. Finally, for the 
AGMA1/BACEDDA complexes, there is a pronounced switch from anionic surface charge to cati-
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onic surface charge with increasing cationic/anionic ratio, passing through the point of zero charge 
(PZC) at a mole ratio of 2, roughly  consistent with the relative charges on the AGMA1 
(+0.5/monomer) and BACEDDA (-2/monomer) monomer units. Here, the size of the complex mir-
rors the charge, increasing with mole ratio, Figure 4.3 D. Again a minimum is seen in the particle 
size vs composition dependence, but at a [cat]/[an] = 0.5.
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Figure S1c; !-potential and particle size for nanoparticles formed from NP3 (AGMA1/ISA23) 
as a function of mole ratio. 
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Figure 4.3 C. ζ-potential and particle size for nanoparticles formed from NP3 (AGMA1/ISA23) as a function of mole 
ratio.
At high values of [cat]/[an], viz5-8, the charge on the particles follows the order ISA1/ISA23 < 
AGMA1/ISA23 < ISA1/BACEDDA < AGMA1/BACEDDA whereas at low values of [cat]/[an], the 
order is somewhat different AGMA1/BACEDDA < ISA1/BACEDDA < ISA1/ISA23 < AGMA1/
ISA23; both of these trends are consistent with the charge on the respective monomers at pH 7.4 
[ISA1 (+1), AGMA1 (+0.5), ISA23 (-0.33), BACEDDA (-2)].
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Figure S1d; !-potential and particle size for nanoparticles formed from NP4 
(AGMA1/BACEDDA) as a function of mole ratio. 
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Figure 4.3 D. ζ-potential and particle size for nanoparticles formed from NP4 (AGMA1/BACEDDA) as a function of 
mole ratio. 
Formation of multilayer nanoparticles (pH 7.4). Given this detailed knowledge of the charge and 
size of these polymer-polymer complexes, a fixed ratio of two oppositely  charged polymers was 
selected in the various combinations, to form the core of the particles on which to build the layer-
by-layer assemblies. Such self-assembling structures were formed successfully from all combina-
tions of these polymers, with three nanoparticle assemblies (ISA1/BACEDDA – NP2; ISA23/
AGMA1 – NP3; AGMA1/BACEDDA – NP4) showing charge inversion through the various layers, 
and some electrostatic induced collapse of the particle size, Figures 4.3 E-H. 
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Figure 1a; !-potential and particle size for nanoparticles formed from NP1 (ISA1/ISA23) 
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Figure 4.3 E. ζ-potential and particle size for nanoparticles formed from NP1 (ISA1/ISA23).
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Figure 1b; !-potential and particle size for nanoparticles formed from NP2 (ISA1/BACEDDA) 
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Figure 4.3 F. ζ-potential and particle size for nanoparticles formed from NP2 (ISA1/BACEDDA).
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Figure 1c; !-potential and particle size for nanoparticles formed from NP3 (ISA23/AGMA1) 
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Figure 4.3 G. ζ-potential and particle ze for nanoparticles formed from NP3 (AGMA1/ISA23).
The ISA1/ISA23 (NP1) combination showed no such charge inversion, and we conclude that stable 
nanoparticles were not formed. Charge inversion arises due to the presence of excess of either the 
cationic or anion charge within the alternating layers. For NP2, NP3 and NP4, the absolute zeta-
potential and the change in that potential as the layer number increases are greater when the differ-
ence in charge/monomer is largest c.f. Figure 4.3 F, NP2 formed from the combination of the +1 
charge on ISA1 and the -2 on BACEDDA and Figure 4.3 G, NP3 formed from the +0.5 charge on 
AGMA1 and -0.33 on ISA23. The seemingly erratic increase in particle size is a manifestation of an 
expansion of the structure as the layers are built up, with a smaller superimposed collapse ascribed 
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to an electrostatically driven association of the oppositely charged monomers, with the greatest ef-
fect imposed by the much greater charge density of the anionic component.
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Figure 1d; !-potential and particle size for nanoparticles formed from NP4 
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Figure 4.3 H. ζ-potential and particle size for nanoparticles formed from NP4 (AGMA11/BACEDDA). 
One approach to quantify the structure and dynamics within the various layers forming the multi-
layer particles is to use an EPR label grafted to one of the polymers located within a specific layer. 
Here, TEMPO-labelled versions of ISA23, ISA1 and AGMA1 have been incorporated into the par-
ticles, as per Scheme 4.3 A. The spin-labelled nanoparticles obtained by using these method are re-
ported in Table 4.3 B.
14 
 
 
 
 
 
 
Scheme 1; Nomenclature pertaining to the location of the spin-label within the multi-layer 
nanoparticles. The anionic core particle is defined as n=1, such that the first in this example, 
cationic polymer layer corresponds to n=2, the second to n=4, whereas the anionic polymer 
layer is n=3, the second n=5 etc. 
 
Two independent quantities are measurable in an EPR spin-label experiment, the hyperfine 
coupling constant (polarity) sensed by the spin-label (defined largely by the degree of 
hydration) and the rotational correlation time, the former extracted from the position of the 
resonance lines, the latter from the lineshapes, figures 2a-d. Also presented for comparison, 
is the equivalent parameter for the TEMPO-labelled polymer in free solution, i.e. in the 
absence of any second complexing polymer.  
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Scheme 4.3 A. Nomenclature pertaining to the location of the spin-label within the multi-layer nanoparticles. The ani-
onic core particle is defined as n=1, such that the first i this example, cationic polymer layer corresponds to n=2,  the 
second to n=4, whereas the anionic polymers is n=3.
Results and Discussion
136
Table 4.3 B. Spin-labelled multilayer (4 layer) nanoparticles obtained at pH 
7.4 labelled in the core (NP1{n=1}), (NP2 {n=1}), (NP3{n=1}), in the first 
(NP1{n=2}), (NP2 {n=2}), (NP3{n=2}) and in the third (NP1{n=4}), (NP2 
{n=4}), (NP3{n=4}).
Sample ISA1 AGMA1 ISA23 BACEDDA
NP1{n=1} + - (+) -
NP1{n=2} + - (+) -
NP1{n=4} + - (+) -
NP2{n=1} (+) - - +
NP2{n=2} (+) - - +
NP2{n=4} (+) - - +
NP3{n=1} - (+) + -
NP3{n=2] - (+) + -
NP3{n=4} - (+) + -
NP4{n=1} - (+) - +
NP4{n=2} - (+) - +
NP4{n=4} - (+) - +
Table 5. Spin-labelled multilayer (4 layer) nanoparticles obtained at pH 7.4 labelled in 
the  core  (NP1{n=1},  NP2{n=1},  NP3{n=1},  NP4{n=1}),  in  the  first  (NP1{n=2}, 
NP2{n=2},  NP3{n=2},  NP4{n=2},)  and in  the third  (NP1{n=4},NP2{n=4},  NP3{n=4}, 
NP4{n=4}, layer. The spin-labelled probe is reported in parentheses.
23
The spin-labelled probe is reported in parentheses.
Two independent quantities are measurable in an EPR spin-label experiment, the hyperfine coupling 
constant (polarity) sensed by the spin-label (defined largely by the degree of hydration) and the ro-
tational correlation time, the former extracted from the position of the resonance lines, the latter 
from the lineshapes, Figures 4.  I-M. Also presented for comparison, is the equivalent parameter for 
the TEMPO-labelled polymer in free solution, i.e. in the absence of any second complexing poly-
mer.
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Figure 2a; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) as a function of label position for nanoparticles formed from NP1 (ISA1/ISA23). The 
dotted line corresponds to the hyperfine coupling constant for the labelled polymer in 
solution, whereas the dashed line is the rotational correlation time. 
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Figure 4.3 I. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) as a function 
of label position for nanoparticles formed from NP1 (ISA1/ISA23).  The dotted line corresponds to the hyperfine cou-
pling constant for the labelled polymer in solution, whereas the dashed line is its rotational correlation time.
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Figure 2b; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) as a function of label position for nanoparticles formed from NP2 (ISA1/BACEDDA). 
The dotted line corresponds to the hyperfine coupling constant for the labelled polymer in 
solution, whereas the dashed line is the rotational correlation time. 
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Figure 4.3 K. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) as a function 
of label position for nanoparticles formed from NP2 (ISA1/BACEDDA). The dotted line corresponds to the hyperfine 
coupling constant for the labelled polymer in solution, whereas the dashed line is its rotational correlation time.
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Figure 2c; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) as a function of label position for nanoparticles formed from NP3 (ISA23/AGMA1). 
The dotted line corresponds to the hyperfine coupling constant for the labelled polymer in 
solution, whereas the dashed line is the rotational correlation time. 
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Figure 4.3 L. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) as a function 
of label position for nanoparticles formed from NP3 (AGMA1/ISA23). The dotted line corresponds to the hyperfine 
coupling constant for the la elled polymer in solution, whereas the dashe line is its rotational correlation time.
For NP2, NP3 and NP4, the rotational correlation time for the TEMPO label in layer i (τri) in-
creases with increasing layer number in all three cases. Interestingly, τrcore is smaller than the 
equivalent value for the corresponding polymer in solution, τrsoln, implying that the probe experi-
ences a more mobile environment within the core compared to the solution environment. As the 
layers are built up, τri increases (τrcore< τr1 < τr3) and appears to reach a value that is comparable 
to (NP4) or slightly greater than τrsoln (NP2,3). Since a long correlation time corresponds to slow 
motion, the increasing correlation time corresponds to a decrease in mobility. For these three nano-
particles, this implies that the core environment is rather mobile, and that the polymer chains added 
to the periphery of the particle are somewhat less mobile than the core suggesting a densification of 
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the outer layers. Changes in the polarity  sensed by the probe in the various locations as the particles 
are built  up are small. For NP1, NP2 and NP3, the polarity decreases from the core to the first layer 
but subsequently increase in the third layer.
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Figure 2d; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) as a function of label position for nanoparticles formed from NP4 
(AGMA1/BACEDDA). The dotted line corresponds to the hyperfine coupling constant for the 
labelled polymer in solution, whereas the dashed line is the rotational correlation time. 
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Figure 4.3 M. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) as a function 
of label position for nanoparticles formed from NP4 (AGAM1/BACEDDA). The dotted line corresponds to the hyper-
fine coupling constant for the labelled polymer in solution, whereas the dashed line is its rotational correlation time.
For NP4, a maximum (rather than a minimum) is shown in polarity within layer n=2. These two 
combined EPR insights, coupled with the particle size/zeta-potential analysis, imply  that NP2, NP3 
and NP4 possess rather loose, flexible internal structures that are somewhat similar to the polymer 
in solution, with some collapse of the polymer structure around the surface of the particle. They  are 
rather different to solid-core nanoparticles. This flexible character has interesting implications for 
their ability  to solubilise and release any  encapsulated material. For NP1, the structures formed 
from ISA1/ISA23 show a behavior that is analogous to the labelled ISA23, and we conclude that 
these structures are rather ill-defined and consequently, were not further considered. 
Cytotoxicyty assay of Multilayer Nanoparticles. All multilayer nanoparticles described herein were 
evaluated from the toxicity  point of view on B16 and VERO cells. The MTT assay  was performed 
to quantify the cell viability after incubation for 68 hours at 37 °C at concentration whitin 0.5-5 mg/
ml. The cytotoxicyties (IC50) of all four samples (the three nanoparticles NP2, NP3 and NP4, as 
well as the structures present in the NP1 mixture) were found to be largely independent of the 
nanoparticle structure and type, Figure 4.3 N, much higher than PEI controls, and comparable to the 
cytotoxicity of the component polymers themselves20.
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20 Richardson, S.; Ferruti, P.; Duncan, R., J. Drug Targeting, 1999, 6, 391-404.
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Figure S4; IC50 for the nanoparticles studied here in epithelial (Vero) and murine (B16) cells.  
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Figure 4.3 N. IC50 for the nanoparticles studied here in epithelial (Vero) and murine (B16) cells.
Nanoparticle disassembly. In ord r to understand how t  nanoparticle will disassemble in solution, 
the interaction of the labelled polymers in solution and in various layers within the nanoparticles 
has been examined in the presence of common surfactants. The interaction of the simple TEMPO-
labelled polymers with the anionic surfactant sodium dodecylsulphate, SDS, or the cationic surfac-
tant cetyltrimethylammonium bromide, CTAB, was first examined, Figures 4.3 O and 4.3 P. Clearly, 
the rotational correlation time is unchanged on addition of SDS for ISA23, which can be understood 
as found previously, by a lack of an interaction due to the anionic nature of both polymer and sur-
factant. The other two polymers, ISA1 and AGMA1, show a decrease in correlation time with in-
creasing [SDS], at least above [SDS] = 0.5 mM, indicating the onset of surfactant  binding. Below 
that value, the rotational correlation time for the TEMPO probe is unchanged for AGMA1, imply-
ing that the critical amount of SDS for an interaction (CMC(1)) is 0.5 mM, and that CMC(1) in-
creases slightly for ISA1 consistent with its greater cationic character. A similar response may be 
induced in the ISA23 case by addition of the cationic surfactant, CTAB, highlighting the electro-
static nature of the interaction.
Results and Discussion
140
41 
 
Concentration of sodium dodecylsulphate, [SDS] / mM
0 1
R
o
ta
ti
o
n
a
l 
c
o
rr
e
la
ti
o
n
 t
im
e
 /
 s
1e-10
1e-9
ISA1
ISA23
AGMA1
 
 
Figure S2; Rotational correlation time for parent polymers in the presence of sodium 
dodecylsulphate, SDS.  
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Figure 4.3 O. Rotational correlation time for parent polymers in the presence of sodium dodecylsulphate (SDS).
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Figure S3; Rotational correlation time for ISA23 in the presence of cetryltrimethylammonium 
bromide, CTAB.  
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Figure 4.3 P. Rotational correlation ti  for ISA23 in the presence of cetyltrimethylam onium bromide (CTAB).
For the nanoparticles, figures 4.3 Q-S, there is a general increase in the rotational correlation time 
with increasing [SDS], indicating that the spin-label is reported a more rigid environment. The po-
larity behavior is rather more complex, but in essence, the polarity rises to a maximum – more hy-
drated - before subsequently starting to decrease at  high [SDS]. Over this surfactant concentration 
range, it is probable that there is not full dissolution of the nanoparticle, but the anionic surfactant is 
complexing with the cationic polymer, making the polymer conformation around the spin-label 
rather rigid but hydrated given the ionic interaction.
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Figure 3a; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) for nanoparticles formed from NP2 (ISA1/BACEDDA) in the presence of sodium 
dodecylsulphate, SDS.  
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Figure 4.3 Q. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) for nanopar-
ticles formed from NP2 (ISA1/BACEDDA) in the presence of sodium dodecylsulphete (SDS).
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Figure 3b; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) for nanoparticles formed from NP3 (ISA23/AGMA1) in the presence of sodium 
dodecylsulphate, SDS. 
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Figure 4.3 R. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) for nanopar-
ticles formed from NP3 (AGMA1/ISA23) in the presence of sodium dodecylsulphete (SDS).
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Figure 3c; Hyperfine coupling constant (open symbols) and rotational correlation time (filled 
symbols) for nanoparticles formed from NP4 (AGMA1/BACEDDA) in the presence of sodium 
dodecylsulphate, SDS. 
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Figure 4.3 S. Hyperfine coupling constant (open symbols) and rotational correlation time (filled symbols) for nanoparti-
cles formed from NP4 (AGMA1/BACEDDA) in the presence of sodium dodecylsulphete (SDS).
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4.4 ISA23-BSA CONJUGATE AS ANTIMALARIAL DELIVERY SYSTEM
BAC-MP, previously mentioned in the section 4.1, was chosen as hetero-difunctional dimer for syn-
thesizing PAA-protein graft copolymers because the resultant polymer shell (ISA23) was found to 
be highly biocompatible and stealth-like.21 BSA was chosen because of its binding ability against 
drugs and its high molecular weight that ensures a suitable clearance of the payloaded drug. In spite 
of the fact that it usually  binds acidic drugs, we expected acidic moyety of ISA23 shell to provide 
binding ability  towards basic drugs, such as primaquine and chloroquine. This was simply  achieved 
by triggering the BAC-MP polymerization in aqueous medium in the presence of BSA that partici-
pated in the polymerization through its exposed NH2 and SH groups (Scheme 4.4 A). The occur-
rence of BAC-MP grafting onto BSA was evaluated by SEC connected in series with RI, light scat-
tering and viscometric detectors.
Four-arm star-like PAAs (BP-MP-C and B C-MP-C) were
synthesized from BP-MP and BAC-MP and 1,4,8,11-tetraa-
zacyclotetradecane (cyclam; Scheme 5). The polymeriza-
tion reactions were performed, as usual, in aqueous solu-
tion at pH 9 and monitored by 1H NMR. The products
were isolated when the signals attributed to the double
bond hydrogens fell below the instrument’s detection
threshold.
In the case of BP-MP-C, the adopted HDD/cyclam molar ratio
was 10. The Mn of the product was 3300, with Mw/Mn 1.21.
These values were in close agreement with the values of
3400 and 1.29 calculated from the classic literature’s formu-
las18,19 extrapolated for p ¼ 1 (eqs 2 and 3):
!Xn ¼ ðfrpþ 1$ rpÞð1$ rpÞ (2)
!Xw
!Xn
¼ 1þ frpðfrpþ 1$ rpÞ2 (3)
where f is the number of reactive functions of the multifunc-
tional monomer (four for cyclam), r ¼ NaNb þf Nb0 , Na ¼ Nb is the
molar amount of HDD and Nb’ is the molar amount of the
multifunctional monomer. In the case of BAC-MP-C, the
adopted HDD/cyclam molar ratio was 34.2. The product had
Mn 10,800 with Mw/Mn 1.08, to be compared with the calcu-
lated values of 10,700 and 1.26. It may be observed that Mn
was in excellent agreement with the expected value, whereas
the Mw/Mn ratio was remarkably lower. In fact, the product
obtained was quasi-monodisperse. Interestingly, this effect
was not observed with BP-MP, suggesting that the zwitterionic
nature of BAC-MP was largely responsible for it. Possibly,
BAC-MP reversibly interacted with cyclam, resulting in a local
catalytic activity of the latter favoring the growth of the
chains attached to it over that of ‘‘free’’ molecular species.
Thus, the behavior of the BAC-MP/cyclam system as regards
the molecular weight distribution of the resultant polymer
approached that of a cyclic monomer growing on a multifunc-
tional center. The LCB frequency of BP-MP-C and BAC-MP-C
was determined by SEC connected in series with refractive
index (RI), light scattering, and viscometric detectors (see Ex-
perimental) and found in both cases of & two side chains per
macromolecule. This LCB frequency value was consistent with
the expected four-arm architecture originating from a cyclam
core.
BAC-P, BAC-MP, BP-P, and BSA were chosen as model HDDs
and pr tein for the preparation of PAA-protein gr ft copoly-
mers. This was simply achieved by triggering the HDD poly-
merization in aqueous medium in the presence of BSA that
participated in the polymerization through its exposed NH2
and SH groups. To give an example, the synthesis of BAC-
MP-g-BSA is reported in Scheme 6.
The occurrence of PAA grafting onto BSA was evaluated by
SEC connected in series with RI, light scattering, and visco-
metric detectors. The data, reported in Table 2, provided clear
evidence of the increasing of the molecular weight of copoly-
mers with respect to native BSA, always accompanied by low
polydispersities and higher values of the Mark–Houwink con-
stants, hence higher hydrodynamic radii. A further
SCHEME 5 Synthesis of four-arm star-like PAAs from BP-MP
and BAC-MP and cyclam.
SCHEME 6 Synthesis of BAC-MP-g-BSA by polymerization of BAC-MP in the presence of BSA.
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Scheme 4.4 A. Synthesis of ISA23-BSA conjugate by polymerization of BAC-MP in the presence of BSA. The BAC-
MP dimer was obtained as previously described in chapter 4.1.
The data, reported in Table 4.4 A, provided clear evidence of the increasing of the molecular weight 
of the copolymer with respect to native BSA, always accompanied by low polydisperisities and 
higher values of the Mark-Houwink constants, hence higher hydrodynamic radii. 
Table 4.4 A. Molecular weight and viscosimetric data of BAC-MP-g-BSA 
sample compared with BSA.
confirmation was provided by the far higher solubility in
aqueous media of the copolymers compared with virgin BSA.
The BP-P-g-BSA copolymer was further characterized by
comparing the tracing of its potentiometric titrations with
those of virgin BSA/linear BP-P mixtures of known composi-
tion (Fig. 3), as previously reported.13 The titration curves of
the copolymer and of the BSA/BP-P mixtures exhibited two
evident inflections at pH values close to the inflections of the
BP-P titration curve, whereas the BSA curve was character-
ized by a semicontinuous decrease of pH on acid addition
without clearly detectable inflections. Considering that the
amine character of the albumin ANH2 groups involved in the
grafting reaction is preserved, we may reasonably suppose
that PAA/BSA mixtures are good models for PAA-grafted al-
bumin, as far as titration is concerned. Therefore, from the
family of titration curves reported in Figure 3, the PAA con-
tent in the grafted product can be determined as ! 20% by
weight. This value was consistent with the molecular weight
difference of the BP-P-g-BSA copolymer with respect that of
BSA (calculated 18,000, experimentally found 21,100).
Assuming that no BP-P was present, as the copolymer had
been extensively ultrafiltered through a membrane with mo-
lecular weight cut-off 50,000, this correspondence confirmed
that grafting reaction occurred as expected. No titration
experiments were performed with BAC-MP-g-BSA and BAC-
P-g-BSA as the acid–base properties of BAC-MP and BAC-P
are close to those of BSA.
‘‘Tadpole-like’’ PAA-cholesterol amphiphiles were obtained by
performing the polymerization of HDDs in the presence of
TC, which participates in the Michael polyaddition through
its SH group (Scheme 7).
These reaction systems closely resembled the preparation of
mono-functional PAAs by copolymerization of HDDs with
monofunctional amines or acrylamides, as the SH group
reacts with activated double bonds in the same way as the
amine groups.20,21 Being TC insoluble in water, the prepara-
tions of HDD-TC conjugates were performed in a diethy-
lether/water slurry. TC resided in the former solvent and the
HDDs in the latter. The two solutions were vigorously stirred
under nitrogen at room temperature in a closed vessel until
the signals due to the acrylic hydrogens of bisacrylamides
were no longer detectable in the 1H NMR spectra of the
aqueous phases. The feasibility of this process was ascer-
tained with BAC-MP, MBA-P, BP-P, and BP-MP. A 10:1 HDD/
TC molar ratio was used for obtaining polymers with 10
repeating units of HDD per TC molecule. This value was cho-
sen because literature data22,23 suggested it as leading to a
suitable hydrophilic/lipophilic balance to form and hydro-
phobically stabilize polyelectrolyte emulsions. In the case of
BAC-MP-TC and MBA-P-TC, their amphiphilic nature led to
phase segregation both in aqueous media and organic sol-
vents. Consequently, their 1H NMR spectra showed neither
traces of the PAA backbone in deuterated water, nor of the
cholesterol moiety in deuterated chloroform, as expected.
BP-P turned to be hardly soluble in both solvents, probably
due to the tendency of the BP-P chain to crystallize (data not
shown). Only in the case of BP-MP-TC both components were
soluble in deuterated chloroform. This allowed obtaining
clear homogeneous solutions and running 1H NMR spectra in
this solvent. These spectra did not significantly differ from
those of a previously synthesized BP-MP PAA carrying pendant
TC moieties24 and showed the presence of the diagnostic peaks
of both components. The calculated and experimentally
FIGURE 3 Potentiometric titration curves of BP-P-g-BSA copol-
ymer and of BSA/linear BP-P mixtures of known composition.
TABLE 2 Molecular Weight and Viscometric Data of
PAA-Grafted BSA Samples Compared with BSA
Sample Mn
a Mw/Mn
b
[g]c
(dL/g) ad log Ke
Rh
f
(nm)
BSA 67,000 1.04 0.054 0.034 "1.45 3.92
BAC-MP-g-BSA 1,01,000 1.07 0.067 0.203 "2.74 6.1
BAC-P-g-BSA 84,900 1.17 0.053 0.265 "2.58 4.11
BP-P-g-BSA 88,100 1.14 0.083 0.163 "2.04 5.90
a Number average molecular weight.
b Polydispersity index.
c Intrinsic viscosity.
d,e Mark–Houwink constants.
f Hydrodynamic radius.
SCHEME 7 Synthesis of ‘‘tadpole-like’’ PAA-cholesterol amphiphiles by polymerization of HDDs in the presence of TC.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG ARTICLE
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY 2012, 000, 000–000 9
a Number average molecular weight; b Polydispersity index; c Intrinsic vis-
cosity; d,e Mark-Houwink const nts; f Hydrodynamic radius.
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A further confirmation was provided by the far higher solubility in aqueous media of the copoly-
mers compared with virgin BSA. The copolymer size was also investigated by cryo-TEM  analysis, 
that showed a quasi-spherical shape of the polymeric nanovector (Figure 4.4 A). This point out that 
this system might efficiently circulate throughout the body  for reaching specific cell districts, with-
out leading to thrombosis-like events caused by shear stress after intravenous administration.22 23 
Furthermore, it  is generally recognized that nanoparticles with dimensions in the range 200-300 nm 
may be internalized into cells in vitro, but are unsuitable for in vivo use, whereas 150 nm represents 
the highest threshold size value for nonspecific cell uptake in vivo.
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Figure 4.4 A. cryo-TEM analysis of ISA23-BSA conjugate
The binding ability of the copolymer was evaluated by equilibrium dialysis test in which pri-
maquine (PQ) or chloroquine (CQ) solutions were dialyzed against  a solution of BSA at fixed con-
centration. The copolymer binding data are shown in Figure 4.4 B, where the absence of an out-
standing relationship between drug concentration and copolymer binding can be seen. Nevertheless, 
the percent of binding seems to decrease by  increasing the pre-dialysis concentration of the drug, 
almost certainly due to the saturation of copolymer binding sites. The binding data showed also sig-
nificant differences between CQ and PQ (59.1±1.3% vs 78.3±1.5%), giving us an insight into the 
higher affinity of the copolymer for PQ rather than CQ. The higer binding of PQ may be explained 
by the hypothesis that it can interact more easly  with the copolymer for the simple reason that it  is 
sterically favorite by the presence of a primary amine instead of a tert-amine. Furthermore, primary 
amine may form hydrogen bond, strengthening the binding to the copolymer. 
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Figure 4.4 B. Plotting of ISA23-BSA binding ability towards CQ (black) and PQ (red) obtained by equilibrium dialysis 
test.
The copolymer considered in this study was also characterized in terms of cytotoxicity on HUVEC 
cells. Figure 4.4 C (Panel A) shows the cytotoxicity profile of this sample. It can be noticed that 
ISA23-BSA conjugate was found to be definitely  non-toxic, even if compared with Dextran (95% 
availability). Owing to after intravenous injection of polyelectrolytes hemolysis can occur, the 
hemolytic activity of the copolymer was studied. Results are reported in Figure 4.4 C (Panel B).
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Figure 4.4 C. Cytotoxicity and hemolytic profile of ISA23-BSA conjugate.  Cytotoxicity on HUVEC cells (Panel A). 
Hemolysis activity of ISA23-BSA (1 mg/mL) (yellow) on RBCs by comparison with TritonX-100 (blue) and dextran 
(orange) as positive and negative control respectively (standard deviation was smaller than 4%).
As expected, no significant hemolytic activity was observed for the copolymer at  concentration of 1 
mg/mL after 24 hrs incubation in RBC with 3% hematocrit at 37 °C. Hence it combines strong 
binding ability  towards PQ and CQ with negligible cytotoxicity  and hemolytic activity up to a con-
centration of 1 mg/mL. This positive combination of properties makes the copolymer rather excep-
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tional as antimalarial nanovector and lead us to consider its as valuable candidate as PQ and CQ 
carrier not only in vitro, but also in vivo.
To assess passive targeting of the copolymer towards Plasmodium-infected red blood cells (pRBC) 
we performed in vitro immunofluorescence experiments, where Plasmodium parasites were colocal-
ized together with the polymer and RBC (Figure 4.4 D). In fact, pRBC usually shows a significant 
increasing of membrane permeability, arising from the physiological allostasis, that is liable for bio-
accumulation of such systems.
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Figure 4.4 D.  Confocal fluorescence microscopy analysis of the interaction of ISA23-BSA-FITC conjugate with in-
fected pRBCs: single confocal section (Panel A, Panel 2B). RBC plasma membrane (red), ISA23-BSA-FITC conjugate 
(green), nuclei (blue) and hemozoin (pink). Light microscopy image of the selected field (Panel 1B).
Immunofluorescence results indicated that FITC-labelled ISA23-BSA conjugate interacts preferen-
tially  with pRBC and seems to colocalize with the parasite. In addition, flow cytometry experiments 
confirmed immunofluorescence results without reservations. This results clearly highlighted a re-
markable passive targeting of the copolymer into pRBC, that can be exploited to selectively in-
crease the local concentration of CQ and PQ into pRBC providing a better efficacy  of drugs. Fur-
thermore, the higher amount of drugs inside pRBC rather than RBC and plasma avoids side effects 
and resistance mechanisms that usually jeopardize the therapeutic efficacy of the treatment. 
On account of the above considerations, we prepared two isotonic formulations of ISA23-BSA/drug 
complex, one for each drug (PQ and CQ), in PBS at pH 7.4. This was accomplished by simply mix-
ing the copolymer solution with a PBS solution of PQ or CQ dropwise, obtaining a formulation 
with 5.5% (w/w) PQ or CQ. The copolymer was found to have PQ and CQ binding ability due to 
the hinerent  properties of native BSA to bind both drugs 24 and as consequence of the presence of 
the ISA23 shell, in which carboxylic groups may electrostatically  interact with the amino group of 
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both drugs. However, it might be expected that a bit  of free drug (22% and 41% respectively) must 
be in solution as consequence of the impending thermodynamic equilibrium between three species 
(see also Figure 4.4 B):
Kd
ISA23-BSA⋅PQ                    ISA23-BSA + PQ
The amount of free drug is hardly influenced by the drug/ISA23 ratio, as it depends primarily from 
the maximum loading threshold of the polymer (11.2±0.9% and 7.9±1.1% w/w). Thus exceeding 
this threshold the drug obviously became free. 
To establish if the formulations were able to enhance the efficacy of the two drugs, we measured the 
reduction of parasitemia in vitro on pRBC after incubation for 48 h and with respect to the same 
concentration of the plane drugs. The in vitro antimalarial activity of ISA23-BSA/PQ and ISA23/
CQ formulations are reported in Figure 4.4 E as function of the logarithm of drug concentration 
(Panel A and B respectively). 
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Figure 4.4 E.  In vitro antimalarial activity of PQ and CQ formulations expressed as percentage of parasite reduction 
respective to the parasitemia of controls (%Activity). Panel A: PQ (blue line) and ISA23-BSA/PQ formulation (red line) 
formulation. Panel B: CQ (blue line) and ISA23-BSA/CQ formulation (red line).
Results obtained show significant differences between the effect  of the copolymer on PQ and CQ 
antimalarial activity. As ISA23-BSA/CQ formulation followed the same trend than that observed 
for the plane CQ (Figure 4.4 E, Panel B), in the case of ISA23-BSA/PQ sample the antimalarial ac-
tivity was slightly  higher with respect to the plane PQ, especially  at low drug concentration (Figure 
4.4 E, Panel A). The small increase in antimalarial activity  of PQ observed when encapsulated in 
ISA23-BSA conjugate can be explained considering that it can not be easily released in a mono-
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compartimental system, in which the in vitro experiments are usually  performed. In fact, in a mono-
compartimental system, where the sink condition was not held, the release of drug at equilibrium 
may not quickly occurred due to the very slow clearance of the free drug from the medium. 
Along this line, ISA23-BSA/PQ formulation was hence selected to perform further studies in vivo 
on mice. The in vivo toxicity of the copolymer was first investigated in mice with 100 mg/Kg dose 
and 200 mg/Kg dose. Results shown that it is endowed with negligible toxicity after intraperitoneal 
injection at high dose too, enabling it to be used for in vivo medical applications (Figure 4.4 F). 
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Figure 4.4 F.  Acute Toxicity in vivo of ISA23-BSA/PQ formulation (blue) after i.p. injection in mice com-
pared with PBS injection as control (orange).
The in vivo antimalarial activity  of ISA23-BSA/PQ formulation was evaluated by using a 4-days 
suppressive test, in which parasite-infected mice were treated with an intraperitoneal injection (i.p.) 
of the formulation after 2 h from the Pasmodium yoelii yoelii 17XL (Pyl) inoculation, followed  by 
identical administration for 3 days. Usually ineffective doses, that means non suitable chemother-
apy treatment, lead to mice death within four days; in contrast, the administration of a proper ther-
apy provides healthy mice avoiding death. For comparative purposes, all results were reported to-
gether the activity perceived after i.p. of the same amount of plane PQ (Figure 4.4 G). Results ob-
tained on day 4 indicate that in the lower SA23-BSA/PQ dose (6.25 mg/Kg PQ equivalent dose) 
there is an increased antimalarial activity of ISA23-BSA/PQ formulation if compared with plane 
PQ. Much as no significant difference is observed in mice treated with higher dose of drug (6.25 
mg/Kg).
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Figure 4.4 G. 4-day suppressive test on mice. In vivo antimalarial activity of plane PQ (blue) and ISA23-BSA/PQ 
formulation (orange) after 4 days. The values of the in vivo antimalarial activity (% activity) are expressed as percent-
age of parasite reduction respective to the parasitemia of controls.
Furthermore, in spite of the results observed in vitro, mice treated with ISA23-BSA/PQ formulation 
(6.25 mg/Kg daily dose of PQ) were found to be healthy  after 4 days and after 7 days they without 
doubt achieved clearance of the parasitemia. However, only 2 out of 3 mice treated with the higher 
dose of ISA23-BSA/PQ (12.5 mg/Kg daily dose of PQ) were cured. Surprisingly, the other one died 
after 2 days, maybe owing to a paroxysmal toxic effect. The apparent higher toxicity  observed for 
high dose treatment might be explained by the greater oncotic pressure due to the presence of high 
amount of copolymer, that  in some case provides water retention that might afford to cardiac in-
farct. In contrast, all mice treated with the identical amount of  the plane PQ died whitin 4 days, in-
dicating that the ISA23-BSA/PQ formulation was much more effective after i.p. administration in 
vivo. Pharmacokinetics studies should be needed to better investigate why this complex improve the 
PQ efficacy in vivo. Still this imply  that the ISA23-BSA conjugate releases the PQ payload only 
into pRBC, where the parasite is placed, holding high amount of drug only  in the site of action and 
thus avoiding resistance mechanisms. We have no data, at the present, to ascertain which specific 
mechanism allow the PQ payload from the formulation in vivo. Nevertheless, broadly speaking, it is 
reasonable to think that the clearance of the drug from plasma compartment (Sink conditions) pro-
vides suitable environment to release PQ payload from the complex at non-equilibrium circum-
stance. This also make clear to us sharp differences in antimalarial activity observed by  in vivo and 
in vitro experiments.
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4.5 POLYAMIDOAMINE HYDROGELS AS SCAFFOLDS FOR IN VITRO CULTURING OF 
PERIPHERAL NERVOUS SYSTEM CELLS
Planning structures. MBA hydrogels were prepared by polyaddition of piperazine with N,N’-
methylenebisacrylamide, using 1,2-diaminoethane as cross-linking agent (Scheme 4.5 A). 
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Scheme 1 
 
 
 
 
Scheme 4.5 A. General synthesis of MBA-P and BP-P hydrogels.
These monomers were chosen considering that the main aim of this study was to obtain hydrogels 
combining mechanical strength in the swollen state with biocompatibility. The mechanical strength 
might be expected to increase in the presence of amide hydrogen bonds and cyclic structures along 
the polymer chain. N,N’-methylenebisacrylamide provided the former and piperazine the latter. On 
the other side, the biocompatibility of PAAs is usually higher the lower their cationic charge at pH 
7.4. A library of acid-base properties of PAAs indicates that the piperazine-deriving ones are the 
weakest of all, with pKa1 and pKa2 in the order of 7.4 and 3.8, respectively, independently of the 
structure of the bisacrylamide moiety.25 Therefore, it can be predicted that at physiological pH only 
one–half of the piperazine moieties bears a positive charge, resulting in a modest density of positive 
charges along the polymer chain, on the average one every 500 Da. Moreover, the physico-chemical 
properties of the linear PAA deriving from the polyaddition of piperazine, 2-methylpiperazine or 
trans,2,5-dimethylpiperazine with N,N’-methylenebisacrylamide pointed out that only PAA deriv-
ing from piperazine is able to form highly ordered structures that can be exploited to prepare hydro-
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25 E. Ranucci, P. Ferruti, E. Lattanzio, A. Manfredi, M. Rossi, P. R. Mussini, F. Chiellini, C. Bartoli, J. Polym. Sci., Part A: Polym. Chem. 2009, 47, 
6977.
gels with suitable mechanical strenght. In particular, the higher molecular weight and the lower 
solubility in water of the piperazine-based polymer, namely MBA-P, led us to this conclusion. 
BP hydrogels were prepared by polyaddition of piperazine with N,N’-bisacryloylpiperazine, using 
1,2-diaminoethane as cross-linking agent  (Scheme 4.5 A). These monomers were chosen based on 
the knowledge on the physico-chemical and biological properties of the linear PAA deriving from 
the polyaddition of piperazine, 2-methylpiperazine or trans,2,5-dimethylpiperazine with N,N’-
bisacryloylpiperazine. Among these PAAs, that obtained with piperazine proved in preliminary  ex-
periments to be highly crystalline in the solid state and to have a strong tendency to crystallize from 
its aqueous solutions at pH ≥ 7 and at temperatures ≤ 40 °C. The latter property prompted the hy-
pothesis, later on confirmed by experiments, that it could partially  crystallize even when inserted 
into a cross-linked structure and that crystalline domains could be maintained in the swollen hydro-
gel, thus increasing the hydrogel’s strength.
Preparation and properties of linear PAAs. The linear counterparts of the hydrogels, namely MBA-
P, MBA-MP, MBA-DMP and BP-P, BP-MP and BP-DMP were prepared first  in order to obtain 
exact information on the physico-chemical polymer properties, such as for instance solubility and 
thermal behavior, thus facilitating the interpretation of the hydrogel performance. The preparation 
conditions for MBA-MP, MBA-DMP, BP-MP and BP-DMP were 2 M  concentration of both 
monomers in water at 25 °C and no added catalysts. In the case of MBA-P, the preferred reaction 
medium was ethylene glycol because in water, at the same concentration, some of the product pre-
cipitated in gel form. Gel precipitation could be avoided by performing the reaction at higher dilu-
tion, but this practice reduces the molecular weight of the resultant PAAs. In the case of BP-P, car-
rying out the polymerization reactions in aqueous solution and at room temperature, as usual for 
PAAs, after the first  reaction steps a sharp phase separation due to crystallization occurred. The sys-
tem became homogeneous on heating at 60-70 °C and at this temperature the reaction proceeded to 
some extent, as apparent from the viscosity increasing. Eventually, however, the polymer precipi-
tated again. Much interesting, BP-P was insoluble at r.t. in all common solvents, but soluble in boil-
ing water. DSC analysis revealed a melting peak centered at approximately  278 °C (see below). On 
the opposite, the others PAAs was soluble in aqueous media and high molecular weight samples 
were obtained (Table 4.5 A). They were apparently amorphous in the dry state, as revealed by DSC 
analysis. Furthermore their molecular weight follow the trend P>MP>DMP, probably  because the 
methyl group in α position to the amine bias the rate of the polyaddition reaction.
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Table 4.5 A. Number average and weight average molecular weight (Mn and Mw respectively), 
polydispersity index (Mw/Mn) and water solubility of linear PAAs.
TABLES. 
Table 1.  Reagents used in the synthesis of  PAA hydrogels. 
Sample
Water 
(mL)
MBA
(mmol)
BP 
(mmol)
BAC
(mmol)
P
(mmol)
2MP
(mmol)
DMP
(mmol)
EDA
(mmol)
MBA-P10 5.60 16.70 - 15.00 - - 0.80
MBA-P15 5.60 16.70 - 14.20 - - 1.30
MBA-P30 5.60 16.70 - 11.70 - - 2.50
MBA-P30Ca 5.60 15.00 1.70 11.70 - - 2.50
MBA-2MP10 5.60 16.70 - - 15.00 - 0.80
MBA-2MP15 5.60 16.70 - - 14.20 - 1.30
MBA-2MP30 5.60 16.70 - - 11.70 - 2.50
MBA-2MP30Ca 5.60 15.00 1.70 - 11.70 - 2.50
MBA-DMP10 5.60 16.70 - - - 15.00 0.80
MBA-DMP15 5.60 16.70 - - - 14.20 1.30
MBA-DMP30 5.60 16.70 - - - 11.70 2.50
MBA-DMP30Ca 5.60 15.00 1.70 - - 11.70 2.50
BP-P25 5.60 - 16.70 - 12.53 - - 2.09
BP-P30 5.60 - 16.70 - 11.69 - - 2.51
BP-P40 5.60 - 16.70 - 10.02 - - 3.34
a with addition of 1.7 mmol NaOH
Table 2. Molecular weight and solubility of the linear PAAs.
Sample Mn Mw Mw/Mn
Solubility a)
(mg/mL)
Solubility b)
(mg/mL)
MBA-P 109500 171000 1.56 490 > 1000
MBA-MP 38500 48900 1.27 > 1000 n.dc)
MBA-DMP 37200 52400 1.41 > 1000 n.dc)
BP-P n.dc) n.dc) n.dc) <1 645
BP-MP 22200 29100 1.31 >1000 n.dc)
BP-DMP 17100 23000 1.35 > 1000 n.dc)
a solubility of the polymer in cold water
51
a) Solubility at r.t.; b) solubility at boiling point; c) not determined 
Hydrogel synthesis. Cross-linked MBA-P and BP-P hydrogels were obtained by  partially substitut-
ing 1,2-diaminoethane for piperazine in the polymerization recipes (Scheme 4.5 A). This cross-
linking method did not introduce non-biodegradable segments in the hydrogels structure. All po-
lymerizations were performed in aqueous solution with precise stoichiometric equivalence between 
double bonds and amine hydrogens. Two hydrogel series were prepared, one for each bisacrylamide 
and, within each series, three different cross-linking degrees (calculated as the percentage of amine 
hydrogens pertaining to 1,2-diaminoethane over the total amount of N-H functions) were chosen, in 
particular 10, 15 and 30% for MBA-P hydrogels and 25, 30 and 40 % for BP-P ones. The choice of 
the cross-linking degree of the latter hydrogels was based upon preliminary experiments that al-
lowed identifying 25% as the minimum threshold value needed to ensure gelation. All reaction mix-
tures set within 30 hrs. However, in order to maximize the reaction yield, the products were isolated 
after five days. In the case of MBA-P, transparent homogeneous hydrogels were invariably  ob-
tained, with no evidence of phase separation. In the case of BP-P, partial precipitation occurred 
since the initial stages, due to the formation of crystalline domains inside the polymer network dur-
ing hydrogel formation. Nonetheless, all resultant hydrogels were elastic and pliable. As a rule, hy-
drogel samples were prepared as 10 x 10 x 0.1 cm sheets, measured on the swollen phase, although 
hydrogels in the form of solid cylinders and hollow tubes of various dimensions were also prepared 
for demonstration purposes. All hydrogels were tough and pliable irrespective of shape and dimen-
sion (Figure 4.5 A).
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Figure 4.5 A. Example of PAA hydrogels obtained with different shape: MBA-P30 tubing (A), cylinder of MBA-P10 
(B) and sheet of BP-P30 (C).
Hydrogel swelling behavior. The swelling behavior of MBA-P and BP-P hydrogels in water, PBS 
pH 7.4 and ethanol is reported in Figure 4.5 B. 
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 B. Swelling behavior of MBA hydrogels in water, PBS and ethanol: MBA-P and BP-P.
It may be observed that in the MBA-P series the equilibrium swelling decreased by increasing the 
cross-linking degree, as expected. No significant differences were observed between swelling in 
PBS and water. The swelling behavior of the BP-P hydrogels exhibited the opposite trend. This ap-
parent inconsistency was explained by the loss of crystallinity  following the formation of the poly-
mer network. Unexpectedly, this factor was not balanced by  the reduction in the mesh size normally 
causing shrinking. The hydrogel swelling turned to be pH sensitive, albeit to a minor extent for BP-
P, as shown in the diagrams reported in Figure 4.5 C. It is apparent that swelling increased from pH 
5 downward, reaching a maximum between pH 3 and 1. There is little doubt that this behavior cor-
responded to the protonation of the amine groups of the repeating units, one of which is only 
weakly  basic. Not surprisingly, the pH sensitivity was higher for the less cross-linked samples. The 
less pronounced pH sensitivity  of BP-P hydrogels was no doubt due to the presence of crystalline 
domains. 
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Figure 4.5 C. Swelling percent of the MBA-P and BP-P hydrogels at different pH. For MBA-P series: 10% cross-linker 
(■), 15% cross-linker (●) and 30% cross-linker (▶). For BP-P series: 25% cross-linker (□), 30% cross-linker (○) and 
40% cross-linker (?).
Degradation kinetics. The hydrogel degradation rate was studied at 37 °C in PBS buffer pH 7.4. 
The variations of the percent residual weight and swelling on time of the hydrogels are reported in 
Figure 4.5 D. 
! "#
!
!
!"#$%&'()!$%&'()(*+,-!.',/+0%1!+-!234!.5!678!(-)!96!:;!,/!<3=>2?@!A=BC!<3=>2?D!A3B!<3=>
29@!A;BC!32>2"D!A$BC!32>29@!AEB!32>28@!AFB7!!"G!AH0(IJ!1KLH,0B!(-)!"#G!A'%)!1KLH,0B7!
!
!
!"#$%&'*)!$4;!.',/+0%1!,/!32>2!MK)',&%01!HK!I,L.('+1,-!N+*M!*M%!0+-%('!32>2O!32>2"D!!A0+&M*!
.P'.0%!0+-%BC!32>29@!A&'%%-!0+-%BC!32>28@!A'%)!0+-%B!(-)!0+-%('!32>2!AH0(IJ!),**%)!0+-%B7!!
'
Page 29 of 42
ACS Paragon Plus Environment
Biomacromolecules
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 4.5 D. Degradation profiles in PBS and 37 °C of MBA-P10 (A), MBA-P15 (B) MBA-P30 (C), BP-P25 (D), BP-
P-30, and BP-P40. SW% (black symbol) and Wr% (red symbol).
Under the above conditions MBA-P10 dissolved completely  within 35 days, but the dissolution 
times of MBA-P15 and MBA-P30 were higher than 48 days. The intersection of the swelling and 
the residual weight curves provided a comparative estimate of the degradation rate. In fact, the for-
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mer increased and the latter decreased as effect of the progressive bond cleavage, resulting in two 
curves whose slopes were of opposite sign and of absolute values higher the faster the sample de-
graded. Both curves obviously  vanished after a certain degradation degree, when the samples dis-
solved. For comparison purposes, the intersection point and dissolution time of all hydrogels are 
reported in Table 4.5 B. 
Table 4.5 B. Intersection time of the SW% and Wr% 
degradation curve of PAA hydrogels.
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Table 2. Number average and weight average molecular weight ( n and w respectively), 
polydispersity index ( w/ n) and water solubility of the linear PAAs.  
 
Hydrogel n 
 
w 
 
w / n 
 
Solubility
 a)
 
[mg · mL
!1
] 
Solubility
 b)
 
[mg · mL
!1
] 
MBA-P 109500 171000 1.56 490 >1000 
BP-P nd
c)
 nd nd <1 645 
 
a)
 Solubility at r.t; 
b)
 solubility at boiling point; 
c)
 not determined 
 
 
 
 
Table 3. Intersection time of the SW% and Wr% degradation curves of PAAs hydrogels.  
 
Hydrogel Degradation 
time 
[h] 
Intersection 
time 
[h] 
MBA-P10 780 465 
MBA-P15 >1580 790 
MBA-P30 >1580 >1580 
BP-P25 >1580 >1580 
BP-P30 >1580 >1580 
BP-P40 >1580 >1580 
 
 
 
Table 4. Degradation time of PAA hydrogels at 60 °C in PBS saline.  
 
Hydrogel Time 
[h] 
MBA-P10 96 
MBA-P15 168 
MBA-P30 816 
BP-P25 580 
BP-P30 520 
BP-P40 510 
 
Unlike the MBA hydrogels, the percent residual weight of the BP-P hydrogels decreased by  increas-
ing the cross-linking degree. In particular, after 45 days BP-P25 degraded up  to 10 wt.%, whereas 
BP-P30 and BP-P40 degraded up to 17 and 20 wt.%, respectively. This behavior followed the swel-
ling degree trend, the more swollen samples degrading faster. 
Table 4.5 C. Degradation time of PAA hydrogels 
at 60 °C in PBS.
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Table 4. Degradation time of PAA hydrogels at 60 °C in PBS saline.  
 
Hydrogel Time 
[h] 
MBA-P10 96 
MBA-P15 168 
MBA-P30 816 
BP-P25 580 
BP-P30 520 
BP-P40 510 
 
Rapid degradation tests were also carried out at 60 °C in PBS, in order to demonstrate within rea-
sonable times the complete hydrogel dissolution. The results, reported in Table 4.5 C, confirmed the 
complete degradability of all hydrogels with a trend consistent with that of the degradation experi-
ments at 37 °C. 
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Thermal characterization. The degree of crystallinity of BP-P hydrogels was evaluated by DSC 
analysis of dry  samples by comparison with linear BP-P, taken as reference. DSC profiles of both 
linear BP-P and BP-P hydrogels are shown in Figure 4.5 E. 
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Figure 4.5 E.  DSC profiles of BP-P hydrogels by comparison with the linear BP-P: BP-P25 (light purple line), BP-P30 
(green line), BP-P40 (red line) and linear BP-P (black dotted line).
All traces revealed endotherms in the range 60-110 °C due to evaporation of residual water. No 
melting peaks were observed in the trace of the totally  amorphous BP-P40, whereas both BP-P25 
and BP-P30 exhibited broad endotherms due to the melting of crystalline domains. In particular, 
BP-P25 exhibited one single endotherm with minimum at 272 °C. 
Table 4.5 D. Crystallinity degree of BP-P hydrogels obtained by DSC.
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Table 5. Cristallinity degree of BP-P hydrogels obtained by DSC. 
  
Sample Peak 1 
[°C] 
Enthalpy 1 
[J ·  g
!1
] 
Peak 2 
[°C] 
Enthalpy 2 
[J ·  g
!1
] 
Peak 3 
[°C] 
Enthalpy 3 
[J ·  g
!1
] 
%C
a)
 
 
BP-P 278.1 -166.2 - - - - 100.0 
BP-P25 272.0 -63.4 - - - - 38.2 
BP-P30 207.3 36.4 255.6 -36.7 266.6 -40.7 24.5 
BP-P40 - - - - - - 0.0 
 
a)
The cristallinity degree (%C) of the BP-P hydrogels was calculated comparing the enthalpy 
of the linear polymer with the hydrogels 
 
 
 
Table 6. Storage modulus G’ of PAA hydrogels at 10 rad · s
!1
 obtained at different 
compressive force. 
  
Hydrogel 0.2 N 0.5 N 1 N 
MBA-P10 3.9 7.5 9.5 
MBA-P15 4.2 10.3 28.9 
MBA-P30 9.7 16.7 37.6 
BP-P25 11.1 27.3 41.4 
BP-P30 24.6 34.3 55.6 
BP-P40 61.2 71.2 81.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) The crystallinity degree (%C) of the BP-P hydrogels was calculated comparing the enthalpy of 
the linear polymer (BP-P) with the hydrogels
By contrast, BP-P30 displayed a crystallization exotherm centered at 207 °C, and two partly  over-
lapping melting peaks in the range 240 – 275 °C with minima placed at 256 and 267 °C, respec-
tively, the first ascribed to the melting of the crystalline component generated during the heating 
process and the second of the native crystalline domains. The relative crystallinity  degree was cal-
culated by comparing the enthalpy of the BP-P hydrogels with linear BP-P using the following for-
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mula: (Hh/Hl)·100. Where Hl is the enthalpy of the linear BP-P and Hh  is the enthalpy of the BP-P 
based hydrogel. Results are shown in Table 4.5 D. As expected, the crystallinity  decreased by in-
creasing the hydrogel cross-linking degree, due to higher amount of amorphous-like phase gener-
ated by the replacement of piperazine with 1,2-diaminoethane. 
Confocal microscopy analysis. The confocal microscopy  analysis of BP-P hydrogels was performed 
to characterize the morphology of the crystalline domains embedded in the swollen phase of BP-
P25 and BP-P30 hydrogels. As shown in Figure 4.5 F, spherulites were observed in BP-P25 and in 
BP-P30 with average diameters of about 15 and 7 µm, respectively; whereas no presence of crystal-
lites was observed in BP-P40, in agreement with DSC data. 
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Figure 4.5 F. Confocal microscopy coupled with diffraction-limited laser beam of BP-P hydrogels: BP-P25 (Panel A), 
BP-P30 (Panel B) and BP-P40 (Panel C).
Rheological characterization. The rheological characteristics of hydrogels are key parameters to 
understand their structure and consequently their application fields. To define the linear viscoelastic 
zone, the samples were subjected to a strain sweep analysis in which they were deformed at differ-
ent shear strains at 1.0 Hz frequency, while compressive forces of 0.2, 0.5 and 1.0 N were applied to 
the samples. A typical strain sweep analysis is shown in Figure 4.5 G for sample MBA-P10. The 
shear storage modulus G’ stayed relatively constant below 1% shear strain. Above 1% shear strain, 
G’ decreased as the shear strain increased, thus indicating a transition from linear to non-linear 
behavior.26  At very high strain (>3%), the collapse of the hydrogel network was observed due to 
macroscopic damage of the sample. 
Results and Discussion
158
26 D. Ma, X. Xie, M. L. Zhang, J. Polym Sci. Part B: Polym. Phys. 2009, 47, 740.
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Figure 4.5 G. Strain sweep tests at different compressive force for MBA-P10 (Panel A): 0.2 N (■),  0.5 N (●) and 1 N 
(▲).  B. Frequency sweep tests at different compressive force for MBA-P15 (G’ solid symbol and G’’ empty symbol): 
0.2 N (□), 0.5 N (○) and 1 N (?).
Consequently, a deformation of 0.1% was chosen in the subsequent tests to ensure that each meas-
urement was made in the linear viscoelastic region. Each sample was then subjected to a frequency 
sweep over the range of frequencies from 0.1 to 10 rad · s−1. The viscoelastic behavior of all the 
samples was qualitatively similar. As illustrated for sample MBA-P15 in Figure  4.5 G, a strongly 
solid like behavior was observed (G’>> G”) and G’ was always independent of the applied fre-
quency, thus indicating the formation of well-developed cross-linked and mechanically  robust 
network.27  The frequency sweeps were repeated by applying different compressive forces and the 
storage modulus G’ was found to increase as the compressive force increased. This effect was 
probably  due to a parallel decrease of the equilibrium water content.28 The storage modulus G’ at 10 
rad · s−1, recorded during the frequency sweep tests at  different compressive forces, are collected in 
Table 4.5 E. The trend of the storage modulus G’, at the fixed compressive force of 1.0 N, as a func-
tion of the cross-linker amount for the two hydrogel series are depicted in Figure 4.5 H. In all cases, 
G’ increased with the cross-linker amount.29 30 In addition, there was a straightforward relation be-
tween the elastic modulus and the swelling degree. The elastic modulus within MBA-P series de-
creased regularly as the swelling degree increased following the decrease of the cross-linking den-
sity (Figure 4.5 H).
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27 A. S. Sarvestani, X. He, E. Jabbari, Biopolymers 2006, 85, 370.
28 E. Karpuskin, M. Dušková-Smrčková, T. Remmler, M. Lapčiková, K. Dušek, Polym. Int. 2012, 61, 328.
29 K. S. Anseth, C. N. Bowman, L. Brannon-Peppas, Biomaterials 1996, 17, 1647.
30 J. L. Trompette, E. Fabrégue, G. Cassanas, J. Polym Sci., Part B: Polym. Phys. 1997, 35, 2535.
Table 4.5 E. Storage modulus G’ of PAA hydrogels at 10 rad·s-1 
obtained at different compressive force.
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BP-P30 24.6 34.3 55.6 
BP-P40 61.2 71.2 81.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reverse behavior shown within the BP-P series, in which both the elastic modulus and the swel-
ling degree increased by increasing the cross-linking degree, was probably  related to the semicrys-
talline nature of these hydrogels. As the amount of the cross-linking agent increased, the amount of 
crystalline regions decreased, thus giving the network a great freedom to swell.
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A                                                                                     B
Figure 4.5 H. Trend of storage modulus G’ of PAA hydrogels at 10 rad·s-1 and compressive force of 1 N. Panel A: G’ as 
function of % of cross-linker; MBA-P (●) and BP-P (○).  Panel B: G’ as function of  swelling degree in PBS; MBA-P 
(●) and BP-P (○).
Biological experiments: SC culturing. To compare validity and reliability of the experiments, SC 
culture seeded on PLL-coated dishes were first  used to verify  and characterize that SC populations 
were a pure culture. Primary Schwann cultures showed a typical morphology with spindle-shaped 
bodies and bipolar processes. Moreover, SC were characterized by  immunofluorescence with spe-
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cific antibodies against the SC markers protein S100 (Figure 4.5 I, Panel A) and glycoprotein P0,31 
revealing a cell purity higher than 98 %. Additionally, SC were grown under standard culture condi-
tion (i.e. DMEM-10% FCS, forskolin 2 µM  onto TCPS PLL-coated dishes), monitored at 1, 3, 5, 7 
and 10 div and used as control for proliferation and cytocompatibility assays. As shown in Figure 
4.5 I (panels B, C and D) the SC were already at confluence at 3 div (Figure 4.5 I, panel B), 
whereas cell proliferation did not substantially changed at later times in vitro, 5 and 10 div respec-
tively (Figure 4.5 I  Panels C and D).
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Figure 4.5 I. Immunofluorescence of SC seeded on TCPS PLL-coated dishes by an antiS100 antibody revealing a cells 
purity more than 98% (Panel A). SC growth was then monitored at 3,  5 and 10 day in vitro (div). SC were at confluence 
at 3 div (Panel B), whereas cell proliferation did not substantially change at later times, 5 and 10 div respectively (pan-
els C and D). Scale bar 20 µm.
SC cytocompatibility and proliferation on hydrogels. The hydrogels were evaluated as scaffold for 
SC cultures to assess in parallel the cytocompatibility, the cell proliferation and the degradation rate 
of the material at 3, 5 and 10 div. SC at 3 div culture assumed a typical spindle-shaped morphology 
when seeded onto MBA-P10 (Figure 4.5 K). However, at  5 div SC slightly survived on MBA-P10, 
maybe due to the rapid degradation rate of the hydrogel matrix, that  did not match the proliferation 
doubling of SC, so that the substrate for the cell growing disappeared. At 3 div, SC also showed a 
normal spindle-shaped morphology when seeded onto MBA-P15 (Figure 4.5 K), although the hy-
drogel swelling biased to some extent the optical field making difficult to obtain good pictures of 
the cells. 
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31 V. Magnaghi, M. Ballabio, I.T.C. Cavarretta, W. Froestl, J. J. Lambert, I. Zucchi, R. C. Melcangi, Eur. J. Neurosci. 2004, 19, 2641.
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Figure 4.5 K. Cytocompatibility and proliferation of SC grown onto hydrogels of MBA-P10 (Panel A), MBA-P15 
(Panel B) and MBA-P30 (Panel C), at 3, 5 and 10 div. Scale bar 20 µm.
At 5 div, SC seeded onto MBA-P15 displayed a good proliferation, which apparently  increased at 
10 div. Moreover, when the SC were seeded on MBA-P30 they  presented good morphology at 3 
and 5 div (Figure 4.5 K), similar to that of TCPS PLL-coated control cultures (Figure 4.5 I) al-
though SC morphology looked better onto MBA-P30 at 10 div (Figure 4.5 K). Altogether the mor-
phological results indicated that among all hydrogels tested, the MBA-P30 apparently showed the 
best cytocompatibility for SC. Given that BP-P exhibited better physico-chemical properties, also 
the BP-P25, 30 and 40% hydrogels were evaluated as scaffold for SC culturing. The cytocompati-
bility and its correlation with the degradation rate of hydrogels was evaluated at 3, 5 and 10 div. As 
shown in Figure 4.5 L, the SC seeded onto all substrates BP-P25, 30, 40 presented the typical 
spindle-shaped morphology at 3 div, even though the cell growth appeared slightly delayed, particu-
larly on BP-P30, 40 (Figure 4.5 L). Then, the doubling of SC was apparently normal, compared to 
SC seeded onto TCPS PLL-coated dishes (Figure 4.5 I), evidencing a general good proliferation 
rate at 5 and 10 div (Figure 4.5 L). In order to support this finding the SC proliferation were quanti-
tatively evaluated at 1, 3, 5, 7 and 10 div. (Figure 4.5 M). Quantitative data were compared to SC 
plated on TCPS PLL-coated dishes, used as control (TCPS). 
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Figure 4.5 L.  Cytocompatibility and proliferation of SC grown onto hydrogels of BP-P25 (Panel A), BP-P30 (Panel B) 
and BP-P40 (Panel C), at 3, 5 and 10 div. Scale bar 20 µm.
After an initial growing phase, the SC plated on MBA-P10 and MBA-P15 showed a strong decrease 
in proliferation, at 5 and 7 div respectively (Figure 4.5 M, Panel A), in agreement with morphologi-
cal data. 
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Figure 11 
 
 
 
 
Figure 12 
 
 
 
 
 
 
Figure 4.5 M. Quantitative proliferation rate by MTS analysis of SC grown onto MBA-P10, MBA-P15, MBA-P30 
(Panel A), BP-P25, BP-P30 and BP-P40 (Panel B). Date are compared to SC grown onto TCPS PLL-coated dishes used 
as positive control. Data analyzed at 1, 3, 5, 7, 10 div were the mean SEM of experiments in triplicate. Panel A: TCPS 
(○), MBA-P10 (?), MBA-P15 (●), MBA-P30 (?). Panel B: TCPS (○), BP-P25 (?), BP-P30 (●) and BP-P40 (?).
Results and Discussion
163
Surprisingly, MBA-P30, which proved to be the best scaffold considering cell morphology, showed 
a decrease in cell proliferation at 7 div (Figure 4.5 M, Panel A). As regards the BP-P series, all sam-
ples showed an initial 5-6 div delay in growing, but later proved to be good supports for SC prolif-
eration. Among them, BP-P30 turned out to be the best scaffold with proliferation doubling of SC in 
10 div (Figure 4.5 M, Panel B).
DRG neurons cytocompatibility and proliferation on hydrogels. The sensitive neurons having their 
soma in the DRG represent another main cell population in the peripheral nervous system. [33] Not-
withstanding these neurons are generally used as reliable tool for in vitro studies of peripheral 
nerves, their preparation is rather complicated and their fairy survival very brittle. In this context, 
the ability of the most promising hydrogels, that is those of the BP-P series, to support  adhesion of 
DRG neurons and extension of neurite was investigated to evaluate whether they could promote 
nerve regeneration. The cytocompatibility  and its correlation with the hydrogel degradation rate was 
assessed at 3, 5 and 7 div (Figure 4.5 N). 
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Figure 4.5 N. Cytocompatibility and proliferation of DRG neurons grown onto BP-P25 (Panel B), BP-P30 (Panel C) 
and BP-P40 (Panel D) at 3, 5 and 7 div.  DRG neurite growth was compared to cells grown onto TCPS lamini-coated 
dishes and used as positive control (Panel A). Scale bar 20 µm.
Primary  DRG neuron cultures grown on TCPS laminin-coated dishes, showing the typical mor-
phology with rounded cell bodies, and a network of long axonal processes, were used as control. 
Neurite outgrowth was assessed using a contrast-phase microscope and evaluating parameters like 
process-bearing neurons and length of neurites. Morphological analysis showed the extent of neu-
rite outgrowth for DRG neurons in all the three types of hydrogels at 3, 5 and 7 div (Figure 4.5 N). 
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The neurite outgrowth was visibly enhanced on day 5 and 7 on BP-P30 hydrogel. These results 
were confirmed by immunofluorescence for βIII-tubulin, which showed an increase in the neuron 
sprouting and neurite length when the DRG neurons were cultured on BP-P30 (Figure 4.5 O). 
Summing up, the evidence collected on SC and DRG neuron cytocompatibility and proliferation 
indicated that among all hydrogels tested, those of the BP-P series, and in particular BP-P30, proved 
suitable substrates and definitely warrant potential as culturing scaffolds for the main cells forming 
the peripheral nerves in vivo.
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Figure 4.5 O. Immunofluorescence of DRG neurons in culture on BP-P30 at 5 and 7 div. The use of an anti-βIIItubulin 
antibody revealed a typical morphology with strong neurite sprouting and intact soma neurons. Scale bar 20 µm.
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CHAPTER 5
CONCLUSIONS
5.1 HETERO-DIFUNCTIONAL DIMERS AS BUILDING BLOCKS FOR THE SYNTHESIS OF 
POLYAMIDOAMINES WITH HETERO-DIFUNCTIONAL CHAIN TERMINALS
There was no simple method hitherto to easily prepare PAAs with differently functionalized chain 
termini, that is, PAAs solely containing molecules of a........b type.  The devised strategy to over-
come this problem was to prepare hetero-difunctional dimers (HDDs) of “aabb” type, that is, 
the mono-addition products of a bis-sec-amine to a bisacrylamide, which as strong acid salts could 
be indefinitely kept dormant in the dry state at  0-5 °C, but polymerized in aqueous media at 
pH>7.5. In this work, we report on the preparation of a selected number of HDDs and provide evi-
dence of their synthetic potential by  performing several model reactions. In particular, PAAs of con-
trolled average molecular weight and mono-functionalized with an acrylamide- or a sec-amine 
group at one end, PAAs with a star-like molecular architecture, graft-PAA-protein conjugates, 
“tadpole-like” PAA conjugates with hydrophobic moieties able to self-assemble into nanoparticles 
in aqueous media were successfully  synthesized. It should be noticed that the specificity  of the Mi-
chael addition of amines to bisacrylamides in aqueous media, shared only by  thiols under the PAA 
preparation conditions, allowed preparing most of the above derivatives by simply performing the 
polymerization of HDDs in the presence of the substrates of interest with no need of pre-
synthesizing PAAs mono-functionalized at one end with an activated double bond. This greatly 
simplified the synthetic processes negligibly  affecting the products’ characteristics. Taking every-
thing into account, it can be concluded that the aim of this research has been adequately fulfilled, 
thus demonstrating the wide synthetic potential of HDDs.
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5.2 HYPERBRANCHED POLYAMIDOAMINES FOR THE SYNTHESIS OF HIGH-
PERFORMANCE BIOMATERIALS
The critical ratio, below which the reaction leads to hyperbranched PAAs, for two systems involv-
ing different multifunctional monomers, namely cyclam (System  A) and ethylenediamine (System 
B), has been established. The polyaddition reaction for these systems followed the Flory-
Stockmayer theory. In particular, cyclam has been found to react as tetrafunctional monomer both 
with excess of amine hydrogens and with excess of double bonds. As for the ethylenediamine, it has 
proved capable to react as trifunctional monomer when reactions contained excess of amine hydro-
gens. In contrast, with excess of double bonds all hydrogens were able to react, and as a result it 
behaves like a tetrafunctional monomer. On the whole, a synthetic protocol to prepare hyper-
branched PAAs with proper molecular weight and polydispersity  was defined. Using these assump-
tions hyperbranched PAAs with multiple chain ends carrying only one type of reactive functions, 
that is to say aminic or acrylic one, have been easily prepared by modulating the stoichiometric bal-
ance of all monomers. They had a reasonable molecular weight, over the range 2.200 < Mn < 5.800, 
with moderate polydispersity. 
In view of biomedical applications, these multifunctional hyperbranched PAAs might be used for 
further specific functionalizations in order to tune their physico-chemical characteristics and bio-
logical performance. Overall, these findings provides the thrust to develop  many purpose tailoring 
biomaterials with dendrimer-like characteristics, such as for instance: self assembling systems, 
surface-targeted nanoparticles and macromolecular pro-drugs with well-defined architectures.
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5.3 POLYAMIDOAMINE-BASED MULTILAYER NANOPARTICLES AS POTENTIAL GENE 
AND PROTEIN DELIVERY SYSTEMS
A series of nanoparticles with low IC50 values suitable for the delivery  of proteins and genes have 
been prepared from oppositely charged polymers using a layer-by-layer approach. Their physical 
size, charge and internal mobility  have been characterized as a function of polymer type, composi-
tion and number of layers. This study  demonstrates that the preparation of stable dispersions of such 
particles is feasible, and from a small number of building blocks, a wide range of particles is acces-
sible. Hence, the insight derived from these results will have a wider implication for the rational 
design of such particles in the future.   
This work clearly  shows the preparation of a novel type of particle, with a modular design, formed 
from biocompatible polymers. One can easily  anticipate that this approach will allow a variety  of 
actives to be solubilized into the particles, protected and delivered by control of the structure of the 
polymer used to define the outer most layer. The design will also enable spatial separation of differ-
ent actives, where each particular active can be solubilized into a discrete layer.
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5.4 ISA23-BSA CONJUGATE AS ANTIMALARIAL DELIVERY SYSTEM
A BSA-PAA conjugate with high molecular weight have been obtained by simply self polymerizing 
an hetero-difunctional dimer, used as precursor of a well-characterized PAA named ISA23. It  was 
non-cytotoxic and non-hemolytic neither in vitro on HUVETEC and RBC cells nor in vivo (mouse 
model) after intraperitoneal administration at  100 and 200 mg/Kg doses. This has bee studied as 
macromolecular carries for in vivo administration of two antimalarial drugs, namely primaquine 
(PQ) and chloroquine (CQ). The copolymer first  proved able to efficiently bind both drugs forming 
stable complexes at equilibrium with the free drug. In particular, the binding experiments in PBS 
showed significant differences between the two drugs, PQ being more highly bound than CQ (about 
78% vs 59%). Immunofluorescence assay clearly  demonstrates that it was also able to colocalize 
with the parasite into parasite-infected RBC (pRBC). Isotonic formulations of this copolymer with 
5.5% (w/w) PQ or CQ, named ISA23-BSA/PQ and ISA-BSA/CQ respectively, were prepared in 
PBS to perform biological experiments to establish their antimalarial activity. Among the formula-
tions only ISA23-BSA/PQ was found to be able to enhance the in vitro PQ antimalarial activity. 
Hence it was selected to perform in vivo experiments in mouse model, in which it proved to cure 
mice after repeated intraperitoneal administrations. Whereas the mice treated with the same amount 
of plane PQ died within four days from the inoculation of parasites. These results outwardly  support 
the mode of action of this copolymer, that is to say, the targeting of bound PQ into pRBC and the 
increase in bioavailability.
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5.5 POLYAMIDOAMINE HYDROGELS AS SCAFFOLDS FOR IN VITRO CULTURING OF 
PERIPHERAL NERVOUS SYSTEM CELLS
The results of this research point to the conclusion that PAA hydrogels based on piperazine and 
N,N’-methylenebisacrylamide or 1,4-bisacryloylpiperazine with 1,2-diaminoethane as cross-linking 
agent combined cytocompatibility and ability to promote SC adhesion and proliferation with a set 
of tunable physico-chemical and mechanical properties, degradability and ease of fabrication, im-
parting them potential for applications as scaffolds for SC culturing and as guides for peripheral 
nerve regeneration. In particular, rheological measurements showed the formation of well-
developed cross-linked networks. The mechanical strength, always inversely  related to the swelling 
degree, was found to depend on subtle details of the macromolecular structure. In particular, the hy-
drogels of the BP-P series with moderate cross-linking degrees (BP-P25 and BP-P30) were re-
markably robust in the swollen state owing to the presence of ordered domains acting as reinforcing 
agents. As regards biological properties, BP-P30 and MBA-P30 hydrogels were able to promote SC 
proliferation for a long time, albeit following different trends. Whereas SC rapidly grew on MBA-
P30, they followed a slow but constant in vitro growing on BP-P30, that proceeded even after 10 
days. The hydrogels of the BP-P series proved good culturing scaffolds also for DRG neurons, well-
known for their fragility. The peculiar combination of favorable properties exhibited by the PAA 
hydrogels reported in this paper is seldom encountered in synthetic polymer scaffolds for peripheral 
nerve cells culturing.
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